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Abstract 
Many genes and cellular pathways have been implicated in the initiation and regulation 
of testicular differentiation, development and function. The genes generally have a 
temporal expression profile. This study aimed to characterise several of the key genes 
involved in the androgen synthetic pathway, in both normal mice and also mutant 
strains. LH receptor and 5 a reductase were the two major genes of interest. Using 
molecular biology techniques it was established that the LH receptor exists in several 
forms throughout development, with smaller, alternate-spliced forms being the 
predominant transcripts expressed in testis during fetal life. It is inconclusive from this 
study whether these spliced forms encode functional proteins, but the consistency of 
their expression patterns suggests that they do. Expression levels of the two isoforms of 
5 a reductase were found to be very low in mouse testis throughout development, and in 
addition androgen may be involved in regulation of expression of the type 1 isoform, as 
levels were significantly reduced in the AR-null mouse testis both at puberty and 
adulthood. Previously unpublished sequence from both type I and type2 5 a reductase 
transcripts was obtained using peR primers designed from rat sequence and mouse EST 
sequence. The results from this study highlight the importance specific genes play in 
regulation and expression of others and the down stream signalling pathways which 
may be involved in development and regulation of a functional testis. 
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Real time PCR results demonstrated that not only is there a temporal differences in 
expression patterns with the genes of interest throughout development, but there are also 
differences observed between the mutant and normal strains. 
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1 The Testis 
The testes are central to the male reproductive system. In most mammals the testes are 
situated externally as they function optimally at a temperature slightly cooler than that 
of the rest of the body. The testes have interrelated functions, which include the 
production of gametes (gametogenesis) and the production of steroids (steroidogenesis). 
Gametogenesis results in the formation of spermatozoa, which contain the male genes 
and contribute to the formation of new life, and steroidogenesis results in the formation 
of steroid hormones, primarily testosterone which functions in the regulation of the 
development of spermatazoa and the differentiation, growth and functional development 
of accessory reproductive glands and structures. 
The testis produces several different hormones including estrogen, activin and inhibin 
but the most important type is the androgens. Production of androgens and spermatazoa 
occurs in two separate compartments within the testes. The spermatazoa develop 
through a series of cellular differentiation stages from the precursor primordial germ 
cells. These are situated within the tubules and are in close association with the Sertoli 
cells, which at one time were also known as nurse cells, as they support and nourish the 
developing sperm. Spermatogenesis is the process by which the mature sperm are 
formed and it consists ofthree essential stages. Firstly, mitotic proliferation of the germ 
cells, in order to generate large numbers of cells. Secondly, meiotic division to create 
genetic diversity and halve the chromosome number and finally extensive cell 
modelling, to package the chromosomes for effective delivery to the oocyte. All these 
stages occur in the tubules of the testes aided by the Sertoli cells. 
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Androgen synthesis on the other hand occurs between the tubules in specialised 
steroidogenic cells. These are called the Leydig cells. Androgens are essential for sexual 
differentiation of the body during fetal life, growth and maturation of reproductive tract 
at puberty, and initiation and maintenance of spermatogenesis from puberty through to 
adult life. In addition the androgens are responsible for masculinisation of the brain and 
control of reproductive behaviour. 
Figure 1-1 Cellular components of the testis. LC = Leydig cells, SC = Sertoli cells STL = 
seminiferous tubule lumen. 
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1.1 Sexual differentiation 
The process of sexual differentiation is the commitment of a developing organism to 
follow either a male or female pathway. Different species have evolved different 
mechanisms which initiate this commitment. In invertebrates such as Drosophila 
melanogaster and Caenorhabdites elegans, sex determination is controlled by a gene 
dosage mechanism (parkhurst and Meneely 1994). Whereas in some reptilian species 
sex is determined by the surrounding temperature (Crews et aI1994). 
In mammals, a system known as male heterogamety exists within the sex chromosomes, 
with males being XY and females xx. The presence or absence of a Y chromosome 
leads to two different sex-determining pathways, which involve a series of complex 
interacting networks of genetic, cellular and hormonal signals leading to the 
development of a male or female phenotype. Development occurs in a stepwise chain of 
events, which can be divided into four essential processes. Firstly, there is the 
establishment of chromosomal sex at fertilisation also known as the genetic sex. This is 
accomplished when either an X or Y carrying sperm fertilises the oocyte and the nuclei 
of the two cells fuse leading to formation of an embryo after a series of cell divisions. 
Secondly, there is development of the undifferentiated gonads into either ovaries or 
testes (gonadal sex), This occurs due to a gene-signalling cascade which differs between 
the sexes, with the presence or absence of a Y chromosome determining which pathway 
is undertaken. Thirdly, there is differentiation of the internal duct system and external 
genitalia, which is in accordance with the gonadal sex. The last step in this 
differentiation pathway is establishment of gender. There are key areas in the brain 
which must be exposed to appropriate levels of testosterone during a critical time period 
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in development in order for male gender to be established (Gorski 1985). This is 
sometimes known as the psychological sex. In the absence of this occurring, the 
individual would adopt a female gender. 
5 
Iftestes develop, the male phenotype is controlled by two testicular hormones, 
testosterone which is produced by the fetal Leydig cells, and is required for 
differentiation of the internal duct system, and anti Mullerian hormone (AMH) 
produced by the fetal Sertoli cells, which causes regression of the Mullerian ducts. This 
step characterises the phenotypic sex. 
A single V-linked entity, the testis-determining factor (TDF), is required for 
commitment of the bipotential gonad to develop into a testis. After establishment of the 
gonads, all subsequent sexual characteristics arise as a result of the presence or absence 
of hormones produced by the testis or ovary. Pioneering experiments in this field by 
Alfred Jost in the 1940's showed that removal of the undifferentiated gonads from 
developing rabbit fetuses resulted in all rabbits developing as females (Jost 1947). lost 
showed that endocrine activity in the ovaries is not essential for sexual differentiation 
during fetal life. In contrast the testes must be present and secrete the two essential 
hormones indicated above, testosterone and AMH in order for development to proceed 
along the male pathway of differentiation. 
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1.2 Development and Differentiation of the Testes 
Many complex genetic, cellular and honnonal interactions must occur in order for 
nonnal development and function of the testis to be established. Specific gene 
expression at critical time points instructs the indifferent gonad to fonn a testis. Cells 
within will then receive various signals instructing them to differentiate in certain 
directions, these signals are from both honnonal and environmental influences. 
Gonadal development begins with ridges appearing as mesodennal proliferations along 
the medial surface of the mesonephros. (O'Rahilly and Muller 1987) The outgrowth 
from the mesonephros is tenned the gonadal ridge. Many studies since then have 
provided substantial evidence in support of mesonephric derived cells contributing 
substantially to the gonadal cell population (Beur et ai1993, Merchant-Larios 1998). 
Coelomic epithelium also has a contributory role in gonadal development and has been 
shown to give rise to the Serto1i and granulosa cells. (Karl and Capel 1998) 
The gonadal ridges appear at around 10 days post coitum (dpc) in the mouse, and are 
present as a narrow band of tightly packed cells along the mesonephros. Differentiation 
occurs at 11.5dpc in male but not female gonads. The band of tightly packed cells is 
invaded by stromal cells from the mesonephros and thus histological differences 
between male and female gonads are established. This has been shown experimentally 
in mice using gonad/mesonephros grafts, and it is suggested that interactions with 
mesonephric cells and supporting cells in the genital ridge is important for seminiferous 
cord fonnation. (Merchant-Larios et ai., 1993) 
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1.3 Genes involved in gonadal differentiation 
Many genes playa role in the initiation of sexual differentiation and subsequent 
development of the gonads. The importance of the role played can be established by 
examining the effects of absence of expression. Recent research has identified the 
following genes and expression of them at crucial times during development as essential 
for male sexual differentiation to occur. 
1.3.1 SRY 
The gene which triggers the testis determining cascade, SRY (Sex determining region, 
V), is located on the Y chromosome. It consists of a single exon with a central 
conserved motif, which was first identified in the High Mobility Group proteins (HMG) 
(Sinclair et a/1990). This motif is termed HMG-box and has DNA-binding and bending 
activities, suggesting that SRY functions as a transcriptional regulator. Subsequent 
cloning and molecular studies showed that SRY is in fact the testes determining factor 
(TDF). (Goodfellow and Lovell-Badge 1993). The evidence equating SRYwith TDF 
came from the following studies: 
1. Demonstration that some XY females had point mutations of SRY, thus underlining 
the importance of this gene in the male pathway of differentiation. (reviewed by 
Goodfellow and Lovell-badge 1993) 
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2. Production of transgenic XX male mice expressing SRY. Experimental evidence 
showed that SRY is the TDF and that presence of the entire Y chromosome is not 
necessary for male development to occur. Only key parts of it are required (Koopman et 
a/1991). 
The SRY gene encodes a protein comprising three regions, each one of approximately 
eighty amino acids. The amino terminal and carboxy terminal segments possess no 
obvious structural motifs and show no sequence homology to proteins in current 
databases; moreover, these domains appear to be evolving rapidly (Whitfield et a/1993) 
The central domain, as described above, has homology with the DNA binding HMG 
proteins and is thus referred to as the HMG binding region. SRYbelongs to a subset of 
HMG box proteins that are expressed in a tissue-specific or developmentally regulated 
manner and that preferentially bind to specific DNA sequences (Laudet et a11993) 
Molecular studies of the SRY gene have revealed two areas of expression: the adult 
testes and the embryonic gonadal ridge during differentiation. Although biochemical 
studies have failed to identify genes which regulate SRY directly, a number of genes 
appear to have a crucial role in the development of the undifferentiated gonad, these 
include: SF-I, WTI, and SOX 9. 
1.3.2 Steroidogenic Factor 1 (SF-1). 
This gene was identified initially as a transcription factor that regulates tissue-specific 
expression of the cytochrome P-450 steroid hydroxylases (Ikeda et al 1994). These are 
enzymes that catalyse most ofthe reactions required for the synthesis of steroid 
hormones. SF-J also regulates adrenal and gonadal expression of many genes involved 
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in steroidogenesis, including 3B-hydroxysteroid dehydrogenase (3PHSD), the ACTH 
receptor, and the steroidogenic acute regulatory (StAR) protein. Transgenic studies with 
knockout mice suggest that SF-l also regulates Sertoli cell expression of AMH (Shen et 
aI1994). Crucially however, SF-l knockout mice lack both gonads and adrenal glands 
(both arrest in development and regress) (Luo et a11994) and these mice develop 
phenotypically as females .. Thus SF-l is required for differentiation and development of 
the gonadal ridge 
SF-l gene expression in mice begins from day 9dpc and is absent by day 12.Sdpc in 
females, but persists in males (Ikeda et aI1994). With the onset of testicular 
differentiation, the levels of SF-l transcripts increase in both functional compartments 
of the testes: the interstitial region (i.e. androgen-producing Leydig cells) and the 
testicular cords (i.e. AMH producing Sertoli cells). Thus, it is possible that SF-l 
controls the production of both honnones required for male phenotypic differentiation 
1.3.3 Wilms Tumour (WT-1) 
The WT-l gene gets its name from its association with the childhood kidney cancer 
Wilms tumour. It is in fact a tumour suppresser gene and mutations were found to cause 
the Wilms tumour condition and/or gonadal and genital abnonnalities (Call et a11990; 
Caricasole et aI1996.) In situ hydbridisation and immunochemistry studies have shown 
WT-J is expressed at highest levels throughout the urogenital ridge in the developing 
kidney and gonad (Haber et a/1991; Annstrong et a/ 1992). It is believed to mediate 
both the outgrowth of the ureteric bud, and the response of the metanephric 
mesenchyme to the growth of the ureteric bud during kidney development. In WT-J 
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mutant mice, kidney development is arrested, the coelomic epithelium fails to thicken 
and the gonad is completely regressed by day 14.5 p.c. (Kreidberg et aI1993). These 
studies show that WT-l is essential for the very earliest stages of kidney and gonadal 
development. As far as the gonad is concerned the phenotype is very similar to that 
found with SF-l knockout mice, hence the two genes act early in gonadal development 
and perhaps interact directly (Lou et aI1994). 
1.3.4 SOX9 
Studies have shown that SOX9 is expressed in the genital ridge of both male and female 
mouse embryos at 10.5dpc. Expression of SOX9 is first detected in the cells of the sex 
cords (cord formation is the first visible indicator of testes differentiation). These cells 
then go on to become Sertoli cells. After 11.5dpc expression of SOX9 is very abundant 
in XY embryos but is absent in :xx embryos (Morais de Silva et aI1996). These 
differential patterns of expression are likely to be due to SRY. Studies have shown that 
another SOX gene, namely SOX3 suppresses the expression of SOX9, however SOX3 
expression is itself suppressed by SRY (Graves, 1998). Due to the absence therefore of 
SRY in females SOX3 is expressed and SOX9 suppressed, thus leading to development 
of ovaries and related ducts and tracts. In XY individuals suppression of SOX9 is over-
ridden by expression ofthe SRY. In humans, mutations in the SOX9 gene have been 
linked to a severe dwarfism syndrome known as campomelic dysplasia (Foster et at 
1994) Patients with this syndrome have a number of congenital and skeletal 
abnormalities and more than 75% ofXY patients show sex reversal with a gradation of 
genital defects. 
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Fibroblast growth factor 9 (FGF9) is also thought to have a role in SRY mediated 
events. It is thought to act upstream of SOX9 by initiating proliferation of the 
mesonchymal tissue and contributes to testicular cord fonnation. Absence of FGF9 
expression in mice results in a female phenotype. (Colvin et a/200t) 
1.3.5 GATA4 
11 
GATA4 is a transcription factor Which is known to play critical roles in various 
developmental processes, including hematopoietic and T cell differentiation, cardiac and 
coronary vasculature development, and liver, lung and gut morphogenesis (reviewed by 
Orkin, 2000, Molkentin, 2000, Ho and Glimcher, 2002) Recent studies have 
demonstrated that GATA4 and its co-factor FOG2 are required for gonadal 
differentiation. Mouse fetuses homozygous for a null allele of FOG2 or homozygous for 
a targeted mutation in GATA4 exhibit abnonnalities in gonadogenesis. It was shown that 
SRYtranscript levels were significantly reduced in XY FOG2(-/-) gonads at EIl.5, 
which is the time when SRYexpression normally reaches its peak in mice. In addition, 
three genes crucial for normal Sertoli cell function (SOX9, AMH and Dhh) and three 
Leydig cell steroid biosynthetic enzymes (p450scc, 3~HSD and p450c17) were not 
expressed in XY FOG2 -/- and GATA4 -/- gonads. (Tevosian et a12002) Results from 
this study clearly suggest that GAT A4 does playa crucial role in modulation of various 
genes which playa key role in the differentiation pathway. 
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Figure 1-2 Flow diagram showing the relationship of the different key genes involved in 
the initiation of the sexual differentiation pathway for both males and females. 
1.3.7 Desert Hedgehog 
The Desert hedgehog (Dhh) gene encodes a signalling molecule produced by Sertoli 
cells, (Clarke et a/2000). It is expressed in the testes, but not the ovary. It has been 
shown to have a role in testicular development. Differentiation of peritubular myoid cells 
and the consequent formation of testis cords are regulated by Dhh (Hung-Chang yao et 
al 2002). In the mouse it is first expressed in the pre Sertoli cells at around 11.5dpc, 
preceded by SRYexpression which is detectable from lO.Sdpc. The SRY transcription 
factor may even be a modulator of Dhh expression as it is the only other known male 
specific gene besides AMH to be expressed at such an early stage in development. The 
protein encoded by Dhh binds to a cell surface receptor called patched (Pte). Expression 
of the Pte gene is restricted to the Leydig cells within the testes, suggesting that Dhh 
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may have a role in their regulation. Generation of a Dhh knockout mouse demonstrated 
that homozygous null females had normal reproduction, but the males were sterile. 
(Bitgood et aI1996). Besides being sterile most of the Dhh null male mice were also 
phenotypically feminised, with evidence of mammary teats and a blind vaginal opening. 
Internally however these animals do posses testes although they are much smaller than 
normal and undescended. (Clark, et a/2000). These findings suggest that Dhh is 
required for fetal Leydig cell differentiation and that in its absence fewer Leydig cells are 
present in the fetal gonad, leading to reduced androgen production and 
pseudohermaphroditism. (Clark et a12000) 
Genital Ridge 
I 






Leydig cells ~ Sertoli cells 
~ "Dhh/ ~ 
Testosterone 
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Mullerian duct regression 
Figure 1-3 Summary diagram of key genes in gonadal development and the areas of 
expression 
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1.4 The Cells of the testis 
There are several different cell types, which are present within the testes and each type 
plays a contributory role in maintenance of function. This can be in a structural and 
supporting capacity like the peritubular myoid cells which surround the seminiferous 
tubules. Or they may be involved in hormone production and regulate spermatogenesis 
like the Leydig and Sertoli cells. Alternatively, the cells themselves can give rise to 
mature sperm through mitotic and meiotic division of the germ cells. 
1.5 Germ Cells 
14 
During gonadogenesis, precursors of the supporting and steroidogenic cell lineage are 
thought to be present within the gonad itself, in contrast to primordial germ cells, which 
originate near the stalk of the allantois and migrate by ameboid movement through the 
dorsal mesentery to become incorporated into the primitive gonad, proliferating as they 
go. Different factors control the proliferation of germ cells and their migration towards 
the genital ridge. Steel factor (SF) is the most important of these factors. It is a growth 
factor and it influences the growth and differentiation of primordial germ cells (reviewed 
by Merchant-Larios and Moreno-Mendoza, 2001). 
The primordial germ cells arise as a small population during the earliest stages of 
embryogenesis and originate from different areas depending on species. In mice they are 
set aside from other cell lineages at around 6.5 - 7.Sdpc. Once formed the primordial 
germ cells enter the embryonic endoderm that will give rise to the hind gut (Tam and 
Snow, 1981). From 9.S-11.Sdpc they migrate from the hind gut to the genital ridges and 
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The primordial genn cells arise as a small population during the earliest stages of 
embryogenesis and originate from different areas depending on species. In mice they are 
set aside from other cell lineages at around 6.5 -7.5dpc. Once fonned the primordial 
germ cells enter the embryonic endoderm that will give rise to the hind gut (Tam and 
Snow, 1981). From 9.5-11.5dpc they migrate from the hind gut to the genital ridges and 
during migration they are extensively in contact via dendritic processes. They continue 
to divide mitotically until 13.5dpc. The germ cells in the male embryo then arrest and 
do not resume mitosis until a week later, just after birth (McLaren 1984) In the female 
they undergo one further round of DNA replication and then enter prophase of the first 
meiotic division .. The first meiotic divisions in the male occur a week after birth. It is 
thought that these differences in fate of the male and female genn cells are due to a 
factor produced by the testes, which inhibits the entry of germ cells into meiosis. 
(McLaren and Southee, 1997). Although the germ cells are a crucial component of the 
testes they are not required for cord formation. There is some evidence that cord 
formation is slightly delayed in sterile mutants, but cords do form, and the structure of 
the testis is normal. (McLaren, 1988) 
1.6 Sertoli Cells 
Testicular differentiation is marked by the appearance of fetal Sertoli cells and their 
organisation around the germ cells. By 12.5dpc in mice they have formed testicular 
cords and are surrounded by a flattened layer of peri tubular myoid cells (Skinner et at 
1985). It is accompanied by migration of cells from the mesonephros to the gonadal 
primordium. The Sertoli cells are believed to act as the organising centre of the male 
gonad as they are the first cell type to differentiate (McLaren 2000). In situ 
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hybridisation studies show that the SRY gene is expressed in mouse gonads at 11.5dpc 
(Koopman et aI1990). Experiments by Palmer and Burgoyne (Palmer and Burgoyne 
1991) using mosaic mice generated between XX and XY cells indicate that the pre -
Sertoli cell is the only one in the testis in which SRY exerts an effect. Therefore it is 
probable that SRY initiates testicular development through induction of the pre-Sertoli 
cells by instructing them to differentiate from migrating coelomic epithelium cells. SR Y 
is also thought to have a proliferating effect on the Sertoli cell precursors as mitosis is 
enhanced in response to SRY (Capel 2000). 
Evidence has shown the coelomic epithelium is indeed the source of pre-Sertoli cell 
origin, this was established through studies using a fluorescent dye which traces the 
route and fate of the migrating coelomic epithelium. Results showed that these injected 
cells differentiate to form Sertoli cells (Karl and Capel, 1998). The mesonephric cells 
start migrating into the gonad at 11.5dpc and these contribute to the other testis cell 
popUlations like the peritubular myoid cells which contribute to the formation of the 
seminiferous cords and are necessary for the maintenance of their structure. 
A major role of the Sertoli cell is to define two separate and physiologically distinct 
compartments in the seminiferous tubule. The basal compartment, near the periphery, is 
sealed off from the luminal compartment by processes of adjacent Sertoli cells that 
"reach out" and make contact. At the point of contact these fuse to form occluding 
junctions. With cord and tubule formation the Sertoli cells provide an appropriate 
microenvironment for the development of germ cells. They form tight junctional 
complexes providing a protective barrier. The compartmentalisation of the seminiferous 
epithelium allows the Sertoli cells to establish micro environments which allow the 
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spennatogenic cells to proceed through meiosis and other differentiative events. The 
Sertoli cells also provide nutritive, regulatory and trophic factors that enhance and 
stimulate the survival and development of spenn. 
1.7 Leydig Cells 
The Leydig cells first appear in the interstitial region of the testis after cord formation, 
and they are derived from mesenchyme-like stem cells. Their exact embryonic origin is 
as yet unclear, however one hypothesis is that they are mesodermal, appearing first in 
the mesonephros and then migrating into the presumptive interstitial tissue. This was 
proposed from observations of an experiment using gonad / mesonephros grafts and co -
cultures (Merchant-Larios and Moreno-Mendoza 1998), and is generally the more 
accepted hypothesis for origin of the Leydig cells. Another hypothesis however, is that 
Leydig stem cells derive from neural crest. This is based on evidence that Leydig cells 
express several neural specific proteins such as neural cell adhesion molecule, 
neurofilament protein 200 and microtubular-associated protein (Mayerhof et at 1992, 
1996, Davidoff et at 1993, Middendorff et at 1993). 
As the differentiation of the first Leydig cells occurs after that ofthe Sertoli cells in all 
species studied, it has been proposed that the trigger for differentiation may be under the 
paracrine action of Sertoli cells. This idea has been supported by the findings of several 
studies using experimental models. (Jost et at 1973, Byskov 1986). In further support 
of this is a report by Vainio et at (1999) who suggests that the Sertoli cells may act to 
suppress Wnt4 expression. Wnt4 is known to repress the early differentiation of the fetal 
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Leydig cells. In addition and as discussed earlier, Dhh secreted from the Sertoli cells is 
thought to initiate Leydig cell differentiation (Yao et al 2002). 
The Leydig cells exist between the seminiferous tubules of the testes, they are present in 
small clusters of three to four cells and are generally located near blood vessels. This is 
indicative of their endocrine function, and can be observed histologically by the frothy 
appearance of the cytoplasm, which is a characteristic of active steroid synthesis. 
In mammals ontogenesis of Leydig cell function involves at least two generations of 
cells. In mice the "fetal" population arises shortly after differentiation of the testis and 
occurs at around 12.5dpc. and 15dpc in rats. This first generation is essential for 
masculinisation of the fetus as they produce the androgens required to stimulate 
Wolffian duct development and promote male sexual differentiation. There remains 
some controversy as to whether this population of cells disappears, dedifferentiates or 
remains functionally intact during neonatal life. Current thought suggests that it is likely 
they persist in the adult, but are a minor component compared to the adult popUlation of 
cells. (Lejeune et a/1998) Either way, they do appear to become functionally quiescent 
as androgen production decreases dramatically in the neonate testis. 
A second population of Leydig cells appears from about day 5 in mice and they are 
functional from puberty (Habert et aI2001). These cells produce the androgens required 
for establishment of male secondary sexual characteristics. In humans this includes, 
deepening voice, appearance of facial and body hair, greater musculature and in other 
mammalian species it may be growth of hom or antlers or even a change in body colour. 
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The androgens are also essential for maintenance of spermatogenesis and male 
reproductive function. 
1.7.1 Fetal Leydig cells 
19 
There is a widely accepted belief that the fetal Leydig cells originate from mesonephric 
cells, which invade the gonadal ridge early on in development. Studies supporting this 
hypothesis include grafting of gonads from E1l.5 mice onto mesonephros, the donor 
mice were transgenic and carried markers such as p galactosidase, these markers were 
later traced to the peri tubular myoid and interstitial cells of the testis (Buehr et a11993, 
Merchant-Larios et a11993, Nishoma et aI2000). Some of these migratory cells 
acquired ultra structural features of steroidogenic Leydig cells (Merchant-Larios and 
Moreno-Mendoza 1998) While it is clear that the adult Leydig cells require LH, there is 
now considerable evidence that differentiation and function of the fetalleydig cells does 
not require gonadotrophins. In vivo they develop in a gonadotrophin-free environment 
from 12.5dpc in mice and 14.4dpc in rats. LH is not detected in the pituitary until 
17.5dpc in the rat by immuno histochemistry (Tougard et a11977) at 16.5dpc by RT-
peR (EI Gehani et al 1998) and 17dpc by radio immunoassay (Aubert et aI1985). In 
the plasma, LH becomes detectable on day 17.5pc (EI Gehani et aI1998); moreover, its 
concentration remains very low until fetal day 19.5 and high LH levels are only 
observed from fetal day 20.5 onwards. (Habert and Picon, 1982). Furthermore, 
decapitated rat fetuses have exactly the same increase in testicular testosterone in vivo 
between 16.5dpc and 19.5dpc as controls (Habert and Picon, 1982). 
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Gonadotrophins have, nevertheless, been shown to have a positive effect on neonatal 
Leydig cell differentiation since a single injection of CG to neonatal rats causes a rapid 
increase in the number of Leydig cells, and an increase in the expression ofLH 
receptors and steroidogenic enzymes. (Huhtaniemi et al., 1982). Another study showed 
that testes from rat fetuses aged 20.5 or 21.5 dpc, decapitated the previous day, secreted 
ex vivo amounts of testosterone, eight times lower than did the control litter mates 
(Habert and Picon, 1982). This suggests that LH is required for the maintenance of 
physiological testicular steroidogenesis in vivo from fetal day 20.5 onwards. In earlier 
studies the requirement of LH on the differentiation of Leydig cells in late fetal life was 
determined by measuring the volume of Leydig cells in decapitated fetuses. An effect 
was found as early as 17.5 dpc, (Eguchi and Morikawa, 1968), but these results appear 
doubtful, as no LH is detectable in the plasma before 17.5dpc. More recently, Migrenne 
et al200 1 showed that the number of Leydig cells per testis in 21.5 dpc fetuses 
decapitated before onset ofLH synthesis (16.5 dpc) or secretion (17.5dpc) was the same 
as in control litter mates. Thus the generation of new fetal Leydig cells does not depend 
on LH during late fetal life. 
Further evidence for independent differentiation of Leydig cells exists in the 
hypo gonadal (hpg) mouse. This is a natural mutant strain which carries a deletion 
mutation in the gene coding for gonadotrophin releasing hormone (GnRH), (Mason et 
al 1986). The gonads thus lack exposure to endogenous gonadotrophins during 
development. Studies using the hpg mouse have shown that fetal Leydig cell 
development and function in the mouse is normal in the absence of endogenous 
circulating gonadotrophins, and that the Leydig cells become dependent on 
gonadotrophins shortly after birth (O'Shaughnessy et al., 1998) 
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A recent study has also used the hpg mouse to detennine whether fetal Leydig cell 
differentiation and proliferation are also gonadotrophin independent. Results showed 
that establishment of cell number is a gonadotrophin independent event, as there was no 
difference between the normal and hpg embryonic testes. In contrast, the adult 
population of cells, which arise at day 5, are obviously greatly dependant on 
gonadotrophins for proliferation, as there was a marked decrease in cell number at this 
time in the hpg mouse when compared to the wild type (Baker and O'Shaughnessy, 
2001). This study also showed that at birth Leydig cell volume in hpg mice was normal, 
a further indication therefore that function in these cells is normal. After birth there was 
a marked decrease in the amount of testosterone produced by the testes ofhpg mice 
compared to wild type, suggesting that this is the time when gonadotrophin dependance 
occurs. 
The fetalleydig cells are highly active, and androgen production per cell is much greater 
than that of the adult leydig cells (Huhtaniemi, et al1984) (Tapanainen, et alI984). 
Until fairly recently it was always assumed that the entire pathway for testosterone 
synthesis occurred in the fetal Leydig cells, it has since been shown however that this is 
not the case. The final step in the biosynthesis of testosterone is the reduction of 
androstendione by the enzyme 17P-hydroxysteroid dehydrogenase (17PHSD). This 
enzyme exists in four isoforms and it is the type three isoform which is involved in 
testosterone synthesis. One study in mice showed that expression of this isoform is 
restricted to the seminiferous tubules during development and is absent in the fetal 
population of Leydig cells. In the adult testis, however, expression is localised to the 
Leydig cells. These findings suggest that the major androgen secreted by the fetal 
Leydig cells is androstendione and production of testosterone up until puberty is 
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dependant on 17PHSD activity in the seminiferous tubules (O'Shaughnessy et aI2000). 
It has been suggested from the evidence that the fetal Leydig cells are older in 
evolutionary terms, than the adult cells and may have evolved to take on the endocrine, 
steroid producing function of the Sertoli cells (O'Shaughnessy et aI2000). 
After initial differentiation of the fetal Leydig cells, testicular steroidogenesis increases 
markedly as does the number of Leydig cells. This increase is due mainly to 
differentiation of stem cells as differentiated fetal Leydig cells do not undergo mitosis. 
It was suggested that the initial induction of fetal Leydig cell differentiation was due to 
some Sertoli cell secreted factor (Byskov, 1986). As indicated earlier, recent evidence 
suggests that this is indeed the case, and it is proposed that Dhh, a Sertoli cell secreted 
signalling molecule, is responsible for induction of fetal Leydig cell differentiation as it 
was demonstrated that interterstitial cells ie Leydig cell precursors of 12.5dpc mouse 
gonads express the Dhh receptor patched I (Ptch 1) (Yao et al 2002). In addition, Dhh 
null mice were shown to have no p450 side chain cleavage (p450SCC) positive 
interstitial cells. This is a key regulatory enzyme in the steroidogenic pathway described 
here, and its presence is a good marker of functioning Leydig cells. Its absence in the 
Dhh null mice and absence of mature functioning Leydig cells further suggest that Dhh 
is indeed an important signalling molecule for this process (Yao et a12002) 
1.7.2 Adult Leydig Cells 
There is strong evidence that the adult Leydig cell popUlation also arise from 
undifferentiated mesenchymal cells (Lording and Krester 1972, Russell et a11995, 
Haider et aI1995). These cells originate from the mesonephros and they invade they 
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gonadal ridge early on in development. In the rat, adult Leydig cell differentiation takes 
place around 10dpc (Mendis-Handagama et aI1987). There are several distinct stages of 
adult Leydig cell differentiation, the first being proliferation of the precursor cells, next 
the cells become committed and differentiate into Leydig cell progenitors. At this stage 
they simultaneously acquire 3 beta hydroxy steroid dehdrogenase (3~HSD), cytochrome 
P450scc and P45OC17. It has been demonstrated that they acquire these steroidogenic 
enzymes prior to gaining LH receptors (Hardy et al 1989). After this they finally 
become mature Leydig cells, which are distinguishable histologically by their high lipid 
content. (Reviewed by Mendis-Handagama and Ariyaratne 2001). 
In the mouse the timing of adult Leydig cell differentiation can be pinpointed to start 
between post natal days 7 and 10. Evidence comes from expression of the adult Leydig 
cell markers 3~ HSD IV and relaxin like factor (Baker et aI1999). 
In addition to regulating fetal Leydig cell differentiation, Dhh is thought to playa vital 
role in signalling initiation of adult Leydig cell differentiation. Evidence from this 
comes from the fact that adult Leydig cells express the Dhh receptor known as Pte, and 
also studies using the Dhh knockout mouse have shown that phenotypically the males 
have very small and undescended testes. Histological examination shows there to be no 
adult Leydig cells present, only undifferentiated stem cells. (Clark, 2000). It is 
suggested that Dhh null mice lack Leydig cells precursors and that Dh is therefore 
required for differentiation and migration of these cells (Clark 2000). 
Once the adult population of Leydig cells has differentiated and become established 
they do not undergo mitosis, numbers remain stable from proliferation of the stem cells. 
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A study by (Moore et a/1992) showed this to be the case. Using 12sI_Iabelled 
iododeoxy-uridine incorporation, they were able to identify the DNA-synthesising cells 
in adult rat testes. Their results showed that DNA synthesis is not associated with the 
adult Leydig cells. (Moore et al., 1992). The presence ofintennediate stages of Leydig 
cell differentiation in adult rat backs the proposal that stability of the population of adult 
Leydig cells is maintained through proliferation and differentiation of the stem cells. 
(Hardy et al., 1989). 
Although it is well established that the major regulator of adult leydig cell function is 
LH, there is also some evidence for a regulatory role for dihydrotestosterone (DHT). 
This was shown in a study whereby rat Leydig cells were isolated from testes just prior 
to differentiation (between days 14-28). The cells were cultured with either LH or DHT 
alone or coupled with other steroids or androgen receptor antagonist (to block action of 
DHT). The results showed that Leydig cells when cultured with LH or DHT alone did 
produce some testosterone. However by far the greatest effect on cell function was by 
culturing them with a combination of LH and DHT, this increased testosterone 
production dramatically, and adding an androgen receptor antagonist prevented 
testosterone production completely. (Hardy et a/1990). Some doubt surrounds these 
results, however, since others have reported an inability to repeat the experiments 
(Teerds et a/1989). 
Another gene which may be involved in the regulation of development and function of 
the adult Leydig cells is platelet derived growth factor-A (PDGF-A). Mice which carry a 
mutation for this gene were found to show a reduction in number of morphologically 
recognizable Leydig cells. The differences in testis morphology between wild type and 
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mutant were detectable from post natal day 10 and became progressively more apparent 
until at post natal day 42 there were no mature Leydig cells present within the mutant 
testis. The conclusion drawn from this study was that PDGF-A is required for 
proliferation of the precursor adult Leydig cell population and in its absence this fails to 
occur (Gnessi et a12000) 
1.7.3 Differences between Fetal and Adult Leydig cells 
There are several differences between the fetal and adult popUlation of Leydig cells. 
One is the dependence on LH for differentiation and function. The adult Leydig cells are 
entirely dependent on LH for both differentiation and also maintenance of differentiated 
function (payne and O'Shaughnessy 1996). Another distinction between the two is the 
expression of 17~HSD type 3. As previously described, this enzyme is only expressed 
in the adult popUlation and not the fetal cells. 3~HSD type VI is another isofonn of the 
hydroxy steroid enzymes which is expressed only in the adult Leydig cells (Baker et at 
1999) These enzymes can therefore act as good markers for distinguishing between 
adult and fetal Leydig cells. 
In addition, it appears that the regulation of LH receptor gene expression in the testes is 
dependent on the developmental stage of the Leydig cells. LH stimulation up-regulates 
LHR expression in the fetal rat testis, whereas similar stimulation down-regulates 
receptor expression in the adult cells. (Pakarinen et a11990) 
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1.7.4 Functional regulation of the Leydig cells 
Testosterone biosynthesis in Leydig cells is dependent on two cytochrome P450 
enzymes, cholesterol side-chain cleavage (P450scc) and 1 7a-hydroxylase/Cl 7-20 lyase 
(P4S0c17). The expression of these two enzymes is differentially regulated by LH 
acting via its second messenger, cyclic adenosine 3',S'-monophosphate (cAMP), and by 
specific steroid honnones. 
IGF may be a candidate for the initiating factor of steroidogenesis in the fetal cell 
population. There is evidence to suggest that IGF-l has a regulatory role in the 
expression ofluteinising honnone receptor (LHR). Addition oflGF-l to cultured 
Leydig cells results in a dose-dependant increase in LHR gene expression and actual 
receptor number was increased by 300% of unstimulated control cells (Zhang et al 
1998). Further studies have shown that when added to primary cultures, IGF -I can 
enhance Leydig cell steroidogenesis (Lin et al 1986, Lin 1995) 
Several other factors have also been implicated in the involvement of modulation of 
testosterone synthesis by Leydig cells. Testicular macrophages are known to secrete 
both inhibitory and stimulatory factors. The inhibitory factors include interleukin 1 (lL 
1) and TNF a.. These are produced during an inflammatory reaction and their inhibitory 
action is directed at the steroidogenic enzymes. Once an inflammatory response is 
initiated Leydig cell function is depressed (Hedger, 1997). In contrast, resting resident 
macrophages have been shown to have a stimulatory effect on Leydig cell 
steroidogenesis, possibly through their trophic actions (Hedger, 1997). 
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Estrogen is also thought to playa regulatory role in Leydig cell steroidogenesis,. This 
was first proposed with the discovery that the testis concentrates estradiol (Stumpf 
1969). Further studies revealed that the intersitium of the rat testis contains a specific, 
high affinity estrogen receptor (Kato et aJ 1974, Abney 1976) and, furthermore that 
Leydig cell steroidogenesis is directly inhibited by estradiol treatment (Sairarn and 
Berman 1979, Kalla et a/1980). These findings suggest that the regulatory role played 
by estrogen in Leydig cell function is in a negative fashion. In addition, it has been 
demonstrated that exposure of male fetal rats to estrogen increases the incidence of 
cryptorchidism, (Rajfer and Walsh 1977, Yasuda et a/1985) a defect which is known to 
occur due to lack of androgens. 
Most studies agree that LH is certainly a key regulator of adult Leydig cell differentiation 
and function whereas fetal Leydig cells can develop and function independent of its 
presence. Evidence for this exists in hpg mice and LHR null mice. Both strains lack 
cellular exposure to LH. In hpg mice this is because there is no LH, due to a mutation in 
the gonadotrophin releasing honnone gene and thus absence of circulating 
gonadotrophins. As previously mentioned, the fetal Leydig cell population differentiates 
and functions normally until around day 5, and only after this stage is LH required 
(Baker et al200 1) 
Similarly, the LHR null mouse shows normal masculinisation at birth suggesting that it 
also produces normal levels of testosterone during fetal development. In addition the first 
transabdominal descent of the testes occurs in LHR-null mice, and this event is known to 
be dependant on androgen action, suggesting therefore that sufficient testosterone has 
been produced in the complete absence of LH action on Leydig cells. By 7 weeks there is 
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By 7 weeks there is a marked reduction in testosterone production in the LHR-null mice 
compared to normal mice suggesting that LH is required for normal functioning of the 




Figure 1 ~ Histological sections of adult mouse testis showing different cell types and 
their location in relation to each other. 
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1.8 Gonadotrophins 
The gonadotrophins are so called because their main target site is the gonads. The two 
main ones are follicle-stimulating hormone (FSH) and luteinising hormone (LH) 
Regulation of their production and release is under the control of the hypothalamus. A 
third gonadotrophin is produced by the placenta of some species during fetal life and is 
known as chorionic gonadotrophin. FSH and LH are synthesized in the same cells of the 
pituitary, the gonadotrophs. Both are heterodimeric glycoprotein hormones, which share 
a common a subunit, but have their own specific J3-subunit. The hormone-specific 13-
subunit of each of these hormones is noncovalentIy linked to the a-subunit and confers 
receptor specificity and, hence, the biological specificity. The regulation of both a-
subunit and FSH and LH J3-subunit gene expression is under stringent control of the 
hypothalamic peptide GnRH, gonadal steroids, and gonadal peptides, including inhibins 
and activins (Haisenleder el a11994) 
In males, FSH is required for spermatogenesis and LH stimulates androgen production 
by the testicular Leydig cells. The cellular target site of action ofLH is the Leydig cells 
of the testis and the theca, granulosa and luteal cells of the ovary. Target sites for FSH 
are the Sertoli cells and the granulosa cells. 
The physiological functions of the gonadotrophins are well documented. FSH stimulates 
follicular maturation and granullosa cell production of estrogen in the ovary and Sertoli 
cell function in the testes. LH, on the other hand, stimulates theca cell production of 
androgen in the ovary and Leydig cell production of androgen in the testes. LH has two 
principle activities in the control of Leydig cell steroidogenesis: Firstly, acute stimulation 
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of testosterone biosynthesis, which is achieved via mobilisation and delivery of the 
cholesterol precursor to the inner mitochondrial membrane and secondly chronic 
stimulation which results in increased gene expression of the steroidogenic enzymes. The 
production of LH is regulated by feedback inhibition of circulating testosterone on the 
pituitary and hypothalamus. FSH secretion is regulated by inhibin, a peptide hormone 
produced by Sertoli cells, and also by circulating testosterone. This endocrine loop is 
known as the hypothalamic-pituitary-testicular axis. 
Plasma levels of gonadotrophins fluctuate depending on the stage of development. In 
mice there is an increase just before and shortly after birth. Levels then decrease at 
around day 4 and remain low until puberty, which occurs at around day 25 - 30. Puberty 
is the period of development during which physical growth and sexual maturation occur. 
The factors responsible for triggering and timing the onset of puberty remain elusive, 
though it is likely that several factors are involved. Environmental factors such as, 
nutrition, photo-period, and population density are known to have a role. Some animals 
can even delay puberty if they are likely to have very poor reproductive success at that 
particular time. This has been clearly demonstrated in mice. (Drickamer 1990) 
The high levels of gonadotrophins at puberty arise as a result of increased stimulation of 
the gonadotrophs of the anterior pituitary by gonadotrophic releasing hormone (GnRH). 
GnRH is assumed to be the most important final common mediator of all influences on 
reproduction conveyed through the central nervous system. Any abnormality in GnRH 
synthesis, storage, release or action will result in partial or complete failure of gonadal 
function. 
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After puberty, regulation of the endocrine and spermatogenic functions of the testes is 
maintained via hormonal interactions involving GnRH, the gonadotrophins and 
testosterone. They are interconnected in a feed back loop system, whereby one controls 
the production and release of another. The major difference between the sexes in the 
control of gonadal activity is that gamete and steroid production in the male occurs 
continuously after puberty whereas in the female these functions occur cyclically. 
Testosterone and LH regulate the production and release of each other, LH through 
steroidogenic promoting action on the Leydig cells, and testosterone by acting at target 
sites in the anterior pituitary and regulating production of LH. High levels of 
testosterone will result in a decrease in production of LH and vice versa. 
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Figure 1-5 Feedback interactions between hypothalamus, anterior pituitary and testis 
Signifies positive hormonal effect 
Signifies negative hormonal effect 
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1 .9 LH Receptor 
The LH receptor (LHR) plays a pivotal role in the hormonal regulation of reproduction. 
It is a cell membrane glycoprotein hormone receptor. It is a member of a family of 
proteins called G-coupled protein receptors, and along with the FSH receptor and 
thyroid stimulating receptor (TSHR), they form a subgroup of this family. Structurally 
they are transmembrane receptors and have a large extra cellular hormone-binding 
domain attached to a seven-pass transmembrane domain, which in tum is linked to an 
intracellular cytoplasmic domain. The gene encoding the LH receptor consists of eleven 
exons, the first ten encode the extracellular domain of the receptor and the eleventh 
encodes the transmembrane and intracellular domain. (Dufau et al 1995) 
The LH receptor is mainly expressed in the Leydig cells of the testes and in theca, 
granulosa, and luteal cells of the ovary. In both males and females the binding ofLHR to 
its ligand LH leads to a cascade of intracellular events which result in the synthesis of 
steroids critical to normal development and reproductive function. The LH receptor acts 
by initiating a second messenger response. The primary, if not sole, second messenger 
mediating the actions of LH in target cells has been shown to be cyclic adenosine 
monophosphate (cAMP) (Hunzicker-Dunn and Bimbaumer 1985). cAMP is produced by 
a membrane bound enzyme called adenylate cyclase. A Gs protein mediates the LH-
induced increase in adenylate cyclase activity. 
Introduction Chapter 1 34 
1.10 G Protein coupled receptors 
G protein-coupled receptors (GCRs) are a component ofa modular system for the 
transduction of specific extracellular signals across the lipid bilayer of the cell and the 
conversion of those signals to an intracellular second messenger pathway. The 
evolutionary role of GCRs as part of a generalised celJular linkage system has been 
described (Kirschner 1992). The LH receptor is associated with a Gs protein which 
consists of three subunits; alpha (a) beta «(3) and gamma (y). In the resting state the a-
subunit is bound to a GDP molecule guanine diphosphate. The protein is activated by 
ligand (LH) binding to the receptor. Upon activation the GDP is replaced on the a-
subunit by a GTP (guanine tri phosphate), the GTP and a-subunit complex then 
dissociates. The G protein is said to be inactive when bound to GDP and active when 
bound to GTP. Upon binding to GTP this causes activation of the enzyme adenylyl 
cyclase. This is a membrane bound enzyme which converts adenosine tri phosphate 
(ATP) to the cyclic form of adenosine mono phosphate (cAMP), cAMP in tum activates 
protein kinase A. Meanwhile any free cAMP is quickly broken down to AMP by the 
enzyme phosphodiesterase. 
Several types of G protein have been identified and they mediate a signalling cascade in 
different ways: 
Gs - Activates adenylyl cyclase activity and leads to an increase in cAMP 
Gilo - Inhibits adenylyl cyclase and leads to a decrease in cAMP. 
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Gq/ll - Activates phospholipase C (this results in an indirect activation of adenylyl 
cyclase via intracellular calcium release.) 
1.11 G-Protein activation 
(f:0. 
ATP cAMP 
~ = heterotrimeric Gs Protein complex 
Figure 1-6 LH receptor activation of Gs protein 
LH binds to receptor 
') Thi creates a binding ite for Gs protein 
3 Thi in tum changes shape of Gs protein so it releases GOP and binds GTP 
4 G / GTP complex moves across membrane and activates adenylyl cyclase 
5 Upon activation of adenylyl cyclase the Gs protein immediately releases its GTP and 
once again binds with GOP, thus resuming its inactive state 
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1. 11. 1 Intracellular signalling cascade initiated by cAMP 
Adenylyl cyclase catalyses the formation of cAMP from adenosine triphosphate (A TP), 
cAMP then mediates its action by phosphorylation of the enzyme protein kinase A 
(PKA) that is situated in the cytoplasmic compartment of the celL This in turn activates 
up regulation of expression levels of steroid acute regulatory (StAR) protein. This 
protein plays a key role in the initial steps of the steroidogeruc pathway by delivering 
cholesterol to the inner mitochondrial membrane. Formation oftestosterone or 
dihydrotestosterone is the final step in the intercellular signalling cascade irutiated by the 
second messenger/ LHReceptor signalling pathway. 
















Figure 1-7 Intracellular signalling cascade initiated by LHR binding, resulting in 
testosterone synthesiS. 
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1.11.3 StAR Protein 
Steroidogenic acute regulatory protein (StAR) is essential for efficient gonadal 
steroidogenesis (Lin et aI1995). The role of this protein is to facilitate delivery of 
cholesterol to cytochrome P450scc, which is situated on the inner mitochondrial 
membrane. Evidence that StAR is essential for steroidogenesis is apparent from the 
demonstration that mutations in the StAR gene cause severe impairment of gonadal 
steroidogenesis at the cholesterol side chain cleavage step (Bose et a11996, Nakae et af 
1997). Targeted disruption of the mouse StAR gene results in a phenotype similar to that 
of congenital lipoid adrenal hyperplasia in humans (Caron et a/1997). cAMP influences 
StAR gene expression and enhances StAR activity by triggering post translational 
modifications (Arakane et all997). StAR is a cholesterol binding protein that appears to 
work on the outer mitochondrial membrane, apparently through a receptor-independent 
action to move cholesterol to the inner membrane, where it can become the substrate for 
P450scc (Stocco and Clark, 1996). Once cholesterol has been delivered to the inner 
mitochondrial membrane it is catalysed by the enzyme cytochrome P450scc. This is the 
first step in steroid synthesis. 
1.12 Steroid hormones 
Steroid hormones have a characteristic chemical structure consisting of 3 six-carbon 
rings plus one 5-carbon ring and are produced by the adrenal cortex, gonads and 
placenta during pregnancy. Cholesterol is the precursor of all steroid hormones. 
Although steroid producing cells synthesise some of their own cholesterol, most of it is 
delivered to the cells by plasma lipoproteins. Steroids are fat-soluble and pass easily 
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through cell membranes; they typically have to bind to water-soluble carrier proteins to 
be transported through the blood to their target tissues. There are several types of 
steroids and the androgens, which include testosterone, dihydrotestosterone and 
androstendione, belong to a group called the C 19 steroids. 
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There are many biological steps in steroid synthesis; each one involves small changes to 
the molecule, mediated by specific enzymes, modifYing enough for it to be deemed a 
separate hormone. The steroidhormones a particular cell produces, depends on the type 
and concentration of the enzymes present within the cell, and also its complement of 
peptide hormone receptors. LH receptor stimulation wi)] result in the production of 
testosterone or progesterone, depending on target cell. 
All steroids are highly lipid soluble and once they are synthesised they simply diffuse 
across the plasma membrane of the steroid producing cell and enter the interstitial fluid 
and then the blood. Blood vessels are always present around steroid producing cells in 
order for the hormones to be picked up and delivered to their target site. 
1.13 Steroidogenesis. 
The rate-limiting and acutely regulated step in steroid hormone biosynthesis is the 
translocation of cholesterol, from the mitochondrial outer membrane to the inner 
membrane; This is governed by the StAR protein. Here it is converted to pregnenolone 
by cleavage of a 6-carbon unit by the cytochrome P450 cholesterol side-chain cleavage 
enzyme (P4S0scc). This conversion is a rate limiting and irreversible step. Pregnenolone 
is in tum converted to progesterone by the enzyme 3PHSD, several other pathways can 
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then be undertaken involving other enzymes depending on: cell type, enzymes present, 
and the end steroid required. 
1. 13. 1 Steroidogenic Enzymes 
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There are many enzymes involved in the steroidogenic pathway and some are crucial as 
key rate determining regulators. The enzymes expressed in anyone steroidogenic cell 
depend greatly on organ location of the cell. In addition one enzyme may exist as several 
isoforms. The gonadal synthesis of testosterone from cholesterol involves four key 
enzymes, namely, cytochrome p450scc, cytochrome P450 17a1pha-hydroxylase/lyase 
(17aOH), 3f3 HSD and 17beta-hydroxysteroid dehydrogenase. (17f3 HSD). 
Upon delivery of cholesterol to the inner mitochondrial membrane it is converted to 
pregnenolone by P450 scc. Pregnenolone itself is not a hormone, but is the immediate 
precursor for the synthesis of all of the steroid hormones. This conversion of cholesterol 
to pregnenolone is the rate limiting step in androgen biosynthesis and the rate of 
conversion is dependent both on the amount ofP450 scc and the rate at which 
cholesterol is imported into mitochondria. 
mRNA for all four enzymes is expressed in the mouse testes from 15dpc (Greco and 
Payne 1994), this is further evidence that steroidogenic activity in fetal gonads is 
independent of LH action as there is no full-length LH receptor transcript detected in 
mouse testis at this early stage in development. 
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1.14 Steroidogenic Pathway 
Cholesterol 
~ P450SCC 17a 17,20 
Pregnenolone HYdroXYlase. 17 -OH Pregnenolonedesmolase. Dihydroepiandrostendione 
~ 3pHSD 17a ~ 3PHSD 17,20 ~ 3PHSD 
Hydroxylase.... desmolase 
Progesterone ~ 17 -OH Progesterone • Androstendione 
Figure 1-8 Sequence of steroidogenic pathway 






Abbreviations HSD = Hydroxysteroid dehydrogenase, see = Side Chain Cleavage 
In fetal Leydig cells the end product is androstendione whereas in adult Leydig cells 
testosterone is the end product of the steroid pathway (O'Shaughnessy et a/2000). 
Testosterone can also undergo further conversion to the more potent androgen 
dihydrotestosterone, by the enzyme 5 a reductase, or to the female hormone estrogen by 
the enzyme aromatase, depending on the target cell and enzymes present. 
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1.14.1 Steroid receptors 
The receptors for steroid honnones are situated within the nucleus of target cells. The 
steroid / receptor complex acts as an intracellular transcription factor, and exerts 
positive or negative effects on the expression of target genes (Beato et al., 1996; Beato 
and Klug, 2000). Steroid receptors consist of a ligand-binding domain, a DNA-binding 
domain, and several transactivation functions distributed along the molecule (Evans et 
alI988). They have a significantly different mode of action from other hormone 
receptors, (eg peptide or glycoprotein) most of which affect cellular function by 
modulation of intracellular second messenger levels. 
1.15 Masculinising effects of androgens 
An early report by Berthold in 1849, showing that a testis transplanted into the abdomen 
of a castrated rooster prevented or reversed the effects of castration, ushered in the 
search for what are now known as androgens and research into how they work. 
However, as early as 200BC the Chinese were using processed extracts of testes to treat 
individuals lacking 'maleness activity'. Perhaps the two most important androgens are 
testosterone and dihydrotestosterone (DHT). Structurally they are very similar and they 
bind to the same receptor known as the androgen receptor. Administration of 
testosterone has such a potent effect on the body that it is now given to transsexual 
females desiring to become male. Honnone therapy will induce a deepening of the voice 
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and other desirable masculinising effects including coarsening of body hair. male pubic 
hair pattern. beard growth. muscle development and loss of subcutaneous fat. 
1.15. 1 Determinate and regulatory effects of testosterone 
Testosterone has two types of effect on the body. The first is determinate and involves 
irreversible changes such as Wolffian duct development. establishment of external 
genitalia and accessory glands and masculinisation of the brain. These events occur 
before birth in mammals. There are also progressive changes initiated which occur from 
birth to puberty. causing changes such as greater musculature and bone growth and 
voice tone. these changes are more pronounced in sexually dimorphic species such as 
humans and are all examples of determinate differentiation. The determinate effects 
therefore are a major contributory factor of the establishment of maleness. 
The second type of effect testosterone has on the body is regulatory. whereby the 
changes that occur are reversible. they can involve both quantitative and qualitative 
changes to established accessory sex organs. These actions are not involved in 
establishing the individual as a male or a female. but are more concerned with ensuring 
that the reproductive tracts and genitalia function effectively in the reproductive process. 
In males the regulatory actions of testosterone are more pronounced in the adult and 
involve initiation and maintenance of spermatogenesis. stimulation of accessory sex 
glands, metabolism. muscle growth, initiation of courtship behaviour and aggression 
towards competing males. and in some species the secondary sexual characteristics such 
as antler growth. The regulatory actions may be continuous or show seasonal variation. 
Introduction Chapter 1 43 
In contrast to the detenninate effects of testosterone, the regulatory effects are 
reversible, and involve changes to already established sex organs and glands. These 
actions, therefore, are not concerned with establishing the individual as male or female, 
but are involved in regulation of the effective functioning of the reproductive system. 
The regulatory effects therefore control fertility whereas the determinate effects 
establish maleness. 
Many experiments have clearly shown that male sexual differentiation is entirely 
dependant on androgens, the most important one being testosterone. It initiates its effect 
in a determinate fashion (establishment of male structures), and has regulatory effect ie 
initiation and maintenance of function of structures. 
Determinate Regulatory 
Development ofWolffian ducts Formation of seasonal secondary sexual 
characteristics eg antlers 
Formation of male external genitalia Initiation and maintenance of 
spermatogenesis. 
Gender identity and sexual preference Regulation of sex glands and organ 
function 
Table 1-1 Summary of determinate and regulatory effects of testosterone 
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1.16 Dihydrotestosterone 
Although testosterone is the main steroid required by the body for masculinisation, there 
are certain areas that require its further conversion by the enzyme Sa-reductase to the 
more potent androgen, dihydrotestosterone. One area in particular is the external 
genitalia. Although dihydrotestosterone binds to the same receptors as testosterone it 
does so with much greater affinity. During development it has been found that 
testosterone promotes virilisation of the male urogenital and duct system in two ways 
1. Testosterone ---.~ Internal duct system and spermatogenesis 
15 a-reductase 
2. Dihydrotestosterone -+ External genetalia and prostate 
1.17 5 Alpha (a) Reductase 
Testosterone is the major steroid hormone synthesized by the mature testis and 
consequently is the major circulating androgen, but for a short period during postnatal 
life in the rat (between 20-40 days), the testes produce mainly S a reduced androgens 
such as Sa-androstan-3a,17p-diol. The predominance of Sa-reduced steroids over 
testosterone at this time period is due to increased levels of S a reductase activity. The 
5 a reductase enzyme exists in two forms known as type 1 and 2 and they are coded for 
by two separate genes. Both types are present in females and males, however the type 2 
isoform is more abundant in males and the gene is expressed largely in androgen target 
tissue. 
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During fetal development, differentiation of the Wolffian ducts to epididymis and vas 
deferens requires testosterone, whereas differentiation of the male external genitalia 
appears to be dihydrotestosterone (DHT)-specific based on the expression profile of 5 a 
reductase type 2 enzyme, and observations in human sex reversal syndromes 
characterized by a deficiency of thi~ enzyme (Thigpen et al 1993) 
DHT is the most potent androgen and it binds selectively to the androgen receptors in 
genital skin and fibroblasts, making its action necessary for the development of normal 
male genital anatomy in the fetus. In order for nonnal development to proceed along the 
male pathway, there must be sufficient 5 a reductase activity occurring within these 
androgen target tissues. Mutations of the type 2 gene lead to diminished DHT 
formation, and hence cause masculinisation defects of varying degree (reviewed by 
Mahendroo and Russell 1999) 
1.18 Disorders of Sexual differentiation 
Disorders of sexual differentiation can occur when a bipotential gonad is incapable of 
developing into a testis or an ovary. The inability to develop testes may occur if a gene 
such as SR Y is absent or deficient. When this is the case, a 46,XY fetus will not receive 
the SR Y signal to develop testes despite the presence of a Y chromosome. At the genetic 
level then, disruption of SRYhere, can result in complete absence of testes. 
Additionally, for example, AMH secretion accompanied by the absence of androgens or 
the inability to respond to androgens (due to lack of active androgen receptors) can 
result in a fetus lacking both male and female internal duct structures. The problems 
tend to originate at the genetic level. For example certain enzymes and receptors playa 
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crucial role in the developmental pathway. Changes in gene sequences such as point 
mutation or base deletion can result in many deleterious effects and completely change 
the anatomy and physiology of the affected individual. There are several examples of 
these types of developmental problems. 
1.19 5 a reductase deficiency 
The absence of 5 <X reductase activity in certain areas of the body can have very marked 
effects and in extreme cases complete phenotypic feminisation can occur. If left 
untreated individuals remain phenotypically female until puberty. At this time there is 
such a surge in testosterone production that virilisation can then occur and the female 
genitalia then change and become male. Failure of development of the male phenotype 
shows that DHT is required for formation of male genetalia. At puberty, the levels of 
testosterone are so high that they can then exert the same effect as dihydrotestosterone at 
the androgen receptor (Grinno et aI1990), and the individuals then develop male 
genetalia. This particular disorder is discussed in more detail in chapter 4. 
In mice there is a slight difference from humans, in that testosterone appears to playa 
more vital role in virilisation without the need of conversion by 5 <X reductase to DHT. 
Evidence of this is apparent in knockout mice. Several studies have assessed the effects 
of the absence of one or both forms of the enzyme. Male mice lacking 5 <X reductase 
type I appear phenotypically normal whereas females exhibit a parturition defect which 
is thought to be due to absence of cervical ripening (Mahendroo et aI1999). Male mice 
without type 2 or without types I and 2 had fully formed internal and external genitalia 
and were fertile, but had smaller prostates and seminal vesicles than normal. In 
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conclusion it appears testosterone is the only androgen required for differentiation and 
virilisation. DHT in normal male mice appears to only enhance the effect of 
testosterone, and the 5 a reductase enzymes have a more vital role in female 
reproduction. (Mahendroo et al 200 1 ) 
1.20 Androgenic disorders 
Androgens act in their target cells via an interaction with the androgen receptor resulting 
in direct regulation of gene expression. The androgen receptor (AR) is comprised of 
910-919 amino acids and is encoded by a gene consisting of8 exons. The AR is a single 
polypeptide comprised of relatively distinct domains: an amino-terminal domain, a 
DNA binding domain, a hinge region, and a steroid-binding domain. The large amino-
terminal domain, encoded by exon 1, is the least conserved region among the steroid 
receptors and is involved in transcriptional activation of target genes. The DNA binding 
domain, encoded by exon 2 and 3, contains two zinc finger motifs and is the most 
highly conserved region (Jenster et a/1991). It is responsible for specific binding to its 
cognate DNA, i.e. androgen response element oftarget genes. The carboxyl-terminal of 
the AR contains the steroid-binding domain, encoded by the 3' portion of exon 4, and 
exons 5-8. It is responsible for the specific high-affinity ligand binding. The carboxyl-
terminal region also contains the areas involved in transcriptional regulation. 
Mutations in the gene encoding the androgen receptor can result in partial to complete 
androgen insensitivity. Individuals have decreased dihydrotestosterone (DHT) levels, 
and a high ratio oftestosteronelDHT, as a consequence ofa secondary 5a-reductase 
deficiency caused by androgen resistance (Imperato-McGinley 1982). 
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1.20.1 Androgen Insensitivity Syndrome 
Androgen Insensitivity Syndrome (AlS) is the most common cause ofvirilisation 
disorders in 46XY individuals and is the result of a defective androgen receptor which 
consequently prevents the normal development of both internal and external male 
structures in 46 XY individuals .. Genetic defects of the human androgen receptor (AR) 
can cause a wide spectrum of androgen insensitivity syndromes (Quigley et a11995) 
ranging from phenotypic females in those with complete AlS (eAlS) ambiguous 
genitalia in partial AlS (pAlS); to male infertility in minimal AlS. 
The majority of these defects are due to point mutations resulting in amino acid 
substitutions. It is however unclear why certain mutations result in partial AlS, whereas 
others in the same exon cause the complete syndrome. eAlS patients have normal 
appearing female external genitalia due to their complete inability to respond to 
androgens. This is because the genital tubercle, genital swellings, and genital folds 
cannot masculinise in these patients despite the presence of functional testes located in 
the abdomen. 
The androgen receptors on these structures fail to recognise and respond to circulating 
androgens. Similarly, Wolffian duct development does not occur because these duct 
structures also require androgens. Mullerian duct development is inhibited in eAlS 
individuals because MIS is secreted. by the Sertoli cells of the testes. In addition to 
possessing normal female external genitalia, eAlS patients also have a female duct 
system. 
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PAIS also affects 46,XY individuals. PAIS patients are born with ambiguous external 
genitalia due to their partial inability to respond to androgens. The genital tubercle is 
larger than a clitoris but smaller than a penis, a partially fused labia/scrotum may be 
present, the testes may be undescended. and perineal hypospadius is often present. 
Wolffian duct development is minimal or non-existent and the Mullerian duct system 
does not develop properly. PAIS patients will experience normal female breast 
development at puberty, along with a small amount of pubic and axillary hair. 
1.21 LH Receptor mutations 
The use of molecular biology techniques in the field of endocrinology has resulted in 
the identification of single gene mutations being the cause of many endocrine hereditary 
conditions. In the case of the LHR, studies have have established at the molecular level 
the function of these mutated genes. Both activating and inactivating mutations have 
been identified. 
1.21. 1 Activating mutations 
Activating mutations in the LHR were first identified in patients with a condition known 
as familial male limited precocious puberty (FMPP). This occurs due to point mutations 
in the gene resulting in a single amino acid change in the protein. To date around seven 
ofthese mutations have been identified in humans. As a result of these mutations, onset 
of puberty in these boys may occur before the age of four years. The phenotype is a 
consequence of increased androgen production by the Leydig cells due to continuous 
Leydig cell stimulation through expression of the mutated LHR gene. This increase in 
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androgen occurs independently of stimulation from LH. Intracellular signal transduction 
is a result of the mutated receptor alone as after birth LH levels are generally very low. 
In addition to these receptors showing elevated basal activity, this will still increase 
upon stimulation with LH when troe puberty occurs. This condition only occurs in 
males. There is no effect on phenotype of females with the activating mutation 
(Themmen et a/1998) 
1.21.2 Inactivating mutations 
Inactivating mutations are also usually a result of a single amino acid change in the 
protein receptor. Mutations of this type in the LHR result in a male 
pseudohermaphrodite characterised by a female external phenotype with a small blind 
ending vagina. Undescended testes are present internally but are greatly educed in size 
due to extreme Leydig cell hypoplasia. (Toledo et aI1985). Although binding with LH 
occurs, the mutant receptor is completely unable to initiate activation of the Os protein 
and consequently adenylyl cyclase. The lack of a male phenotype in these individuals 
therefore is due to complete absence of androgen mediated genital development. 
1.22 Mutant mouse strains 
Introduction of desired mutations into ES cells and generation of knockout mice have 
now become a routine practice, and are a very useful tool in the field of molecular 
biology. Many ofthese mutations act as a model for certain condtitions that occur 
naturally in humans and provide insight and understanding about the importance of 
specific genes and the role they play in normal physiological function. 
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1.22.1 Testicular Feminising mutation (TFM) 
The testicular feminised (Tfin) mouse carries a single base mutation in the gene coding 
for the androgen receptor. It changes the receptor structurally, which means that even in 
the presence of circulating androgen there can be no response, as it is not recognised by 
any of the target cells. Tfm is an X linked disorder and therefore only one copy of the 
defective gene is required for males to be affected. Females on the other hand can be 
carriers or mutants. In Tfm males, the testes are very small and cryptorchid. They fail to 
descend at the normal time (25 days) this suggests that although the testes produce 
testosterone it also has an auto regulatory role within the body. They do not posses 
mesonephric or paramesonephric derivatives and exhibit a female phenotype. 
Spermatogenesis is arrested and testosterone production is reduced due to a deficiency 
in the enzyme cytochrome P450c17, which is essential for the conversion of 
androstendione to testosterone. These mice display resistance to exogenous and 
endogenous testosterone 
Due to the complete insensitivity to androgens this strain of mouse is a good model to 
use to examine the importance ofthe role of testosterone and its receptor, as it is entirely 
unresponsive to androgen. Testosterone clearly has a role in normal steroidogenesis in 
the Leydig cells, because Tfin mice have very high circulating plasma LH levels but 
very low testosterone levels. This is because the Leydig cells of these animals produce 
progesterone as the main steroid rather than testosterone. 
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1.22.2 Testis structure in the Tfm mouse 
Histologically the testes of the Tfm mouse are much smaller (only 10% as large by 
weight as those of normal mice). The small size is due to the underdeveloped 
seminiferous tubules. There is also reduced spermatogenesis and a conspicuous quantity 
of interstitial tissue. (O'Shaughnessy et a' 2002b) 
1.23 LHR Knockout (LHRKO) 
The LHRKO mouse was established by Zhang et al and reported in Jan 2001. It lacks a 
full-length functional LHR capable of anchoring to the plasma membrane and of signal 
transduction. This is due to targeted disruption of exon 11 of the gene, which encodes 
the transmembrane and intracellular domains. Homozygous LHRKO mice of both sexes 
are born phenotypically normal. Testes of the newborn males are similar in size and 
microscopic appearance as those of wild type (WT) littermates, and their intra-
abdominal location adjacent to the urinary bladder is the same as in WT males. 
Postnatally, testicular growth and descent, and external genital and accessory sex organ 
maturation fails to occur in LHRKO males, and spermatogenesis is arrested at the round 
spermatid stage. The number and size of Leydig cells is dramatically reduced. 
The physical differences between mutant and wild type are more obvious by day 30 as 
the LHRKO males have a much smaller penis, shorter anogenital distance and an 
underdeveloped scrotum. Serum and testicular levels of testosterone are greatly reduced 
compared to wild type, however these levels were still higher than those obtained from 
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castrated mice indicating that the testes must be able to undergo a small degree of 
steroidogenesis even in complete absence ofLH / receptor complex activation 
1.23.1 FSH receptor knockout 
53 
This mutant was generated by targeted deletion of exon one of the gene encoding the 
receptor (Abel et al 2000). FSH receptor knockout male mice have underdeveloped 
testis with 50% reduction in Sertoli cells, suggesting that FSHR signaling is required 
very early for gonadal development, maturity, and function (Wahlstrom et a/1983) 
Onset of puberty is delayed in these mice, and adult males show a reduction in serum 
testosterone levels compared to normal controls despite normal circulating LH 
concentrations. This indicates that communication between Sertoli and Leydig cells is 
disturbed and that this communication is vital for normal reproductive function. As a 
result these mice have reduced sperm production and sperm quality. 
1.23.2 FSHP Knockout 
These mice have been generated by targeted deletion of exon of the FSH P subunit. 
Since this region confers hormonal specificity, these mice lack FSH. 
Male mice deficient in FSH are fertile despite a decrease in testis size and reduced sperm 
number and motility (Kumar et a/1997) FSH-deficient female mice are infertile due to a 
block in the progression of ovarian folliculogenesis at the preantral stage. As expected 
the general phenotype of these animals is similar to that of the FSHReceptor-null mice. 
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1.23.3 hpg mouse (Hypogonadal) 
The hpg mouse has a congenital functional gonadotrophin deficiency due to a major 
deletion in the gonadotrophin releasing hormone gene (GnRH) Transcription of the 
remaining gene does occur but there is no detection of the GnRH peptide. (Mason et a/ 
1996). The lack of GnRH in the hpg mouse results in greatly reduced levels of pituitary 
gonadotrophins (Cattanch et a/ 1977). Homozygote hpg males are sterile although 
fertility can be established by administration of testosterone or dihydrotestosterone 
(Singh et a/ 1995). The hpg mouse offers an interesting model in which to study the 
development of Leydig cells in the testis, because it is the pituitary-gonadal axis, but not 
the testis, which is defective in the hpg mouse. Thus, administration of a gonadotrophin, 
such as LH or hCG can lead to a recovery in Leydig cell function and, hence 
testosterone production (Scott et a11990) 
1.23.4 WIW Mouse 
The WW mutant mouse has a mutation affecting the gene in the White-spotting (W) 
locus. This disrupts the membrane-bound tyrosine kinase, c-kit. The c-kit molecule 
serves as a receptor for Steel factor (kit ligand, Stem cell factor), the gene product of the 
Sllocus. Steel factor is expressed during the migratory pathway of primordial germ 
cells (PGCs) and in testicular Sertoli cells. The interaction between c-kit and Steel 
factor is essential for the migration of PGCs to the undifferentiated gonad, and for 
spermatogonial proliferation within the seminiferous tubules of the established testis. In 
the testes of mutants homozygous for either c-kit (WIW) or Steel factor (S/ISL), the 
seminiferous tubules are virtually devoid of germ cells and contain few spermatogonia; 
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these mice are infertile. The gonadal axis in these mice is intact, with the result that the 
Leydig cells seem to show a normal, wild-type phenotype and produce normal 
circulating levels of testosterone. (De Franca et a11994) 
1.24 Aims and Objectives 
The overall aims of this project were to characterise expression mid regulation of genes 
encoding the LHReceptor and Sa-reductase enzyme isoforms in the mouse testis during 
development. At the outset of this project it was considered that these genes were 
essential for the normal development and function of the Leydig cells and for 
masculinisation and development of the male phenotype. Despite this there were only 
limited studies describing the expression of these genes in the mouse and very little was 
known about the regulation of expression. Using molecular techniques and mutant or 
knockout mouse strains, studies described in this thesis set out to characterise 
expression patterns and their control in the mouse testis. 
1.24.1 LH receptor 
With repeet to the LHReeeptor the specific aims were 
I) To establish the presence of alternatively spliced variants of the LH receptor in 
mouse testis during different stages of development from the embryo though to 
adulthood. 
2) To determine the sequence of any variants present and determine whether they 
contain an open reading frame. 
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3) To determine whether there might be fetal Leydig cell-specific expression of 
alternate transcripts, which could be used as markers of fetal Leydig cells. 
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4) To establish whether there might be forms of the receptor which are different in the 
fetal Leydig cells and which might have constitutive activity and thus explain 
the gonadotrophin-independence of the fetal Leydig cells (as it subsequently turned 
out LHR-KO mice are normally masculinised but this was an objectives at the time). 
5) To determine what endocrine factors regulate LH receptor expression during 
development in the mouse. 
1.24.2 5 a Reductase 
With respect to Sa-reductase specific aims were 
1) To obtain sequence for the two isoforms of 50. reductase, type 1 and type 2 in the 
mouse using primers designed to conserved regions across species and, 
subsequently, using gene mining techniques. 
2) To determine which was the predominant isoform expressed in the testis and to 
quantitatively assess expression of the two genes in the testes throughout mouse 
development and in mice lacking specific hormones or hormone receptors. 
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2 Materials and Methods 
2.1 Mouse models 
The mouse is a good model to use for research, and for a better understanding of 
mammalian embryology, development and reproduction. It is readily available, easy 
to feed, raise, mate and handle and it has a short gestation period (18 - 21days). In 
addition it produces large litters (average 8 pups per litter) and has a long period of 
reproductive activity (from 2 - 14 months of age). Many mutant strains exist either 
naturally or induced, and by studying the resulting phenotype this can allow for 
better understanding of the importance of function of the affected gene. 
Another benefit of using mice is that they are non seasonal breeders ie they mate 
readily all year round with the females cycling every four days, and fertile for one 
day. Also with the males there is no reduction in testes size or periods of inactivity as 
is the case with seasonal breeders such as rams. 
Normal mice were bred at the University of Glasgow Veterinary School and 
maintained as required under United Kingdom Home Office regulations. The mice 
used were derived from F 1 hybrids of C3H1HeH and 10 IIH strains. The day of birth 
was designated as day 1. In order to time fetal development, males were caged with 
females overnight and presence of a vaginal plug the next morning was indication of 
a successful mating, and so was designated as embryonic day (E) 0.5. 
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2.2 Summary overview of lab techniques 
The main practical objectives of this project were to detennine presence and 
abundance of specific genes expressed in the mouse testes at different stages of 
development. Various molecular biology techniques were used to achieve this. 
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Testes were removed from mice at various stages of development; total RNA was 
then extracted from them using a sonicator and RNAzol B. The extracted RNA was 
then reverse transcribed in order to obtain a cDNA copy. This was amplified using 
peR with primers specific to the gene of interest, and the resulting peR product was 
then ran on a gel using electrophoresis. Ethidium bromide was added to the gel in 
order to visualise any bands present under UV light. The gel was then subjected to 
southern blot in order to establish if the bands present were representative ofthe gene 
of interest, or the bands were excised from the gel and processed with a mini column 
filter technique and sequence analysis was perfonned on them. The sequences 
obtained were then compared to known sequences in Genbank using GCG and 
BLAST, both of which are molecular biology computing programmes. Alternatively, 
levels of specific mRNA species were quantified by real-time peR and related to an 
internal control (housekeeping gene) or to an external control (luciferase). 
2.2.1 Messenger RNA 
The central dogma of molecular biology is that DNA makes RNA makes protein. 
Extracting mRNA from a tissue at a specific time can give a representation of the 
genes being expressed. It is useful both qualitatively and quantitatively. As the DNA 
is copied the first type of RNA fonned is known as heterogeneous nuclear RNA 
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(hnRNA). This contains both introns and exons. The introns which consist of non 
coding regions are removed by RNA splicing leaving the exons which contain the 
coding information. The processed intron-free mRNA is then used as a template for 
protein synthesis. Each set of three bases, called codons, specifies a certain amino 
acid in the sequence of amino acids that comprise the protein. The sequence of a 
strand of mRNA is based on the sequence of a complementary strand of DNA. 
hnRNA - ...... L....-m_R_N_A---I-.... ·i tRNA 1-...... Protein 
Figure 2·1 Sequence of events for gene expression 
hnRNA = heteronuclear RNA 
mRNA = Messenger RNA 
tRNA = Transfer RNA 
2.2.2 Testes removal 
Embryonic and neonatal mice were sacrificed by decapitation and the juveniles and 
adults were killed by cervical dislocation A T shaped incision was made in the lower 
abdomen and the testes which were situated just below the kidneys were identified 
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in the embryonic and neonate mice by the presence of a more profuse blood supply 
around them, they were also slightly more elongate and larger than the ovaries. At 
the ages used in these studies the sex of the fetus was confirmed by the differentiated 
state of the internal reproductive tract (ie, presence ofWolffian duct or Mullerian 
duct derivatives). Testes of the adult mice were easily identified. Once removed the 
testes were placed into eppendorftubes and stored in liquid nitrogen, or they were 
then further processed for removal of interstitial webs, known to contain the Leydig 
cells. Interstitial webs were stored frozen in liquid nitrogen. It was very important 
that the time between killing the mice and removal of testes was kept as short as 
possible in order to prevent any degradation of the RNA by RNAses. 
2.3 RNA Extraction 
Total mRNA was extracted from the testes of individual animals using RNAzol 
(Biogenesis Ltd., Boummouth, UK). RNAzol was placed on ice and O.5ml added to 
tissue sample in Iml eppendorftube. Sample was then sonicated (see appendix) for 
about twenty seconds to cause disruption of the cell membranes and release cell 
contents. 
A one-tenth volume of chloroform (50J.lI) was added and contents mixed using a 
vortex. The tube was placed on ice for 5mins, and then centrifuged for 15mins at 
1250Orpm. The top aqueous layer was removed with a pipette and transferred to 
another tube (this contained the RNA). An equal volume of isopropanol was added 
and tube left on ice for 30mins then centrifuged for 15mins at 1250Orpm. 
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During centrifugation the RNA fonned a pellet at the bottom of the tube and the 
supernatant was decanted. The pellet was then washed by addition of 500lli of 75% 
ethanol, vortexing for a few seconds and then re-centrifugation for 5mins. The 
ethanol was then removed and the tube left to air dry for a few minutes to remove all 
traces of ethanol. The pellet was resuspended in 30 III H20 (UV treated - see 
appendix), a one tenth volume of 3M sodium acetate pH 7 (3 Ill) and 2 volumes of 
absolute ethanol (60 Ill) were added and the tube was placed at -20°C for at least 
Ihour. The tube and contents were then centrifuged for 15 min at 12500 rpm. The 
liquid phase was removed from the tube using a pipette and the pellet was left on the 
bench to air dry for a few minutes, and then re-suspended in 20 III H20 (UV treated) 
by heating in a water bath at 60°C for two mins. The suspended RNA was the stored 
at -700C or in liquid N2 
2.4 DNAse Treatment of RNA samples 
Genomic DNA, contaminating RNA preparations, can serve as a template in PCR to 
produce a false positive signal from RT-PCR. The problem will only occur if primers 
used for subsequent PCR hybridise to a single exon. This can often be avoided 
during primer design but in some cases the gene structure may not be known and in 
many cases it is not practicable for real-time peR (see below). False positives are 
easily identified by looking at the outcome of a "minus-RT" control (ie reverse 
transcription reaction without active enzyme), but for accurate quantification of 
mRNA levels or identification of some mRNA species it is important to remove 
contaminating DNA. Eliminating the DNA without having an effect on the total 
mRNA can be done using a DNAse treatment. DNAse is an enzyme, which breaks 
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down DNA. It efficiently hydrolyzes .double and single-stranded DNA to a mixture 
of short oligo and mononucleotides, but leaves RNA intact. 
The method in these studies used DNAfree (Ambion Inc, supplied by AMS 
biotechnology, UK). To lOf.ll of the RNA sample 1f.ll of lOx DNAse buffer was 
added followed by 1f.l1 of DNAse and the reaction mix was incubated at 370C for 30 
mins. At the end of the incubation 2f.ll of DNAse inactivation reagent was then added 
to the sample and it was left on the bench at room temperature for 2mins. The 
mixture was then centrifuged for 1 min to pellet the DNAse inactivation reagent and 
the supernatant was removed and transferred to another tube. The RNA prepared this 
way was tested for DNA contamination by PCR using primers known to amplify 
genomic DNA. If DNA contamination was still present a second round of DNAse 
treatment as above was carried out. 
2.5 Reverse Transcription 
Reverse transcriptase is an enzyme used to make a cDNA copy of the mRNA 
template. It is an RNA-dependent DNA polymerase, found in viruses, that catalyzes 
the synthesis of DNA from deoxyribonucleoside 5'-triphosphates, using RNA as a 
template. 
It does so by extending an oligo dT or random hexamer primer in the 3' direction by 
incorporation of deoxynucleotides (dNTPs) An oligo dT primer consists of about 
twenty bases, all of which are thymidines It sits down at the 3' end of the RNA 
molecule at the poly A tail. Random hexamers are small non specific primers 
consisting of 6 bases and they will hybridise at multiple sites on the RNA template. 
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For most studies described here random hexamer primers were used. An RNAse 
inhibitor was usually added to the reaction as this prevents any unwanted degradation 
of the RNA. DTT was also added to the reaction mix to prevent oxidation of the 
newly formed cDNA strands 
2.5.1 Procedure 
In a normal reaction 2.0J,11 of 5 x RT buffer was added to an eppendorf along with 
3.2J,11 .magnesium chloride (MgC12). 2.0J,1lofDTT and water (variable volumes to 
give a final volume of 10f.11). These were then UV treated to eliminate any possible 
PCR-derived DNA contamination. Following UV-treatment, O.5J,11 dNTPs, O.5J,11 
random hexamers, O.3J,11 M-ML V reverse transcriptase, (Gibco Paisley, UK) 0.3J,11 of 
RNAse inhibitor, and 2.0J,11 of RNA were then added and contents mixed gently 
using a pipette. The mixture was then incubated in a water bath at 42°C for Ihour 
then placed on ice, ready to be used as a PCR template 
2.6 peR 
The polymerase chain reaction was developed in the mid eighties and is a technique 
which is used to amplify specific target sequences of DNA, using a pair of 
oligonucleotide primers each complimentary to one end of the DNA target sequence. 
It is not essential to know the sequence in between. The primers are extended 
towards each other by a thermo stable DNA polymerase that is a naturally occurring 
enzyme, which catalyzes the formation and repair of DNA. PCR is a method for 
producing an extremely large number of copies of a specific DNA sequence from a 
DNA mixture without having to clone it. In the words of Paul Rabinow "PCR has 
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transfonned molecular biology through vastly extending the capacity to identify, 
manipulate and reproduce DNA. It makes abundant what was once scarce - the 
genetic material required for experimentation." 
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The requirement of an optimal PCR reaction is to amplify a specific locus without 
any unspecific by-products. Therefore, annealing needs to take place at a sufficiently 
high temperature to allow only the perfect DNA-DNA matches to occur in the 
reaction. For any given primer pair, the PCR program can be selected based on the 
composition (GC content). The reaction cycle consists of three steps. Firstly a 95°C 
step to denature the double stranded DNA - they have to become single stranded in 
order to act as a template for the primers and new strand synthesis. Secondly an 
annealing step of around 56°C - this is usually an optimum temperature for a primer 
to anneal itself to the template strand. Lastly, there is a 72°C step for dNTPS to be 
incorporated into the new strand by the Taq enzyme as it extends the primers. Almost 
any source that contains one or more intact DNA molecule can, in theory be 
amplified by PCR providing appropriate primers can be designed. 
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2.6.1 PCR Cycles 
5' I 3' 
3' t::===================================:::j 5' t Denaturation Cycle 1 






5' 1 Denaturation and annealing of primers 
I 3' 
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Elongation of primers 
Figure 2-2 PCR cycles showing various stages of PCR amplification 
• Double stranded DNA is denatured by higher temperature. 












• Elongation of primers occurs as free dNTPs' are incorporated, forming 
du plicate trand 
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2.6.2 The requirements for PCR 
1. A DNA mixture containing the sequence to be amplified. 
2. A pair of oligonucleotide primers about 20base pairs in length that flank the 5" 
and 3" regions of the DNA sequence of interest. 
3. A mixture of dNTP's for new strand synthesis. 
4. Thermo stable DNA polymerases eg Taq polymerase as it can survive the hot 
denaturation step and forms a copy of the single stranded template using the free 
nucleotides. 
5. Buffer containing KCI, Tris CI and MgCI, these salts provide the necessary ions 
reqired for primer annealing 
2.6.3 Designing primers for PCR 
Primers should be 17-28 bases in length, and base composition should be 45-60% 
guanine and cytosine (G+C). Ideally primers should end in a 3' CG or GC as this 
increases the efficiency of priming. Primers usually have a melting temperature (Tm) 
of between 55-S0°C. The 3'-ends of primers should not be complementary (ie. base 
pair), as otherwise primer dimers will be synthesised preferentially to any other 
product. Primer self-complementarity (ability to form 2° structures such as hairpins) 
should also be avoided, this occurs if the primer folds and anneals to itself due to high 
complimentarity. All primers for this study were designed by obtaining sequence of 
interest from Entrez then assessing which areas corresponded to the required 
parameters. It was also desirable to design primers spanning between two exons as 
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this then reduced the risk of picking up any contaminating genomic DNA during the 
PCR reaction. 
2.6.4 peR protocol 
Each PCR reaction contained Tris/HCl buffer (75 mM, pH 9.0), (NR.)2S04 (20 mM), 
MgCh (2 mM), dNTP's (0.2 mM each), 0.2J.1l Taq Polymerase (2 U per 100 Ill), IJ.11 
of the cDNA template, primers (200 oM each) and H20 to an appropriate volume. All 
components, apart from dNTPs, Taq and template were treated by UV -light to 
remove any PCR-derived DNA contamination. Tubes were placed in the hotlid, which 
had been programmed to undergo the following cycles; 
95°C for Ilh minutes ....... I cycle 
94°C for 30 seconds 
56°C for 30 seconds (primer annealing) x32 cycles 
72°C for 1 - 2 minute depending length of template 
To ensure there was no amplification from any source other than the cDNA template, 
a no-template control was usually included which contained 1 J.11 of dH20 instead of 
template. 
2.6.5 NestedPCR 
Nested peR means that two pairs ofPCR primers were used for a single locus. The 
first pair amplified the locus as seen in any PCR experiment. The second pair of 
68 
Materials and Methods Chapter 2 
primers ( nested primers) bind within the first peR product and produce a second peR 
product that will be shorter than the first one. The logic behind this strategy is that if 
the wrong locus were amplified by mistake, the probability is very low that it would 
also be amplified a second time by a second pair of primers. In addition this is useful 
method of detection for genes which are expressed in low levels. Sometimes there are 
no bands present after running a gel, for this project nested peR was then undertaken 
when this occurred. 
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2.7 Gel Electrophoresis 
Gel electrophoresis is a is a very useful tool for visualising the DNA products of a PCR 
reaction The method is based on separation of molecules consisting of either nucleic 
acids or proteins on the basis of size and electric charge. Since DNA is a negatively 
charged molecule, it moves through an agarose gel matrix with an electric current 
towards the positive electrodes. The smaller molecules will travel further along the gel 
since they can move with much less resistance. Ethidium bromide is added to the 
product as it binds to DNA and can then be visualised under UV light. Molecular size 
markers (usually a 100 base-pair ladder) are also run on the gel along side the PCR 
products and can be used as a size indicator for the bands. The buffer used for loading 
the samples on the gel contains glycerol which makes the samples more dense and 
causes them to sink to the bottom of the wells so they are not lost to the surrounding 
buffer whilst loading. In addition the loading buffer contains the dye bromophenol blue 
as it allows visualisation when loading the gel and because it allows a simple estimate 
of sample migration through the gel during electrophoresis. After the electric current has 
been applied and the products have separated along the gel, the bands can be removed 
from the gel and either re-amplified using internal primers or processed for sequencing. 
Agarose gels were prepared by adding agarose powder to a conical flask along with 0.5 
x TBE buffer. The amount of agarose was usually 1 % (w/v) although this could be 
increased to examine lower molecular size products. The agarose suspension was 
heated in the microwave for about lmin until all the agarose had dissolved. It was then 
left to coolon the bench for 5 mins and 3J.lI of ethidium bromide was added to the 
solution. This was then poured into a gel tank and a comb was inserted to provide 
Materials and Methods Chapter 2 71 
loading wells for the PCR products. Loading buffer was added to each PCR product and 
20J.lI of each was added to an individual well on the gel. A voltage difference 
(-IOV/cm) was applied to the gel and the gel was run for about Ihr 
2.7.1 Southern Blotting 
The Southern blot was invented by EM Southern in 1975, (Southern 1975), and it is a 
means of permanently immobilizing single-stranded nucleic acids to a solid support. 
This can be a very useful technique for identification of bands on a gel and to ensure 
that they do in fact represent the sequence of DNA which it was intended to amplify. It 
works by using a buffer and wick system, which transfers the DNA bands from a gel to 
a nitrocellulose membrane. During this process the DNA is made single stranded. After 
Southern blotting the DNA is usually detected by "probing" with a complementary 
DNA probe. Probe detection involves exposure ofthe nitrocellulose membrane to a 
probe of specific complementary sequence to cDNA of interest. It is labelled usually 
with a radioactive isotope and allowed to hybridise to the amplified products. This can 
then be visualised by exposure to radiographic film. 
In detail the procedure involves the following steps: 
1. Excess gel is trimmed and the top right hand comer cut off for orientation 
2. 500ml O.4M NaOH is prepared to act as a transfer buffer, and 4 pieces of Whatman 
3MM paper are cut to the same size as the gel and one twice as long to be used as a 
wick. The NaOH buffer also acts to denature the DNA during the transfer process. 
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3. Membrane paper (positively charged nylon membrane from Boeringer Mannheim) is 
cut to the size of the gel, marked with a pencil in the top right hand comer and wet 
with transfer buffer. Gel support is placed in Pyrex dish, and transfer buffer added. 
4. The paper wick is placed over the support and edges submerged in the transfer buffer. 
The gel is placed on top of the wick and four strips of parafilm are placed over the edges 
of the gel. This is to prevent the buffer from "short -circuiting" ie to ensure that the 
buffer flows through rather than around the gel. 
5. The membrane is pre-wet in buffer and placed exactly over the gel. Air bubbles are 
carefully removed 
6. Two pieces of3MM paper, the same size as the gel, and wet with transfer buffer are 
placed over the membrane. Paper towels are cut to the same size as the membrane and 
stacked on top of Whatman 3MM papers to a height of about 10cm. This acts as a sink 
to allow flow of buffer through the membrane. 
7. A glass plate is laid on top of the structure and a weight placed on top. This is left 
overnight to ensure transfer of DNA is complete. Membranes are then removed, washed 
in buffer and wrapped in saran wrap. 
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~~~~~~===~~~~~'r- Nitrocellulose membrane 
3MM paper wick 
Support 
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Sodium hydroxide buffer 
Figure 2-3 Requirements for Southern blotting 
2.7.2 Southern hybridisation 
In order to detennine whether bands, which have been amplified by PCR, belong to the 
specific gene, which has been targeted, the membrane is incubated overnight at 65°C in 
a heat proof glass bottle along with a hybridisation solution and a radio-labelled probe. 
This will bind to complementary sequence on the membrane and can then be detected 
by exposing the membrane to Xray film. Areas where radiolabelled probe has bound 
will show up as dark bands on the film. 
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2.7.3 Prehybridisation solution 
The prehybridisation solution consisted of 6 x SSC, 5 x Denhardts reagent, 0.5% SDS 
and lOOJ.1g1ml of denatured, fragmented salmon sperm DNA. 
The nitrocellulose membrane with single stranded DNA transferred from the gel was 
placed in a glass bottle along with 25ml of pre hybrid is at ion solution. This was placed in 
oven at 65°C and left for one hour. 
32p labelled probe was prepared using a gel purified PCR product from amplification of 
exons 1-9 of LH receptor as a template and a random priming labeling kit. BioPrime 
labeling kit (GibcoIBRL) this contains random octamers, reaction buffer, Klenow (a 
DNA polymerase) and dNTP's. Probe was heated to 95°C for 5 mins to denature it. This 
was then added to the glass bottle containing membrane and prehybe solution. The 
bottle was then place in a hybridisation oven and left over night rotating at 65°C. 
Membrane was then washed with X2 SSC and 1 % SDS for 30 min at 65°C then Xl 
SSC and 0.1 % SDS for 5 mins. 
The membrane was removed from the hybridisation bottle and wrapped in saran film, 
this was then placed in a cassette with film (Biomax MR). The cassette was left for an 
appropriate length of time (5 min to overnight) and the film developed. 
2.7.4 Band Extraction 
Sometimes, when PCR products have been run on a gel it may be desirable to extract 
the bands for further processing. The gel would be viewed under UV light box so that 
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desired bands were clearly visible. Bands were then removed using a scalpel blade and 
immediately transferred to a mini column (Chemicon). The length oftime the gel was 
exposed to UV light was kept to a minimum as this degrades the cDNA. The mini 
columns containing gel slices were then centrifuged for 1 min at 1300Orpm. After 
spinning, the gel matrix is trapped on the column and the aqueous phase containig the 
cDNA collects in the bottom of tube. The cDNA can then be stored at -20°C until 
further use. 
2.8 DNA Sequencing 
Sequence analysis of cDNA is the final proof of identity for a PCR product. It is also 
essential if the product sequences are unknown (eg due to alternate splicing). To 
determine the sequence of an amplified PCR product normally it would be extracted 
from an agarose gel, purified as above using a mini column and then sequenced. In this 
study all PCR products were sequenced using an ABI 310 automated sequence 
analyser. 
2.8.1 Principle of DNA cycle sequencing 
DNA sequencing is the determination of the precise sequence ofnucleotides in a sample 
of DNA. The most popular method for doing this is called the dideoxy method. A 
dideoxynucleotide can be added to the growing DNA strand but when it is, chain 
elongation stops because there is no 3' OH for the next nucleotide to be attached to. For 
this reason, the dideoxy method is also called the chain termination method. Because all 
four normal nucleotides are also present, chain elongation proceeds normally until, by 
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chance, DNA polymerase inserts a dideoxy nucleotide instead of the normal 
deoxynucleotide. The ABI31 0 automated sequence analyser uses this method, and each 
of the dideoxynucleotides fluoresces a different colour when illuminated by a laser 
beam and this is detected and exact sequence of DNA template can then be 
determined.There are three major steps in each cycle (like in PCR), which are repeated 
around 30 times. 
I. Denaturation at 94°C: During the denaturation, the double strand melts open to 
single stranded DNA 
2. Annealing at 50°C: In sequencing reactions, only one primer is used, so there is only 
one strand copied 
3. Extension at 60°C: This is the ideal working temperature for the polymerase 
(normally it is 72°C, but the lower temperature is used because it has to incorporate 
ddNTP's, which are chemically modified with a fluorescent label. Whenever a 
ddNTP is incorporated into the strand the extension terminates. 
4. The individual fragments are then ran on a gel within the automated sequencer, each 
fragment is flourescently labelled and as they migrate through the gel the flourescent 
molecule is excited by a laser. This then sends out light of a distinct colour. Each 
base has its own colour, so the sequencer can detect the order ofthe bases in the 
sequenced gene. 
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2.9 Hydrophobicity Analysis of translated Proteins 
Hydrophobicity plots are designed to display the distribution of polar and apolar 
residues along a protein sequence. Hydrophilic groups are typically polar, interacting 
with water by hydrogen bonding. For this reason, they are called "water loving." 
Hydrophobic groups, on the other hand, are nonpolar, unable to interact with water, and 
thus are referred to as "water fearing". The hydrophobicity of the amino acids 
detennines where the amino acid will be located in the final structure of the protein 
(Kyte and Doolittle 1982). 
Hydrophobic amino acids tend to occur in the interior of globular proteins, while at the 
surface of a protein one will preferentially find hydrophilic residues. In transmembrane 
proteins, the regions of the chain that span the membrane tend to be strongly 
hydrophobic. In the case of the full-length receptor transcript, exons 1-10 encode 
hydrophilic amino acids, as this is the extracellular honnone-binding region of the 
receptor, whereas exon 11 has both hydrophobic and hydrophilic regions as the amino 
acid chains span the membrane in a looping fashion. 
Because a hydrophobicity plot has the goal of predicting membrane-spanning segments 
(highly hydrophobic), or regions that are most likely exposed on the surface of proteins 
(hydrophilic domains). A Kyte and Doolittle Hydrophobicity plot was perfonned on the 
amino acid sequences of the three spliced transcripts and full-length fonn of the mouse 
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LH receptor. Each amino acid is given a hydrophobicity score between -4.6 and 4.6. A 
score of 4.6 is the most hydrophobic and a score of-4.6 is the most hydrophilic 
Window size refers to the number of amino acids examined at a time to determine a 
point of hydrophobic character. Window size can be varied from 5 to 25 (default 7) and 
one should choose a window that corresponds to the expected size of the structural 
motif under investigation. A window size of 5-7 is good for finding hydrophilic regions. 
Alternatively a window size of 19-21 will make hydrophobic, membrane-spanning 
domains stand out rather clearly (typically> 1.6 on the Kyte and doolittle scale). A 
window size of9 was used for the analysis on the LHR transcripts to accommodate both 
hydrophobic and hydrophyilic regions. 
2.10 Real Time peR 
Real time peR is a technological step forward from manual quantitative peR and 
allows accurate quatitation of cDNA levels in a sample. It is now an important 
qualitative and quantitative tool in the field of molecular biology. It is qualitative in that 
it detects expression of a particular gene from a cDNA template, and quantitative as it 
shows expression levels relative to a house-keeping gene. It is similar to the manual 
method of semi quantitative peR in that it assesses the amount of peR product 
produced at a specific stage in the reaction, but the method of detection differs as this is 
achieved by a fluorescent dye. This method is much less time consuming, more 
accurate, and allows for larger sample numbers. 
The ability to monitor the real-time progress of the peR completely revolutionizes the 
way one approaches PeR-based quantitation of DNA and RNA. Products of the peR, 
Materials and Methods Chapter 2 79 
measured at the point in time during cycling when amplification of a PCR product is 
first detected (threshold cycle ct) rather than the amount ofPCR product accumulated 
after a fixed number of cycles. The higher the starting copy number of the nucleic acid 
target, then the lower the ct value will be. 
Real Time PCR uses threshold measurements during the exponential phase of amplicon 
production instead of end points. As the PCR proceeds in the TaqMan 5' nuclease assay, 
fluorescence is released in direct proportion to the accumulation of PCR product. 
Through the use of a CCD camera, fluorescence production is continually monitored in 
each of the reaction wells. 
Reverse 
transcription 





Figure 2-4 Sequence of events for semi quantitative peR 
2.10. 1 Primers and Probes 
The probe is an oligonucleotide with both a reporter fluorescent dye and a quencher dye 
attached. While the probe is intact, the proximity of the quencher greatly reduces the 
fluorescence emitted by the reporter. Probe design and synthesis has been simplified by 
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PCR in that they con ist of about a 20base sequence complimentary to specific areas of 
the gene ofintere t Ideally, at lea tone of the primers for each gene would be designed 
from a region of intronl exon boundary to avoid amplificaion of contaminating genomic 
O~A In practice thi i often not po ible (eg lack of information of genomic structure 


















Figure 2-5 Stepwise representation of polymerisation acting on a fluorogenic 
probe during one extension cycle of peR 
The primer and probe to be u ed with the Taqman method were designed using Primer 
E'pre (Applied Bio y tern, Warrington UK.) and are listed in table 2.1. Sequence 
information \\<a obtained from Genbank using the Entrez search facility . Genbank 
contain full or partial cD" sequences previously submitted. With Sa-reductase type] 
ho\,. c\ er there \\ a no publi hed mou e equence in the Genbank database at the time 
the"e "tudle" \\ere camed out, 0 equence was obtained using EST's (expressed 
equence tag ), thee \\ere identified by a basic local alignment search using rat 5a-
reducta ... e t\ pe I Thl .... proc __ is de cribed in detail in Chapter 4. 
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2. 10.2 Probe sequences for genes quantHied 
Gene Genbank Sequence (5' ~ 3') 
F GCGCTAGTCTACCTGGAGGGT 
SaReductase EST's R GAAGAGCCCACCATCTGGAG 
Type 1 P TCCTGGCTTTCGTGGCCTTCGTG 
F CATCCACAGTGACTGCATGC 
SaReductase* R AGGTGGCTTGTTTACGT 
Type 2 P AGGAAGCCCGGAGAGAGGTCATC 
F GACCAAAAGCTGAGGCTGAGA 
LH receptor M81310 R CAATGTGGCCATCAGGGTAGA 
P TGCCATCCCAA TT ATGCTCGGAGGA 
F TCGAAGTATTCCGCGTACGTG 
Luciferase** R GCCCTGGTTCCTGGAACAA 
P TGTTCACCTCGATATGTGCATCTGTAAAA 
F CCAGTGTCCCCATGCTCAAAC 
P450scc AF195119 R TGCATGGGTCCTTCCAGGTCT 
P TGCCTCCAGACTTCTTTCGACTCCTCAGA 
F CCGGAGCAGAGTGGTGTCA 
StAR L36062 R CAGTGGATGAAGCACCATGC 
P CAGTGGATGAAGCACCATGC 
Table 2-1 Sequence of probes used for real time PCR 
* Derived from new mouse sequence obtained from initial PCR studies * * Derived from 
sequence ofrnRNA provided by Promega (Madison, WI) 
F = Forward primer, R = Reverse primer, P = probe 
2.10.3 Standard Curves 
Before performing the actual real time PCR reactions it is first necessary to construct a 
standard curve, which determines the appropriate dilution of cDNA template to achieve 
maximal amplification. A standard curve is obtained using primers and probe for gene of 
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interest and also an internal standard such as the house keeping gene actin or an external 
standard such as Luciferase. The dilution factors used in these experiments were 1, 1/5, 
1/125, 11625. These are plotted in reverse order on the graph with 625 being the most 
concentrate template and 1 the most dilute. The slope of the curve can be used to assess 
efficiency of PCR amplification. Efficiency of reaction is expressed as a percentage, with 
100% being the optimal. A worked example for J3 actin is included below the graph. The 
standard curves provide useful information on amplification efficiency. In order for a 
relative comparison to be made between sample it is important that amplification 




1 5 25 125 
Template concentration (1n) 
Figure 2-6 Real time PCR standard curves 
625 
These standard curves were prepared by serial dilutions of adult testis cDNA. The log of 
the relative template concentration was plotted against the threshold cycle (Ct) and 
regression analysis was used to generate the best-fit line. Results from duplicate 
amplifications of luciferase (A), 18S (+), Wbscrl (_), andfl-actin (T) cDNA are shown 
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Calculation for efficiency of reaction for J3 actin 
Y=-MX+C M=YIX M = slope ofline 
Slope ofline = 1.5046 0.4343/1.5046 = 0.2886 
10°·2886 = 1. 944 - I = 0.944 = 94 ole amplification efficiency 
For most of the Real time PCR experiments B-actin was used as an internal standard. At 
the time this was the most commonly used house keeping gene for quantitation studies. 
Other experiments performed in the lab however later showed that there was not always 
consistency of expression levels with 8-actin and that these could vary greatly between 
fetal and adult tissue and it also depended on tissue type used for eDNA template. For 
example Illg of eDNA from adult tissue may express much higher levels of actin than 
IlJ.g of cDNA from fetal tissue. this then introduces inconsistency and errors in 
measurement. For this reason an external standard was used for any subsequent 
reactions. This is a far more accurate method of quantitation as a known quantity of 
Lueiferase is added to the reaction mix prior to PCR amplification. 
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Figure 2-7 Summary flowchart of sequence of molecular biology techniques 
LH Receptor Chaoter3 
Chapter 3 
Expression of the LH 
Receptor 
in the mouse testis 
during development 
85 
LH Receptor Chapter 3 86 
3 LH Receptor gene 
The LH receptor is encoded by a gene consisting of 11 exons and 10 introns, The 
processed, full length fonn of the mouse LH receptor gene is encoded by 2650 bases. 
Exons 1 - 10 each consist of about 80 bases, whereas exon 11 is much larger with 1750 
bases. Variant fonns of the gene encoding the LH receptor were initially identified during 
porcine LH / CG receptor cDNA analysis and many other studies since then have 
supported these findings (Misrahi 1996, Wang et all991). Cloning of the LH receptor 
has shown that it is a single polypeptide composed of two general domains of equivalent 
size (Minegish et a/199O). It contains an amino (N) - terminal segment, which is 
extracellular (Rodriguez and Ssegaloff 1990) and consists of a repeating leucine rich 
motif (McFarland et a/1989). This domain contains six potential sites for N - linked 
glycosylation and it has been shown that this portion of the molecule is entirely sufficient 
for binding honnone with high affinity (Xie et aI199O). The carboxy terminal contains 
seven regions of hydrophobic amino acids and it spans the membrane seven times, with 
the carboxy - terminal tail extending intracellularly. (McFarland et aI1989). The seven 
transmembrane strands, which fonn the transmembrane core, are linked by three 
exoloops, and four cyto loops. 
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3.1 LH Receptor Structure 
The diagram of the LH receptor depicts these regions. 
..... -N terminal , extra cellular 
Hormone binding domain 
87 




Figure 3-1 Structural diagram of LH receptor depicting functional domains 
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3.2 RNA Splicing 
RNA splicing was discovered just over twenty five years ago, and since then many 
advances have been made in our understanding of the biochemical basis of the splicing 
reaction (Grabowski el a11985. Pagdgett et aI1986). The general understanding of the 
functional significance of RNA splicing is that it has evolved as a mechanism for 
regulating gene expression and generating isoform diversity. 
Alternative splicing usually gives rise to protein isoforms sharing regions of identity, with 
variation only occurring in specific domains. These different isoforms may then allow for 
the fine modulation of gene expression and protein function. All eukaryote RNA must 
first undergo a series of processing events in order for gene expression to occur. These 
processing events include addition ofa 7-methyl guanosine to the 5' end of the RNA 
fragment, this is known as capping. Processing also occurs at the 3' end of the fragment 
with the addition of a poly adenosine (A) tail (Bimstiel el aI1985). At this stage the 
transcript still consists of exons (coding regions) and introns (non coding regions). 
Before translation can successfully occur the introns must be precisely excised and the 
exons correctly ligated to avoid disruption of the open reading frame. 
Splicing involves several steps, which must occur with high precision. Most importantly, 
though, there must be a recognition site in order for the splicing machinery to cleave the 

















Recognition of splicing sites tends to occur around conserved sequences of DNA. The 5' 
splice site consensus sequence is AG / GUR AGU, the intron exon boundary is denoted 
by / and the 3' splice site consensus sequence is AG / G 
3.2.1 Alternative splicing in LH receptor 
It is now well established that the LH receptor exists in multiple isoforms as a result of 
alternate splicing of the gene. Alternative isoforms have been identified and 
characterised in several species such as~ bovine (Kawate and Okuda 1998), ovine (Bacich 
et al 1994), porcine (Loosfelt et a11989) avian (You et a12000) and rodent (Tena-
Sempere et a11994) 
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Several studies have identified multiple LHR isoforms common to various species 
suggesting a common mechanism that may be evolutionary conserved. These isoforms 
are present in both the ovaries and the testes indicating that it is not a sex specific 
phenomenon. At the time of these studies it had been shown that fetal Leydig cell 
function did not require LH. Since it is known that some G-proteins can show 
constitutive activity it was possible that some isoform of the LHR may be expressed in 
the fetal Leydig cells which constitutively activates the cells. The overall objectives of 
this part of the study were: 
3.3 Objectives 
1. Identification of alternate transcripts of the LH receptor gene present in mouse testes 
using molecular biology techniques. 
2. Determination of differential expression of the truncated transcripts at various stages 
of testicular development. from embryonic to adult. 
3. Sequence and protein analysis of the bands. 
4. Quantitation of LH receptor expression using Real Time peR 
3.4 Methods and materials 
Male mice, age range from embryonic day 15 through to adult were sacrificed and testes 
removed. Testes were identified in embryonic mice by greater vasculature than ovaries 
and larger size. These were then stored in liquid N2 until required. Total RNA was 
extracted from whole testis using RNAzol B (described in detail in chapter 2). RNA was 
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reverse transcribed using random hexamers then PCR was perfomed using primer 
combinations spanning extracellular and transmembrane domains of mouse LH receptor. 
PCR products were run on a gel, which was then subjected to Southern blotting using 
mouse LH receptor specific probe from the extracellular region of the gene. In addition, 
the bands were extracted and purified then sequenced using automated sequence 
analysis. 
The sequences obtained were then entered in a blast search to confirm if they were 
indeed mouse LH receptor sequence and also to assess whether alternate splicing had 
occurred. Alignment of bands sequences with the full-length mouse LH receptor cDNA 
sequence allowed for assessment of splice sites. Blast is a molecular biology computing 
programme available from NCBI. It allows various alignments and matches to be 
performed on sequences of DNA, which are entered. It searches various databases such 
as Genbank which contains already published DNA sequences from genes of many 
species and it performs a best fit alignment to DNA sequence entered. This allows you to 
take an unknown sequence of DNA obtained from automated sequencing and assess 
whether it is in fact from the gene which you were initially trying to target with peR. 
The sequence of the LH receptor bands were translated to see if an open reading frame 
could be applied. Protein sequences were then characterised using a Kyte and Doolittle 
hydrophobicity plot to determine hydrophobic or hydrophilic nature of structure. 
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3.4.1 Experimental Design 
Primers were designed from mouse LHR cDNA sequence (Genbank M8131O) 
Primer Sequences 
Primer number 
138 - ACGGCTCGGTGCCCGACCTC 




20 - ATAAAGCGTCTCGTTATTCGC 
PCR was performed using various combinations of these primers. Originally it was 
intended to amplifY the whole gene from 5' of exon 1 to the 3' of exon 11, using primer 
combination 147/283. Several attempts failed to produce any detectable bands on the 
gel, however, a nested PCR was then performed using primer combination 26 1284. This 
did produce some faint bands, but results were inconsistent when repeated several times. 
It was decided, therefore, to amplifY the gene in two sections, firstly using primers 
complimentary to exon 1 and exon lOin order to establish if the full-length extracellular 
domain was being expressed and then using primers complimentary to exons 9 and 11 in 
order to assess whether the full-length transmembrane/intracellular domain was 
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expressed. The primer combinations have been highlighted with red to represent 
extracellular amplification and blue to represent transmembrane amplification. peR was 
perfomed on cD A generated from mouse testis using these primer combinations for 
each age group. In addition to the LH receptor it was decided to examine mRNA 
expression ofP450scc. As this is one of the key enzymes involved in the steroidogenic 
pathway, high expression levels can be used as an indicator of active steroid synthesis. 
In addition P450scc acts as a Leydig cell-specific marker and, therefore, as a positive 
control for sample preparation etc. 
3.4.2 Primer position 
4 <38 • • ,,8J 
• 284 
Figure 3-3 Exon structure of LHR gene showing position of primers and direction of 
primer extension 
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3.5 Hydrophobicity plots 
3.6 Results 
peR with P450scc primers resulted in a band of the expected length for each of the ages 
looked at (Fig 3.4). The bands did vary in intensity although this was not a quantitative 
assay. Amplification of the extracellular region of the LHR resulted in a band of the 
expected size for that particular primer combination in every age group. This indicated 
that full-length extracellular domain was being expressed in at all ages studied (figure 
3.7). Southern blot analysis (figure 3.8) confinned that the bands amplified were indeed 
those belonging to the extracellular region of the mouse LH receptor. With the LHR 
transmembrane primer combinations, various band sizes were obtained for different 
stages of testis development (figure 3.5). At embryonic stages 15 and 16 dpc there was 
no bands of full-length receptor size, but two shorter fonns were present. Bands 
indicative of full-length receptor were detectable from 17dpc~ in addition the shorter 
forms were also present. Southern blot (figure 3.6) analysis confinned that all the bands 
detected were indeed those of mouse LH receptor. 
Over the different ages, 4 bands of varying sizes were clearly detectable after 
amplification of the transmembrane region. The bands varied in size from 400bp -
1400bp, the bands also varied in intensity of fluorescence which could be indicative of 
differences in expression levels. 
The four strongest bands were selected and removed from gel (figure 3.9) Sequence 
analysis of the bands also confirmed that they were mouse LHR and highlighted which 
areas of the transmembrane region were missing due to alternate splicing. 
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Band 1 - 393bp 
Sequence analysis showed that this transcript lacked 972bp of sequence compared to the 
expected ful-Iength sequence. The missing sequence spanned from the end of exon 10 
into exon 11 (figure 3.10). This transcript did remain in frame and was therefore a 
truncated version of the full-length transcript. Stop codon was present after 176bp of 
rejoined sequence. Hydrophobicity analysis on the translated protein showed this 
transcript to be extremely hydrophobic in nature after the 3' splice site. 
Band 2 - 488bp 
Sequence analysis showed that this transcript lacked 877bp of sequence compared to the 
expected full-length sequence. The missing sequence spanned from the end of exon 10 
into exon 11 (figure 3.11). There was a total of 877bp missing from this transcript. 
Translation analysis revealed that from the rejoining site, this transcipt was out offrame 
compared to the full-length transcript. A stop codon was present after 95bp of rejoined 
sequence. Hydrophobicity analysis on the translated protein showed this transcript to be 
hydrophobic in nature after the 3' splice site. 
Band 3 - 945bp 
This was the largest of the three spliced transcripts. Sequence analysis showed that this 
transcript lacked 420bp of sequence compared to the expected full-length sequence. The 
missing sequence spanned from the end of exon 10 into exon 11 (figure 3.12) There was 
a total of 420bp missing from this transcript. A stop codon was present after 266bp of 
rejoined sequence. Like band 2 this transcript was also out of frame with the full-length 
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transcript. Hydrophobicity analysis on the translated protein showed this transcript to be 
hydrophilic in nature. 
3.6.1 Hydrophobicity plots 
All transcripts showed identical hydrophobicity for the first 220 amino acids which span 
from exons 1-10. After the 3' splice site on exon 10 the amino acids differ with only 
transcript I having the same amino acid sequence as the fun-length receptor. 
Hydrophobicity analysis revealed that the protein nature of exon 11 of this transcript was 
extremely hydrophobic with most of the amino acids being greater than 2 on the K yte 
and Doolittle plot . Bands 2 + 3 also displayed the same extent of hydrophobicity with 
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Figure 34 Gel image showing bands representing P450 side chain cleavage expression 
in mouse testes of different ages. 
The enzyme p450 side chain cleavage (p450SCC) was included as a positive control for 
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Figure 3-5 Gel picture showing LH receptor bands spanning transmembrane region 
These bands were obtained from the primer combination 138 / 283 then nested with 138 
/ 284 from exons 9 - 11 . The expected full-length size was 1365bp 
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Figure 3-6 Southern blot image of gel showing bands representing 
transmembrane region 
E15 E16 E17 E18 Dl D5 DI O DI S D20 D25 D30 Adult 
Figure 3-7 Gel 3 showing bands produced with primer combination 282/20 
spanning extracellular region, exons 1 -10. 
Expected band size was 780bp 
98 
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800bp+ 
E15 E16 E17 E18 D1 D5 DIO DI5 D20 D25 D30 Adult 
Figure 3~ Southern blot image of bands representing extracellular region. 
Expected band size was 780bp 
600bp 
400bp 
E15 E16 E17 E18 01 
Figure 3-9. LHR bands extracted for sequencing 
Band 1 393bp Band 3 945bp 
Band 2 488bp Band 4 136Sbp (full-length receptor) 
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All gel and southern blot images presented in this thesis are representative of the many 
results accumulated. PCR's were performed on each age group between 5 and 10 times. 
T estes from 4-8 animals per age group were used. 
3.7 Sequence analysis of bands 
Band 1 size 393bp - 972bp missing (highlighted in red), primer positions and intronlexon 
boundaries are highlighted in blue. PCR primers are highlighted in blue and Real time 
























































gcggcgggtc ccggctctga gacagctgct ggtgctggca atgctggtgc 
acagctgcac tctccagagt tgtcagggtc gcgctgccct gagccctgcg 
ggatggtgcc ctgcgctgcc ctggccctcg agctggcctc gcccgact at 
tctccctgtc aaagtaatcc catcacaagc tttcagggga cttaatgagg 
tgaaatctct cagagtgatt ccctggaaag gatagaagct aatgcctttg 
caatctgtct gaaat actga tccagaacac caaaaacctg ctatacattg 
ttttacaaac ctccctcggt taaaatacct gagcatctgt aacacaggca 
cccagatgtt tcgaagatct cttcctctga atttaatttc attct ggaaa 
cttatacata accaccatac cagggaacgc tttccaaggg atgaataatg 
gct gaaactg tatggaaatg ggtttgaaga agtacaaagc catgcattca 
gctaatctcg ct ggagttaa aagaaaacat ctacctggag aagatgcaca 
ccagggggcc acggggccca gcatcct gga tgtctcttcc accaaattgc 
__ ; q ~~ ~ct catcgccacg tcatcctact 
tctgccctcc agagaaaaat tcaccagcct actggttgcc acgctgacct 
ctgctgtgct ttcaggaatt tgccgaagaa aga acagaat ttttcatttt 
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ggttgctgta agcaccgggc tgaactttac agaaggaagg 
aactccaaaa acggctttcc aagatcaagt aagccttccc 
atagtgcact gtcaacaacc tacacctcca 
2 ccccaaaaaa gtccacccaa 
gtgttttaga aaaaatattt atctttaagc acttcaggtg 
ggtggcccaa gacacttggt gacataaatt tcagaagggt 
atttagaaag aatagttttt gtttgttgaa tctaatatta 
attttccatg tctcttgatc tttttcactt caatctgtga 
tatatattca taacagactg gaaatttaaa gtggtctttg 
tacattcaag agatgcactg tgcagcgtga tagctgttag 
tttcttagcc ataaaaaaaa aaaaaaaaa 
Figure 3-10 Sequence of LHR transcript band 1 
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gcggcgggtc ccggctctga gacagctgct ggtgctggca atgctggtgc 
acagctgcac tctccagagt tgtcagggtc gcgctgccct gagccctgcg 
ggatggtgcc ctgcgctgcc ctggccctcg agctggcctc gcccgact at 
tctccctgtc aaagtaatcc catcacaagc tttcagggga cttaatgagg 
tgaaatctct cagagtgatt ccctggaaag gatagaagct aatgcctttg 
caatctgtct gaaat actga tccagaacac caaaaacctg ctatacattg 
ttttacaaac ctccctcggt taaaatacct gagcatctgt aacacaggca 
cccagatgtt tcgaagatct cttcctctga atttaatttc attct ggaaa 
cttatacata accaccatac cagggaacgc tttccaaggg atgaataatg 
gct gaaactg tatggaaatg ggtttgaaga agtacaaagc catgcattca 
gctaatctcg ct ggagttaa aagaaaacat ctacctggag aagatgcaca 
ccagggggcc acggggccca gcatcct gga tgtctcttcc accaaattgc 
~ ct catcgccacg tcatcctact 
tctgccctcc agagaaaaat tcaccagcct actggttgcc acgctgacct 
ctgctgtgct ttcaggaatt tgccgaagaa aga acagaat ttttcatttt 
aaacttttcc aaacaatgtg aaagcacagt tagagaagcg aataacgag 
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~tgct ggtccttttt tatcctgtca 
attcttgtgc caacccattt ctgtacgcag tgttcacgaa ggcatttcag agagatttct 
ttctcttgct gagcagattt ggttgctgta agcaccgggc tgaactttac agaaggaagg 
aattttctgc atgtaccttc aactccaaaa acggctttcc aagatcaagt aagccttccc 
aggctgccct gaagttatcc atagtgcact gtcaacaacc tacacctcca 
.. d" gca ccccaaaaaa gtccacccaa 
~ 
attagtcact ttaatataat gtgttttaga aaaaatattt atctttaagc acttcaggtg 
aattgaaacc tgcttcaaag ggtggcccaa gacacttggt gacataaatt tcagaagggt 
ttagaaaatt ttttataata atttagaaag aatagttttt gtttgttgaa tctaatatta 
agaaaatcta agttgttgtc attttccatg tctcttgatc tttttcactt caatctgtga 
ttcatgttgc catctctaaa tatatattca taacagactg gaaatttaaa gtggtctttg 
tcctcagata gtttgataaa tacattcaag agatgcactg tgcagcgtga tagctgttag 
ccttacatgg taaataaaag tttcttagcc ataaaaaaaa aaaaaaaaa 
Figure 3-11 Sequence of LHR transcript band 2 
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Band size 3 size 945bp - 420bp missing 
1 gggee~g geggcgggtc ccggctctga gacagetgct ggtgctggca atgctggtgc 
61 tgaagcagtc acagetgcac tetccagagt tgtcagggtc gcgctgccct gagecctgcg 
121 actgegegce ggatggtgcc ctgcgctgec ctggecetcg agctggcctc gcccgact at 
181 ctctcaeeta tcteectgte aaagtaatec catcacaage ttteagggga cttaatgagg 
241 tcgtaaaaat tgaaatetet eagagtgatt ecctggaaag gatagaagct aatgcetttg 
301 acaaecteet eaatetgtct gaaat actga tceagaaeac caaaaacetg ctatacattg 
361 aaceeggtge ttttacaaac ctccctcggt taaaatacct gagcatctgt aacacaggca 
421 tccggaccct eccagatgtt tcgaagatct cttcctctga atttaatttc attct ggaaa 
481 tetgtgataa cttataeata aecaccatac cagggaacge tttecaaggg atgaataatg 
541 agteeatcac gct gaaaetg tatggaaatg ggtttgaaga agtacaaagc catgcattca 
601 atgggacgac gctaatctcg ct ggagttaa aagaaaacat ctacctggag aagatgcaca 
661 gtggeacctt ecagggggcc acggggccca gcatcct gga tgtctcttcc accaaattgc 
721 aggcc ,;d, ~,- '-ct catcgccacg tcatcctact 
781 cactgaaaa e tctgccctcc agagaaaaat tcaccagcct actggttgcc acgctgacct 
841 accetagcca etgetgtgct ttcaggaatt tgccgaagaa aga acagaat ttttcatttt 
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ctggaaaggt ggcacaccat cacctatgct gttcagctgg 
ca ggatgg attttt 
cttgtgggtg tcagcagtta catgaaagtc agcatctgcc 
actctgtcac aagtctacat attatccatc ttgctcctca 
atctgtgctt gctacgttag gatatacttt gcagttcaaa 
aacaaggaca caaaaattgc taagaagatg gccatcctca 
atggcaccca tctcattctt tgccatctca gctgccttca 
accaactcaa aagtt~tgct ggtccttttt tatcctgtca 
ctgtacgcag tgttcacgaa ggcatttcag agagatttct 
ggttgctgta agcaccgggc tgaactttac agaaggaagg 
aactccaaaa acggctttcc aagatcaagt aagccttccc 
atagtgcact gtcaacaacc tacacctcca 
__ ~ __ ~_ ~a c ccccaaaaaa gtccacccaa 
gtgttttaga aaaaatattt atctttaagc acttcaggtg 
ggtggcccaa gacacttggt gacataaatt tcagaagggt 
atttagaaag aatagttttt gtttgttgaa tctaatatta 
attttccatg tctcttgatc tttttcactt c aatctgtga 
tatatattca taacagactg gaaatttaaa gtggtctttg 
tacattcaag agatgcactg tgcagcgtga tagctgttag 
tttcttagcc ataaaaaaaa aaaaaaaaa 
Figure 3-12 Sequence of LHR transcript band 3 
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3.7.1 Translated transcript 1 Band size 393bp 
gggeeatggggcggcgggteccggctctgaqacagctgctggtgctggcaatgctggtgc 
~ ---------+---------+---------+---------+---------+---------+ 
A M G R R V PAL R Q L L V LAM L V L 
tgaagcagtcacagctgcactcteeagagttgtcagggtcgcgctgccctgagccctgcg 
61 ---------+---------+---------+---------+---------T---------, 
K Q S Q L H S PEL S G S Rep E P C D 
actgcgegccgqatggtgccctgcgctgccctggccctcqagctggcctcgcccgactat 
121 ---------+---------+---------+---------+---------+---------+ 
CAP D GAL Rep G P RAG L A R L S 
etctcacctatctccctgtcaaagtaatcccatcacaagctttcaggggacttaatgagg 181 _________ + _________ + _________ + _________ + _________ + _________ + 
L T Y L P V K V IPS Q A F R G L N E V 
tcgtaaaaattgaaatctctcagagtgattccctggaaaggatagaagctaatgcctttg 
241 ---------+---------+---- -- ---+---------+---------+---------+ 
V K I E I S Q S D S L E R I E A N A F D 
acaacctcctcaatctgtctqaaatactqatccagaacaccaaaaacctgctatacattg 
301 ---------+---------+---------+---------+---------+---------+ 
N L L N L S ElL I Q N T K N L L Y I E 
aacccqqtgcttttacaaacctccctcggttaaaatacctgagcatctgtaacacaggca 361 _________ + _________ + _______ _ _ + _________ + _________ + _________ + 
P G AFT N L P R L K Y LSI C N T G I 
tccggaccctcccaqatgtttcqaaqatctcttcctctgaatttaatttcattctggaaa 
421 ---------+---------+---------+------- - -+---------+---------+ 
R T L P D V SKI S SSE F NFl LEI 
tctgtgataacttatacataaccaccataccagggaacgctttccaagggatgaataatg 
481 ---------+---------+---------+---------+---------+---------+ 
C D N L Y ITT I P G N A F Q G M NNE 
agtccatcacgctgaaactgtatggaaatgggtttgaagaagtacaaagccatgcattca 
541 ---------+---------+---------+--- ---- --+---------+---------+ 
SIT L K L Y G N G FEE V Q S H A F N 
a tgggacgacgctaatctcgctggagttaaaagaaaacatctacctggagaagatgcaca 
601 ---------+---------+---------+---------+---------+---------+ 
G TTL I S L ELK E N I Y L E K M H S 
gtggcaccttccagqqgqccacggggcccagcatcctggatgtctcttccaccaaattgc 
661 ---------+---------+---------+---------+---------+---------+ 
G T F Q GAT G PSI L D V SST K L Q 
aggcc ctcatcgccacgtcatcctact 
721 ---------+---------+---------+---------+---------+---------+ 
ALP S H G L E S I Q T L I A T S S Y S 
cactgaaaactctgccctccagagaaaaattcaccagcctactggttgccacgctgacct 
781 ------ - --+---------+---------+---------+---------+---------+ 
L K T L P S R E K F T S L L V A T L T Y 
accctagccactgctgtgctttcagqaatttgccgaaqaaagaacagaatttttcatttt 841 _ _ _______ + _________ + _________ + _________ + _________ + _________ + 
P SHe C A F R N L P K K E Q N F S F S 
ccatttttgaaaacttttccaaacaatgtgaaagcacagttagagaagcgaataacgaga 
901 ---------+---------+---------+---------+---------+---------+ 
I FEN F S K Q C EST V REA NNE T 
egc 
961 ----- - ---+---------+---------+- --------+---------+---------+ 
L F Gee K H RAE L Y R R KEF SAC 
1021 ---------+---------+---------+-------- -+---------+---------+ 
T F N S K N G F P R S S K P S Q A A L K 
1081 + --------+-- - --- -- - +- ------ - -+ - --------+---- -- - --t 
LSI V H C Q Q P T P P R V L I Q * 
Figure 3-13 Translation of transcript 1 
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3' end rejoin::; here 
Figure 3-14 Diagram showing spice sites of transcipt 1 
3.7.2 Translated Transcript 2 Band size 488bp 
gggc catggggcggcgggtcccggctctgagacagctgctggtgctggcaatgctggtgc 
---------+---------+---------+---------+---------+---------+ 
A M G R R V PAL R Q L L V LAM L V L 
tga a gcagt c a c agctgcactctccagagttgtcagggtcgcgctgccctgagccctgcg 
61 --------- + -- -------+- - -------+---------+---------+---------~ 
K S Q L H S PEL S G S Rep E P C D 
a cc g c g c g c cggatggtgccctgcgctgccctggccctcgagctggcctcgcccgactat 
l21 ---- - ----+--- ------+---------+---------+---------+---------+ 
C AP 0 GAL Rep G P RAG L A R L S 
c t ctca cctatctccctgtcaaagtaatcccatcacaagctttcaggggacttaatgagg 
:8: --------- +- - - - -----+---------+---------+ - --------+---------+ 
T Y L P V K V IPS Q A F R G L N E V 
tcg taaaaa ttgaaatctctcagagtgattccctggaaaggatagaagctaatgcctttg 
2 4 1 ---- - ---- +-- - --- ---+---------+---- - ----+---------+- - -------+ 
V K I E I S Q S 0 S L E R I E A N A F D 
acaacctcc t c aatc tgtctgaaatactgatccagaacaccaaaaacctgctatacattg 
201 --------- +--- - --- --+---------+---------+---------+---------+ 
N L L N L S ElL I Q N T K N L L Y I E 
a acccgg t g c ttttacaaacctccctcggttaaaatacctgagcatctgtaacacaggca 
361 --------- + - - - - ---- -+--- --- ---+---------+---------+---------+ 
? G AFT N L P R L K Y LSI C N T G I 
tccggaccctcccagatgtttcgaagatctcttcctctgaatttaatttcattctggaaa 
4 21 --------- +-------- -+------ -- - +- ------ --+---------+---------+ 
PeL P D V SKI S SSE F NFl LEI 
tctgtgataact tatacataaccac cataccagggaacgctttccaagggatgaataatg 
4~1 - - ------- . ---- - ---- +- ----- - --+---------+---------+---------+ 
r D N L Y ITT I P G N A F Q G M NNE 
agtccatca c g c tgaaactgtatggaaatgggtttgaagaagtacaaagccatgcattca 
541 - ------- +--------- +----- - ---+--- - -----+- - - ------+---------+ 
SIT L K L Y G N G FEE V Q S H A F N 
atgggacgacgct aat c t c gctggagttaaaagaaaacatctacctggagaagatgcaca 
-+--------- +---- -----+----- - - - - +---------+- -- -- --- -+ 
M TTL I S L ELK E N I Y L E K M H S 
gtggcaccttccagggggccacggggcccagcatcctggatgtctcttccaccaaattgc 
~;~ + -------- +------- --+--- -- - - - -+ -- - -- - - - - +---------+ 
G 1 F Q G AT G PSI L D V SST K L Q 
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aacccggtgcttttacaaacctccctcggttaaaatacctgagcatctgtaacacaggca 
361 ---------+---------+---------+---------+---------+---------+ 
P G AFT N L P R L K Y LSI C N T G I 
tccggaccctcccagatgtttcgaagatctcttcctctgaatttaatttcattctggaaa 
421 ---------+---------+---------+---------+---------+---------+ 
R T L P D V SKI S SSE F NFl LEI 
tctgtgataacttatacataaccaccataccagggaacgctttccaagggatgaataatg 
481 ---------+---------+---------+---------+---------+---------+ 
C D N L Y ITT I P G N A F Q G M NNE 
Agtccatcacgctgaaactgtatggaaatgggtttgaagaagtacaaagccatgcattca 
541 ---------+---------+---------+---------+---------+---------+ 
SIT L K L Y G N G FEE V Q S H A F N 
atgggacgacgctaatctcgctggagttaaaagaaaacatctacctggagaagatgcaca 
601 ---------+---------+---------+---------+---------+---------+ 
G TTL I S L ELK E N I Y L E K M H S 
gtggcaccttccagggggccacggggcccagcatcctggatgtctcttccaccaaattgc 
661 ---------+---------+---------+---------+---------+--------- + 
G T F Q GAT G PSI L D V SST K L Q 
aggcc ctcatcgccacgtcatcctact 
721 ---------+---------+---------+---------+---------+---------+ 
ALP S H G L E S I Q T L I A T S S Y S 
eaetgaaaaetctgcectceagagaaaaattcaccageetaetggttgecacgctgacct 
7 81 ---------+---------+---------+---------+---------+---------+ 
L K T L P S R E K F T S L L V A T L T Y 
accctagecactgctgtgctttcaggaatttgccgaagaaagaacagaatttttcatttt 
841 ---------+---------+---------+---------+---------+---------+ 
P SHe C A F R N L P K K E Q N F S F S 
ecatttttgaaaacttttccaaacaatgtgaaagcacagttagagaagegaataaegaga 
901 ---------+---------+---------+---------+---------+------ ---+ 
I FEN F S K Q C EST V REA NNE T 
egc 
961 ---------+---------+------ ---+---------+---------+---------+ 
Lew S F F I LSI L V P T H F C T Q C 
1021 ---------+---------+---------+---------+-
S R R H F REI S F S C * 
Figure 3-15 Translation of transcript 2 
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3.7.2 Translated transcript 3 - Band size 945bp 
gggccatggggcggcgggtcccggctctgagacagctgctggtgctggcaatgctggtgc 
1 ---------+---------+---------+---------+---------+---------+ 
A M G R R V PAL R Q L L V LAM L V L 
tgaagcagtcacagctgcactctccagagttgtcagggtcgcgctgccctgagccctgcg 
61 ---------+---------+---------+---------+---------+---------+ 
K S Q L H S PEL S G S Rep E P C D 
actgc gcgccggatggtgccctgcgctgccctggccctcgagctggcctcgcccgactat 
121 ---------+-------- -+---------+---------+---------+---------+ 
CAP D GAL Rep G P RAG L A R L S 
ctctcacctatctccctgtcaaagtaatcccatcacaagctttcaggggacttaatgagg 
181 --------- ---------+---------+---------+---------+---------+ 
L T Y L P V K V IPS Q A F R G L N E R 
tcgtaaaaattgaaatctctcagagtgattccctggaaaggatagaagctaatgcctttg 
241 ---------+---------+---------+---------+---------+---------+ 
V K I E I S Q S D S L E R I E A N A F D 
acaacctcctcaatctgtctgaaatactgatccagaacaccaaaaacctgctatacattg 
301 ---------+---------+---------+---------+---------+---------+ 
N L L N L S ElL I Q N T K N L L Y I E 
aacccggtgcttttacaaacctccctcggttaaaatacctgagcatctgtaacacaggca 
361 ---------+---------+---------+------ ---+- - -------+- --------+ 
P G AFT N L P R L K Y LSI C N T G I 
tccggaccctcccagatgtttcgaagatctcttcctctgaatttaatttcattctggaaa 
421 ---------+---------+---------+---------+---------+---------+ 
R T L P D V SKI S SSE F NFl LEI 
tctgtgataacttatacataaccaccataccagggaacgctttccaagggatgaataatg 
481 ---------+---------+---------+---------+---------+---------+ 
C D N L Y ITT I P G N A F Q G M NNE 
agtccatcacgctgaaactgtatggaaatgggtttgaagaagtacaaagccatgcat tea 
541 ---------+---------+---------+---------+---------+---------+ 
SIT L K L Y G N G FEE V Q S H A F N 
atgggacgacgctaatctcgctggagttaaaagaaaacatctacctggagaagatgcaca 
601 ---------+---------+---------+---------+---------+---------+ 
G TTL I S L ELK E N I Y L E K M H S 
gtggcaccttccagggggccacggggcccagcatcctggatgtctcttccaccaaattgc 
661 ---------+---------+---------+---------+---------+---------+ 
G T F Q GAT G PSI L D V SST K L Q 
aggcc etcategccaegtcatcctact 
721 ---------+-------- -+---------+---------+----- - ---+---------+ 
ALP S H G L E S I Q T L I A T S S Y S 
eactgaaaactctgccctccagagaaaaattcaccagcctactggttgccacgctgacct 
781 ---------+---------+---------+--- ------+---------+---------+ 
L K T L P S R E K F T S L L V A T L T Y 
accetageeactgctgtgctttcaggaatttgccgaagaaagaacagaatttttcatttt 
841 ---------+-------- -+---------+--------- +-- - ------+-------- -+ 
P SHe C A F R N L P K K E Q N F S F S 
ccatttttgaaaacttttccaaacaatgtgaaagcacagttagagaagcgaataacgaga 
901 ---------+---------+------ - --+---------+---------+-------- -+ 
I FEN F S K Q C EST V REA NNE T 
egc 9 
961 ---------+---------+---------+---------+------ -- -+- - -------+ 
L H H S G K V A H H H Lee SAG P K A 
1021 ---------+--- ------+---------+---------+---- - -- --+---------+ 
E A ETC H P N Y A R R M D F F Y P D G 
1081 ---------+---------+--- ------+---------+--- - -----+-- ---- ---+ 
H I APe G C Q Q L H E S Q HLP P H G 
1141 ---------+---------+------ - --+---------+---------+---------+ 
C G I H S V T S L H I I H LAP Q C S G 
_201 ---------+---------+---------+--
L C R H L eLL R * 
Figure 3-16 Translation oftranscript 3 
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Full length transcript 2170bp 
- --------------------1 2 3 4 5 6 7 8 9 10 
Exon; 
Variant 1 1750bp 
----- ---
Variant 2 1293bp 
--- -----
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Transcript 1 - 972bp missing 
I Transcript 2 - 877bp missing 
~~~=:;:~~~~~===~~I Transcript 3 - 420bp missing 
Full -length transcript 
Figure 3-18 full-length and truncated LHR transcripts - signifies Real time 
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Quantitation of LHR expression 
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Figure 3-19 Real Time PCR Quantitation of LHR expression levels relative to luciferase 
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Figure 3-20 Hydrophobicity plot of transcript 1 - 393bp 
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Figure 3-21 Hydrophobicity Plot of transcript 2 - 488bp 
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Figure 3 -22 Hydrophobicity plot of band 3 945bp 
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Figure 3-23Hydrophobicity Plot of full-length LH receptor 
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3.8 Discussion 
Alternate splicing is a common phenomenon in seven transmembrane (7TM) receptors. 
Most of the alternate splicing occurs in the C terminus of the 7TM receptor. The extent 
of splice variants depends on the complexity of the gene structure, and in certain cases 
variant isoforms may be species specific (Reviewd by Kilpatrick et a11999) There is 
also evidence of temporal differences in expression of7TM receptor splice variants 
(Minakami et all995). 
Multiple LH receptor transcripts have been detected in mammalian species such as pig 
(Loosfelt et al 1989), rat (Segaloff et a/199O) and avian species like turkey (You et al 
2000). This suggests a common mechanism that may be evolutionary conserved (at least 
between mammalian and avian species) for the production of multiple soluble or secreted 
proteins from a single LHR gene due to alternate splicing to produce proteins which 
contain only the ligand binding domain. 
Sequence analysis of the three spliced transcripts made it possible to determine exactly 
which region of the gene was missing. It revealed in all three cases that the 5' splice site 
was identical and occurred after 964bp with the consensus sequence cgct. The 3' splice 
region differed in all cases. Protein analysis of the transcripts revealed that only the 
smallest transcript, represented by band I continued with the same open reading frame as 
the full-length mouse LHR this transcript lacked the 7 transmembrane proteins, but 
contained the same carboxy terminal. Sequence and protein analysis of transcripts 2 and 
3 were revealed that they both contained a frame shift, whereby the amino acid sequence 
after the 3' splice site differed from that of the full-length receptor. 
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These results are in complete agreement with previous findings from work carried out on 
the pig LHR This group also identified three smaller truncated forms of the receptor and 
in all cases the N terminal (hormone binding region) was identical and intact. Two of the 
variants they identified displayed a frame shift after the point of junction and thus were 
devoid of the putative transmembrane and intracellular domains. The third variant 
however conserved the same open reading frame after point of divergence and although 
it lacked the transmembrain domain, it still contained the putative carboxy terminal 
intracellular domain of the full-length receptor (Loosefelt et 011989). 
At the time this study commenced one of the main objectives was to determine if these 
truncated forms of the LH receptor played an important role in development and 
function of the testes. With the introduction of the LHR knock out mouse however the 
role of the LHR was clearly elucidated. This mouse contained a mutation in the LHR 
resulting in a frame shift, which completely knocked out exon 11, the transmembrane and 
intracellular coding region of the receptor. Complete absence of these regions suggests 
there would be no intracellular signalling initiation second messenger systems. 
Morphologocal analysis of the gonadal and urogenital system of the LHR-null mouse at 
birth revealed that LHR action was not required for fetal development and function as 
there were no differences when compared to normal mice. It would appear that only 
after birth was there a requirement for expression of a functional LH receptor. This was 
apparent with the changes observed in the LHR-null mouse, such as reduction in testes 
size, androgen production and also a reduction in seminiferous tubules, accessory ducts 
and glands. Growth of these structures are known to be androgen dependant events so 
therefore it can be assumed that after birth the Leydig cells become dependant on 
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expression of a functional LH receptor for the production of androgen (Zhang et al 
2001) 
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It is clear that in addition to the full-length LHR transcript, spliced variants of the LH 
receptor are expressed in the mouse testis throughout all stages of development from 
ISdpc. In the early embryonic stages these spliced forms appear to be the dominant form 
of the receptor. Their precise physiological function though cannot as yet be determined 
although there are several possibilities. 
Splice variants of seven transmembrane proteins are often dismissed as the consequence 
of 'leaky transcription' and hence deemed physiologically irrelevant. This could well be 
the case for some variants, especially where the variant is expressed only in low amounts 
and perhaps does not couple to a second messenger system. However the expression 
patterns observed with the truncated forms of the LH receptor are remarkably consistent 
and of high enough levels to be deemed relevant. In addition, because they are present at 
all stages of development from embryo through to adult, it would seem more likely that 
they have a specific function to play. Although full-length receptor didn't appear to be 
expressed in the embryonic testes until 17dpc, this study is not conclusive enough to rule 
out expression in earlier stages completely. The full-length bands are very strong in the 
adult, but this may be more due to the fact that there is a far greater Leydig cell number 
in adult testes. A more sensitive method of detection would have to be deployed before 
ruling out the presence of full-length transcript expression in the earlier stages. 
The truncated forms of the LH receptor gene may play an important role in testicular 
function but the extent of this is as yet unspecified. There has been a suggestion of a 
modulatory role in full-length receptor expression. Down-regulation of plasma 
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membrane receptors by homologous honnones has been found in diverse cell types. In 
testicular Leydig and ovarian luteal cells for example, treatment with LHfhCG decreases 
LH receptor content. (LaPolt et aI1991). Because of this the smaller truncated forms, 
which have a complete hormone-binding region but lack a functional transmembrane 
binding region can act as a sponge binding the hormone and thus preventing binding to 
the transmembrane located receptors. This would act to prevent down-regulation of 
expression of the full-length transcript. Indirectly these truncated forms, through binding 
to free LH may cause an up regulation in full-length receptor expression levels, as it is 
well documented that a decrease in hormone levels cause an increase in receptor 
numbers. 
It is possible therefore that these truncated fonns could modulate Leydig cell activity by 
binding to and reducing the level of available honnone for cellular signal transduction. 
3.8.1 Comparison with FSH receptor spliced transcripts 
Much work has been done on the FSH receptor and like the LH receptor it is known to 
undergo extensive alternate splicing generating multiple transcripts (Simoni et a11997, 
Khan et al 1993) and several of these have been cloned and characterised from the sheep 
testis (Yarney et aI1997). Three isofonns of the FSH receptor were found and one 
form, which was designated FSHR3, was demonstrated to be a single transmembrane 
growth factor type 1 receptor (Sairam et a/1997). Further studies showed that the 
receptor is expressed on the cell surface in transfected cells exhibiting the same affinity 
for labelled honnone as the full-length FSH receptor transcript. 
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The same FSHRJ transcript has also been identified in mouse ovary. It was localised to 
the cell surface using a specific anti body (Babu et a/I999). Expression levels of this 
transcript were shown to be quickly up-regulated upon addition ofFSH, suggesting that 
transcriptional activation mechanisms including splicing are initiated very quickly. This 
also suggests an important role for the FSHRJ receptor especially as its expression levels 
were consistently higher than those observed for the other two isoforms. 
The FSHRJ was found to initiate a different signalling pathway by mediating rapid 
calcium mobilisation (Touyz. et a/20(0) and extracellular regulated kinase activation 
without elevation of cAMP levels (Babu et a/2000). This may serve to stimulate rapid 
cell proliferation required for follicular growth. 
These findings add strength to the possibility of an alternate role for the LHR truncated 
transcripts. Hydrophobicity analysis on the amino acid sequence of the proteins show 
that the 3' region of the truncated receptor transcripts 1 and 3 have the potential to be 
membrane assosciated receptors, this is highlighted by extensive hydrophobic regions 
indicative of transmembrane regions on the hydrophobicity plots. Transcript 2 however is 
more likely to have an extracellular location due to the hydrophilic nature of the entire 
receptor, which is shown on the hydrophobicity plot. 
This work could be taken further by determining whether these alternative spliced 
isoforms of the LH receptor are indeed translated to functional proteins. Several 
approaches can be undertaken such as Western blots of protein extracted from mouse 
testes at different stages of development. An antibody designed to the extracellular 
region of the receptor should identifY all transcripts if they are translated as all have an 
identical extracellular region. 
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The results suggest that the predominant fonns of the receptor during embryonic stages 
are the two smaller truncated transcripts and that the full-length receptor is the 
predominant fonn during adulthood. It is unclear why this should be, however one 
suggestion is that the truncated receptor fonns play an indirect role in fetal Leydig cells 
function by regulating honnone levels and the full-length receptor playa more functional 
role in the adult Leydig cells by initiating the intracellular signalling cascade which leads 
to androgen production. 
3.8.2 Real Time peR quantitation of LHR 
The Real Time peR results show that LHR is expressed in much higher quantities in the 
adult mouse testis than neonate. This is indicative of the functional aspects of the Leydig 
cells at these different times. The requirement for testosterone would be much greater in 
the adult for spenn production. This function is absent in the day 5 testis and by day 20 
this is just prior to onset of pUberty. The results show an increase in LHR expression 
around this time with highest levels in the adult. The primers and probe would detect 
only the full-length and largest truncated transcript as they are complimentary to regions 
missing in the smaller transcripts. In order to assess levels of the smaller transcripts 
quantitatively separate primers and probes would have to be designed around the 3' 
splice regions. 
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Chapter 4 
5 a Reductase 
5 u Reductase Chapter 4 
4 Characterisation of the 5 (l reductase genes, 
type 1 and type 2 
4.1 Testosterone and dihydrotestosterone 
120 
F ormation of the male phenotype is dependent upon the action of testosterone and 
dihydrotestosterone (DHT). Both androgens bind to the same androgen receptor, but 
DHT does so with much greater affinity. Upon binding, the hormone / receptor complex 
transclocates to the nucleus ofthe target cell where it acts as a transcription factor by 
binding to a hormone response element on the DNA. 
Testosterone serves as a metabolic precursor of DHT. The conversion is catalysed by the 
enzyme Sa-reductase. This enzyme exists in two forms named type 1 and type 2 in the 
order of their discovery. The 5 a reductase conversion of testosterone to DHT is 
essential for many androgen actions (Russell and Wilson 1994) 








Figure 4-1 Conversion of testosterone to dihdrotestosterone by enzyme Sa.reductase 
Testosterone is necessary for the differentiation ofWolffian ducts into seminal vesicles, 
epididymis, and ejaculatory ducts whereas dihydrotestosterone is required for the 
differentiation of the urogenital sinus and genital tubercle into prostate, urethra, penis 
and scrotum. The involvement of distinct androgens in these two developmental 
pathways is very clear from evidence of patients with a defect in the formation of either 
testosterone or dihydrotestosterone. 
Mutations that decrease the synthesis of testosterone affect both developmental 
pathways as this androgen serves as a metabolic precursor of dihydrotestosterone. 
(Andersson et aI1996). In contrast, a decrease in the synthesis of dihydrotestosterone 
results in a defect in the virilisation of the urogenital sinus and genital tubercal, although 
differentiation ofWolffian duct progresses normally. (Imperato-McGinley et aI1974). 
The two androgen model of sexual differentiation is also supported by studies in rats 
(Imperato-McGinley et a11985) 
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It is not clear however whether the requirement for two androgens in the formation of 
the male genotype extends across the mammalian class or, indeed, why this need exists. 
One hypothesis to explain the need for two androgens involves the need for signal 
amplification in specific target tissues, this requirement for a stronger signal may arise 
perhaps due to poor vascularisation resulting in diminished hormone delivery, or even the 
presence of catabolic enzymes which specifically degrades one or the other androgen. 
(Penning 1997). 
4.2 Isoforms of 5 a reductase 
There are two isoforms of the Sa.-reductase enzyme (type 1 and type 2) based on the 
chronological order in which their cDNA's were isolated. The enzymes are coded for by 
two separate, although similar, genes. The length of the coding region in both genes is 
just under 1000bp in length and they each contain five exons of very similar size. The 
intronic positions are essentially identical in both genes suggesting that the two enzymes 
arose by gene duplication (Russell and Wilson 1994). In humans the two genes are 
located on different chromosomes~ type 1 is located on chromosome 5 (band pIS) and 
type 2 is located on chromosome 2 (band 23p). The two enzymes also differ in kinetic 
properties. The type 1 form in the rat has a pH optima of 6 - 8 whereas the type 2 form 
prefers conditions slightly more acidic with a pH optima of 4 - S. Type 1 5 a. reductase 
is expressed predominantly in the skin and liver while type 2, on the other hand, is 
predominantly expressed in androgen target areas such as the prostate and genital tissue, 
(lmperato-McGnley et aI1992) 
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4.2.1 Type 2 Mutations 
Analysis of mutations in the encoding genes elucidates why there are two forms of the 
Sa-reductase enzyme and also how much each type contributes to sexual differentiation 
and reproduction in both sexes. Distinct biological roles for each of these S a reductase 
isozymes have become apparent from studies of individuals with naturally occurring 
inactivating mutations or in mice with engineered knockouts of this gene. 
The role of Sa-reductase in human development was assessed through studies of subjects 
in the Dominican Republic in the 1960's (Walsh et aI1974). These individuals possess a 
genetic mutation in the gene encoding the type 2 isoform causing a defect in its 
enzymatic activity. Phenotypically this results in normal development of the epididymis, 
vas deferens and seminal vesicle from the Wolffian ducts, due to the presence of 
testosterone. In the absence of its further conversion to dihydrotestosterone, however, 
development of the prostate and external genitalia from the urogenital sinus is limited or 
abnormal. These individuals form female genitalia externally, but internally they possess 
fully differentiated testes and a normal male duct system. 
Virilisation in these individuals is eventually achieved at puberty with a massive increase 
in serum testosterone levels. Because of the pubertal onset of genital growth this 
condition has been labelled "penis at twelve" syndrome. Interestingly, individuals with 
type 2 deficiency have been shown to have exceptionally high levels of circulating LH 
(about double that found in normal males). These results suggest that a deficiency of 
DHT results in decreased negative feedback at the level of the hypothalamus and/or 
pituitary, resulting in an increase in mean plasma LH.(Canovatchel et a11994) 
5 a. Reductase Chapter 4 124 
Studies in rhesus monkeys using finisteride, a 5 a reductase type 2 inhibitor confirmed 
these findings, as they too developed abnormalities of the genitalia. No developmental 
abnormalities were observed in females. (prahalada et al 1997) 
Forty-five different mutations in the type two gene have been identified to date and each 
one results in defective enzyme activity and dihydrotestosterone production, giving rise 
to an intersex phenotype (Russell and Wilson 1994). These defects in virilisation due 
type 2 mutation suggest that this form of the enzyme plays a more crucial role in male 
development, particularly as areas of highest expression levels of this gene are all 
androgen target sites such as prostate and genitalia. (Wilson et al 1993. 
Male mice carrying a mutation in the type 2 gene are, surprisingly, much less affected 
than humans. Although virilisation is incomplete, it is still distinguishably male. 
(Mahendroo et a/200 1), therefore effect on phenotype is much less severe and marked 
only by a reduction in size of the secondary sex glands. Fertility in these individuals is 
unaffected. Female mice carrying this mutation show no adverse effects on the 
phenotype and they are indistinguishable from wild type mice with both normal 
development and reproduction. It would appear, therefore, that the type two enzyme 
plays a much more important role in males, whereas it has very little importance in 
females. (Mahendroo and Russell 1999) 
4.2.2 Type 1 Mutations 
The type I form of the enzyme appears to playa more important role in female mice than 
the type 2 form. This is evident from studies on mice carrying a mutation in the gene 
encoding the type 1 form. Males develop normally and reproduction is unaffected, 
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whereas females deficient in the type 1 isozyme of steroid 5 a. reductase fail to deliver 
their young at term and thus manifest a parturition defect. Impaired metabolism of 
progesterone in the cervix of the mutant mice in late gestation leads to an accumulation 
of this steroid in the tissue. It would appear that a failure of cervical ripening underlies 
the parturition defect in mice lacking steroid 5 a. reductase type 1 and that this enzyme 
normally plays an essential role in cervical progesterone catabolism at the end of 
pregnancy. (Mahendroo et a/l999) 
4.3 Objectives 
At the time these studies began there was little information about the sequence of the 
Sa-reductase genes in the mouse, or about developmental regulation of these genes in 
the testis. The purpose of this part of the study therefore was: 
1. To determine the sequence of mouse 5 a. reductase type 1 and 2 genes using 
bioinformatics techniques, RT peR and automated sequence analysis. 
2. To establish expression patterns of type 1 and type 2 at different stages of 
development in mouse testes. 
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4.4 Materials and Methods 
4.4.1 Strategy for determining mouse 5 a reductase 
sequences 
Initially when the objectives of this project were proposed, the complete coding 
sequences of mouse 5 a reductase types 1 and 2 were unknown. Only mouse EST's of 
type 1 were available, and rat sequence for type 2. These were obtained from Genbank 
and EST databases. 
Full-length sequences were not required for the proposed studies but partial sequences 
were necessary to design peR primers. 
To identifY the sequences of mouse type 1 and 2 5 a reductase two approaches were 
taken. Using the molecular biology computing programme GCG, it was possible to fetch 
sequences of the two genes of several species from GenBank database and then perform 
a multi species alignment. Sequences from rat, human, monkey and pig were obtained 
from Genbank and lined up to identifY consensus sequences~ areas of highest homology 
between the four species which were chosen for primer design. To ensure there was no 
cross amplification between types 1 and 2 the primer sequences were chosen on the basis 
of having highest homology between species, but little homology between isoforms. The 
rat sequence was Blasted against mouse ESTs and matching ESTs were lined up to 
generate consensus sequence. Blast is a computer programme available on the NCBI 
web page It allows the user to input sequences and it will then find the best-fit match for 
them, in addition it also allows for a pair wise comparison of two sequences. 
5 a. Reductase Chapter 4 127 
For the type I isofonn primers were designed from rat sequence (with highest homology 
to the other species compared) at the 5' end and mouse sequence obtained from EST's 
for the 3' region. 
The same method was applied to the design of 5 a type 2 primers for both 5' and 3' 
regions of the sequence as there was no mouse EST's available for the type two gene, at 
the time this work was carried out. 
4.4.2 Type 1 primer design 
Alignment of rat and human type 1 sequences allowed for identification of homologous 
sequence regions. The 5' primers were designed this way and the initial 3' primer was 
designed from mouse EST sequence. After initial peR amplification using these primers 
and mouse testis eDNA, it was then possible to extract and sequence the bands obtained, 
and then from this sequence, new mouse primers were designed. For type 1 primers only 
rat and human sequences were aligned. as at the time of this project these were the only 
full-length sequences submitted to Genbank. Sequence from four different species was 
aligned for designing the type 2 primers (Fig 4.2) Areas in blue indicate initial primer 
locations and the yellow highlighted area indicates start codon. 
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Type 1 alignment 
ctggttcatacaggagctgccctcgatggcctggccgc rat 
111111111 11111 111111 I 1111111111111111111I1 11111 
tccqagtgccqqoqcgqqcoqcctgggtggtqcaggaqctqccctcqctgqccctqccqc human 
~gtacgagtacattcgtcctgcagccgcgcgactgggcaacctgcctaaccgcgtcctgc 
I I I I II I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I 
tctaccaqtaoqccaqoqagtcoqccccqcgtctccqcaqoqoqcccaactqcatcctcc 
ggccacgcccccgacccaccacgcgcaaaggacgctggttttcccggtcccgaccaggg 
1111 11111 II 111111111 III II I 1111111 1111111 I I 
tgqccatgttcctogtccactaoggqcatcgqtqcttaatttacccgtttctqatqcqag 
gagggaagcccaccctcctggtcacctttgtcttggccttcctgttctgcaccttcaacg 
I I III I I III I I I I 1111 I 11111111111 1111 
gaggaaag cctatqccactqttggcatqtacaatggoqattatqttctqtacctqtaacg 
--+-gc a gcacagagcagatacttgagccagttt gaccc 
II \I I I II I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
gctatttqcaaagcagata cttgagccattqtqcagtgtatqctqatqactgggtaacag 
a ccctg tttcctgacaggctttgccctgtggttagtgggcatggtgataaatatccact 
1111111 II I III 1111 I 11111111 111111111111111111 I 
atcccoqttttc taatagqttttggcttqtgqttaacagqcatgttgataaacatccatt 
cagaccacatcctgaggaatctgagaaaaccaggggaaactggatacaagatacccaggg 
II 11111 11111111 11111111111 II 11111111111 11111 1111 
ca.gatcatatcctaaggaatctcagaaaaccaggagatactqgatacaaaataccaaggg 
gaggcctgtttgaatacgtatctgcagccaactattttggggagctcgtggagtggtgtg 
11111 I 111111111111 1111111111111111111 II II 111111111111 
gaggcttatttgaatacgtaactqcagccaactattttgqagaaatcatggagtggtgtg 
get tgcactggccagctggtc 
I \I I I I I II I I I I I I I I I I II 
gctatqccctqgccagctqgtc 
GTTCCATAGT TCTCAGGAAG GGCAATGGGA 
GGACAAAGCC AAACAAAAAC TAATCCACCA 
TGCCCAGTAG GTCAGAAGCA GGGAGCAATC 
CTGGTAC CC TTACAACAAG AATTCCAOCC 
CTCCTTCAC AGATACATGT CAGCCCTTGC 









Figure 4-2 Human and rat 5 a reductase type 1 sequence alignment 
128 
Rat sequence appears in normal font and human sequence is in bold. Primer locations are 
highlighted in blue and start codon is in yellow 
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Type 2 alignment 
human . ---------- ---------- GCGGCCACCG GCGAGGAACA CGGCGCGATG CAGGTTCAGT 
monkey ---------- ---------- ---------- ----GGCACG AGGCGCGATG CAGGTTCAGT 
p~g ---------- ---------- ---------- ---------- --------------------
rat GAATTCCGGC TGAGGGGCGG CAGCTACCAA CAGATTGTCT 
human GCCAGCAGAG CCCAGTGCTG GCAGGCAGCG CCACTTTGGT CGCCCTTGGG GCACTGGCCT 
monk ey GC AGCAGAG CCCAGTGCTG GCAGGCAGCG CCACTTTGGT CGCCCTTGGG GCACTGGTCT 
pig ---------- ---------- ---------- -------------------- ----------
ra GCCAT AGGT CACATTGGC CACTATGGGG ACCCTGATCC 
human TGTACGTCGC GAAGCCCTCC GGCTACGGGA AGCACACGGA GAGCCTGAAG CCGGCGGCTA 
monkey TGTACGTCGC GAAGCCCTCC GGCTACGGGA AGCACACGGA GAGCCTGAAG CCCGCGGCTA 
pig ---------- ---------- -------------------- ---------- ----------
rat TGTGCI'TAGG GAAACCCGCC AGTTACGGGA AACACACAGA GAGTGTGTCG TCGGGAGTTC 
human CCCGCCTGCC AGCCCGCGCC GCCTGGTTCC TGCAGGAGCT GCCTTCCTTC GCGGTGCCCG 
mo nkey CCCGCCTGCC AGCCCGCGCA GCCTGGTTCC TGCAGGAGCT GCCCTCCTTC GCGGTGCCCG 
pig ---------- ---------- ---------- --------CT GCCCTCCTTC GTGGTGCCCG 
rat CCTTCCTGCC GGCACGCATC GCCTGGTTCC TGCAGGAGTT GCCTTCCTTT GTGGTGTCGG 
human CGGGGATCCT CGCCCGGCAG CCCCTCTCCC TCTTCGGGCC ACCTGGGACG GTACTTCTGG 
mo nkey CGGGGATCCT CGCTCGGCAG CCCCTCTCCC TCTTCGGGCC ACCTGGGACG GTGCTTCTGG 
pig CGGGGATCCT CGCCGGGCAG CCCCGTTCTC TCTTCGGCCC GCCTGCGACT GTGCTTCTGG 
rat TAGGGATGCI' CGCI'TGGCAG CCGCGCTCCC TCTTCGGACC GCCCGGGAAT GTCCTGCTGG 
human GCCTCTTCTG CGTACATTAC TTCCACAGGA CATTTGTGTA CTCACTGCTC AATCGAGGGA 
mo nkey GCCTCTTCTG CGTACATTAC TTCCACAGGA CATTTGTGTA CTCACTGCTC AATCGAGGGA 
pig GCCTCTTCTC CGCACATTAC TTCCACAGGA CATTTGTTTA CTCACTGCTC ACTAGAGGGA 
rat CTCT TTCTC TGCACATTAC TTCCACAGGA CATTTATTTA CTCGTTGCTC ACAAGAGGGA 
human GGCCTTATCC AGCI'ATACTC ATTCTCAGAG GCACTGCCTT CTGCACTGGA AATGGAGTCC 
mo nkey GGCCTTATCC AGCI'GTACTC ATTTTCCGAG GCATTGCCTT CTGCGCTGGA AATGGATTCC 
pig GGCCTTTTCC AGTTGTATTC CTTTTCAGAG GCTTTGTCTT CTGCATGGGA AATGGACTCC 
rat GGCCTTTCCC AGCGGTGCTG TTTTTGAGAG CCACTGCCTT CTGCATAGGG AACGGACTCC 
h uman TTCAAGGCTA CTATCTGATT TACTGTGCTG AATACCCTGA TGGGTGGTAC ACAGACATAC 
monk ey TTCAAAGCTA CTATCTGATT TACTGTGCTG AATACCCTGA TGGGTGGTAC ACAGACATAC 
pi g TTCAAGGCTA CTATCTGGTT TACTGTGCCG AATACCCTGC TGAGTGGTAC ACAGACATAC 
rat TTCAAGCCTA CTACCTGGTT TACTGCGCAG AATACCCCGA GGAGTGGTAC ACAGATGTGC 
human GGTTTAGCTT GGGTGTCTTC TTATTTATTT TGGGAATGGG AATAAACATT CATAGTGACT 
mo n key GGTTTTGCTT GGGTGTCTTC TTATTTATTT TGGGAATGGG AGTCAACATC CATAGTGACT 
pi g GGTTTAGCCT AGGTGTGTTC TTATTTATTT TGGGCATGGG AATCAACATT CACAGCGACT 
rat GGTTTAGCTT TGGTGTCTTC CTGTTTATTC TGGGGATGGG AATCAACATC CACAGTGACT 
h u man ATATATTGCG CCAGCI'CAGG AAGCCTGGAG AAATCAGCTA CAGGATTCCA CAAGGTGGCT 
mon ke y ATATATTGCG CCAGCTCAGG AAGCCTGGAG AAATCACCTA CAGGATTCCA AAAGGTGGCT 
pig ATATATTGCG CCAGCI'CAGG AAGCCTGGAG AAGTCATCTA TAAGATTCCA CAAGGTGGCT 
r a t ACA CTGCG CCAGCTCAGG AAGCCTGGAG AAGTCATCTA TAGGATTCCT CGAGGTGGCT 
human TGTTTACGTA TGTTTCTGGA GCCAATTTCC TCGGTGAGAT CATTGAATGG ATCGGCTATG 
mon key TGTTTACGTA TGTTTCTGGA GCCAATTTCC TTGGTGAGAT CATTGAATGG ATCGGCTATG 
p ig TGTTCACGTA CGTTTCTGGA GCCAATTTCC TTGGTGAGAT CATTGAATGG ATCGGCTATG 
ra TGTTTACGTA TGTCTCTGGA GCCAATTTCC TGGGCGAGAT TATTGAATGG ATTGGCTACG 
human CCCTGGCCAC TTGGTCCCTC CCAGCACTTG CATTTGCATT TTTCTCACTT TGTTTCCTTG 
monkey CGCTGGCCAC TTGGTCCCTC CCAGCACTTG CATTTGCATT TTTCTCAGTT TGTTTCCTTG 
pig CCTTGG CAC TTGGTCCCTT CCAGCACTTG CATTTGCATT TTTCTCGCTT TGTTTCCTTG 
r at CCTTGGCCAC GTGGTCCGTC CCAGCCTTCG CTTTCGCCTT TTTCACACTT TGTTTCCTGG 
h uma n GGCI'GCGAGC TTTTCACCAC CATAGGTTCT ACCTCAAGAT GTTTGAGGAC TACCCCAAAT 
monkey GGCTGCGAGC TTTTCACCAC CATAGGTTCT ACCTCAAGAT GTTTGAGGAC TACCCCAAAT 
p"g GGCTGCGAGC TTTTCACCAT CATAGGTTCT ACGTCAAGAT GTTTGAGGAC TACCCCAAGT 
ra t GGATG AAGC CTTTTACCAC ACAGGTTCT ACCTTAAGAT GTTTAAGGAT TACCCCAAAT 
huma n CTCGGAAAGC CCTTATTC A 
mor.Key CTCGGAAAGC C TTATTC A 
-a t 
Figure 4-3 multiple species alignment of 5 o.reductase type 2 sequence 
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In addition to determining areas of species homology within the coding region, it was 
also important to design primers, which would not bind to 5 a reductase type 1. Once 
primer sequences were chosen they were entered into a blast search to ensure that they 
were complimentary only to the desired region of the rat 5 a reductase type 2 gene . 
Primer sequences have been highlighted in blue. The same technique was applied to 5 
alpha reductase type I sequence for design of5' primers. The 3' primers were designed 
from Mouse EST sequence. 
4.5 peR primers 
In order to check the quality of the cDNA samples used, peR was performed using actin 
primers. Actin is a house-keeping gene and generally expressed in high levels in most 
tissue types. Various combinations of 5 a reductase type 1 and 2 primers were tried in 
order to get optimal amplification. 
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4.5.1 Expected band sizes from primer combinations 
5 alpha reductase type 1 
Total size of rat sequence in GenBank = 1210bp 
From start to stop codon (signified by *) = 800bp 
I 
323 324 336 333 334 
~* ~ ~~ ~ 
325 335 326 
~ ~* ~ 
Figure 4-t Primer postitions for 5 a. reductase type 1 
323/326 .............. 1176bp 333/325 ............... 585bp 
323 /335 ................. 826 334/326 ................ 780 
323/325 ................. 800 334/335 ............... .400 
324/326 ............... 1046 334/325 ................ 360 
324/325 ................. 610 336/325 ................. 600 
324/335 ................. 650 336/335 ................. 640 
333/326 ................ 1000 
333 /335 ................. 625 
Type 1 Primer Sequences 
323 - GTTGGATGAGCTCTGCCTGCT 
324 - GTGCCCGCGCGACCTGCCTGG 
336 - CAGGAGCTGCCCTCGATGGC 
333 - ATGGCCTGGCCGCTGTACGAG 
334 - GCGGTTTATGCTGAAGACTGGGT 
325- ATTCCATTTGTGCTTTAGTG 
335 - CTCCCATGAGCTGAGTCTGTCTGT 
326- CTTGACTGCAGACCCCTTTG 
131 
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All primers were designed from Rat 5 alpha reductase type 1 sequence (GenBank 
accession no AHOO300) Except primer 326 which was designed from mouse EST 
sequence (accession no AA387848) 
4.5.2 5 alpha reductase type 2 
Total size = 1800bp 








351 329 330 
~~ * ~ 
Figure U Primer postitions for Sa. reductase type 2 
327/330 ............... 844bp 
327/329 ................ 750 
328/330 ................ 800 
328/329 ................ 730 
350/351. ............... 570 
350/329 ............... 650 
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I primer were de igned from Rat 5 alpha reductase type 2 sequence (GenBank 
acce ion no L03843 Except primers 350 and 351 , which were designed from new 
mou e equence 
Different primer combinations gave arying results, therefore an optimal combination 
wa cho en for both gene based on a comparison of intensity of bands obtained from 
amecD template. E entiall this consisted of two outer primers for first round 
amplification (x30 c cle ) then two inner primers for nested peR (x20cycles) 
It was nece ary to perform nested peR as expression levels were so low that the bands 
were barel detectable after first round amplification. 
PI P3 P4 P2 
~I Ex2 II Ex3 IL...--l E_X4----11 ~ 
Figure 4-6 Position of primers on 5 a reductase type 1 and type 2 
Qenes 
P R wa al 0 performed on the various templates using actin primers. Detection of 
expre ion confirmed that cD A was of good enough quality to perform further peR' s 
u ing different primer . 
4.5.3 peR 
ach P R reaction contai ned Tris/HCl buffer (75 mM, pH 9.0), (N"fL)2S04 (20 mM), 
Mg b (2 mM), d TP' (0 .2 mM each), 0.2J.l1 Taq Polymerase (2 U per 100 111 ), I III of 
the cD template, primer (200 nM each) and H20 to an appropriate volume. All 
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components, apart from dNTPs. Taq and template were treated by UV -light to remove 
any PCR-derived DNA contamination. peR was performed using cDNA template from 
mouse testes at various ages 
Full details of the PCR conditions are explained in chapter 2. 
Nested peR 
Because the genes of both isoforms were expressed at such low levels it was necessary 
to perform nested PCR on the PCR products from the first amplification. Primers located 
internally to the first set were used for this purpose for both 5a-reductase type 1 and 2. 
The bands from gels containing nested PCR products for both type 1 and type 2 were 
viewed under UV light and the strongest ones were extracted using a scalpel. These were 
then placed into mini columns and centrifuged for 10 mins to obtain a purified PCR 
product. This was then used as a template for sequencing using 
The sequences obtained from bands of both isoforms were entered into a blast search to 
ensure they were in fact specific for 5 a reductase. 
4.6 Real Time peR 
Although it had been established with PCR studies that expression levels of both 
isoforms 5 a reductase in the testis were very low, it was decided to perform quantitative 
analysis to assess whether there was a temporal expression profile through out 
development. Much of the literature has provided evidence that type 2 is the dominant 
isoform expressed in androgen target tissue. With the testes being such a tissue type, it 
5 <X Reductase Chapter 4 135 
was assumed that this isoform would be expressed in larger Quantities, but it was unclear 
if these levels would change at all with the different age groups assessed. 
Expression levels of the 5 a reductase genes were assessed relative to actin. This is a 
house keeping gene and known to be expressed in high levels in most tissues. At the 
time of carrying out these experiments this was the most widely used internal standard 
used for Quantitation studies, however it was later revealed that this may not be the most 
reliable as in some tissues there can be great variability in expression levels and also 
depending on the role of the tissue type of interest there may be genes expressed at much 
higher levels. It was therefore decided that any further quantitation studies performed 
should be relative to an external standard such as Luciferase, this gives a more accurate 
indication of expression levels and this was used further work carried out to determine 
expression levels of the type 1 isoform. This is explained in greater detail in chapter 5. 
In order to quantify expression levels of the 5 a reductase type 2 gene in mouse testes at 
various stages of development, the Real time peR method of quantitation was used, 
which utilised the Taqman peR method of amplification following reverse transcription 
of the isolated RNA (Bustin 2(00). RNA was extracted from whole testis of mice at 
various ages using RNAzol method (Biogenesis Ltd., Bournemouth, UK) RNA was then 
DNAse treated (DNA:free, Ambion Inc, supplied by AMS biotechnology, UK) and then 
reverse transcribed using random hexamers and Moloney murine leukemia virus reverse 
transcriptase (Superscript II, Life Technologies) (method described in detail in chapter 
2). The eDNA was then used as a template for Real Time peR. The primers and probe 
used for Real rime peR were designed from new mouse sequence obtained from the 
previous study. 
I 
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Cycle number at threshold of detection calculated for both genes and results for 5 a 
reductase type 2 were calculated relative to actin at the same stage of amplification, 
these were then plotted on a graph. The cDNA template for the quantitation study was 
mouse testis at various stages of development 
Primers and Probes for Real Time peR 
Gene Forward primer Probe Reverse primer 
pActin GCTTCTTTGCAGCTCCTTCGT CCGGTCCACACCCGCCACC ATATCGTCATCCATGGCGAAC 
5 a reductase T1 GCGCTAGTCTACCTGGAGGGT TCCTGGCTTTCGTGGCCTTCGTG GAAGAGCCCACCATCTGGAG 
5 a reductase T2 CATCCACAGTGACTGCATGC AGGAAGCCCGGAGAGGTCATC AGGTGGCTTGTTACGT 
Table 4-2 Sequence or Real Time peR primers and probes 
Real Time PCR' s were carried out in a 25~ volume using a 96-welJ plate format. 
Components for real time PCR were purchased from Oswel Ltd (Southampton, UK) 
apart from primers and probes, which were purchased from MWG Biotech (Milton 
Keynes, Uk) Each PCR well contained Ix reaction buffer, 5mM MgCb 200~ dNTP's, 
300nM of each primer, 200 nM probe, and 0.02U/JlI enzyme (HotGoldstar) . Reactions 
were carried out and fluorescence was detected on a GeneAmp 5700 system (Applied 
Biosystems, Warrington, Cheshire, UK) 
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4.6.1 Enzyme Activity 
Included in the results section is a graph showing 5 a reductase activity. It is commonly 
known that gene expression levels do not always necessarily represent what is occurring 
at the protein level of activity. During the course of this study additional work was being 
undertaken in the lab assessing the enzyme activity in the mouse testis at different stages 
of development. It was therefore decided that it would be a useful comparison to include 
these results in this chapter. 
Activity of 5 (l reductase activity was measured by determining the conversion of a 
saturating concentration of titrated testosterone to DHT by homogonates of whole testis 
O'Shaughnessy 1991). Substrate and product were separated by thin layer 
chromatography and enzyme activity was expressed as pmoVrninitestis. 
This work was carried out by Professor O'Shaughnessy as part ofa continued project, 
relating to this study. 
4.7 Results 
4.7.1 peR 
Expression levels of both genes were very low and required nested peR in order for 
them to be detectable on a gel. For 5 a-reductase type 1 the most abundant levels of 
gene expression were detected at 020, this was also the case for the type 2 isoform. 
peR amplification using pactin primers on mouse testis cDNA of various ages, gave 
strong bands after amplification at 30 cycles, (figure 4.7) this was a good indication that 
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the cDNA prepared from previously extracted RNA was of good qUality. All bands were 
of the expected length of 380bp 
5 a Reductase type 1 
Initial peR using primers 336 and 335 and amplification at 30 cycles produced only very 
faint bands at expected size of640bp. suggesting low expression levels (figure 4.8). 
Nested peR using primer combination 336 and 325 produced much stronger bands at 
expected length of600bp (figure 4.9). These bands were extracted and purified, then 
sequenced. 
Sequence analysis of bands showed highest homology to rat 5 a reductase type I when 
entered in a blast search. It was possible therefore to align the new mouse sequence with 
known rat sequence. Approximately 500bp of previously unknown mouse 5 a reductase 
type I sequence was obtained using this method. 
5 a Reductase type 2 
Initial peR was performed using primers 336 and 335 and amplification at 30 cycles 
produced only very faint bands at expected size of 640bp. suggesting low expression 
levels (figure 4.10). Nested peR using primer combination 336 and 325 produced much 
stronger bands at expected length of600bp (figure 4.11). These bands were extracted 
and purified, then sequenced. 
The sequences obtained were entered into a Blast search to see what genes they had the 
highest homology with. In both cases they had the highest homology with rat sequence 
of the same gene. By aligning the two sequences ie new mouse sequence obtained from 
primers targeting Sa reductase type 1 and rat Sa reductase type 1, it was possible to 
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assess where abouts in the gene sequence had actually been obtained from. The same 
was carried out for type 2. By doing several PCR's then nesting using different primer 
combinations for each gene, it was possible to gradually extend on the sequence 
obtained. 
Real Time peR 
The real time PCR results demonstrated that 5 a. reductase rnRNA expression levels are 
very low throughout development in the testis. The temporal pattern of expression 
showed that the greatest levels of expression of both genesoccurred at around d25, 
(4.18A and 4. 18B)Figure the peak in expression is only over a very short period of time 
as by d30 levels had decreased dramatically again, these low levels were maintained until 
adult hood and no other peaks were observed. 
Enzyme activity 
Results from the enzyme assay demonstrated that enzyme activity levels were very low 
initially from d 1 and these then gradually increased at d 15, the increase however was 
very slight until d20 - d25 when there was a seven-fold increase. These levels, however 
were not maintained and there was a sharp reduction in activity by d30 until barely 
detectable levels in the adult tissue. (Figure 4.19). These results are a measurement of 
total enzyme activity from both isoforms. 
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peR and Sequence analysis 
380bp 
Figure 4-7 Gel image showing actin bands in selected mouse testis cDNA 
750bp 
Figure U Gel image showing bands of 5alpha reductase type 1, peR 
amplification was with primers 336 and 335 
5 a. Reductase Chapter 4 
720b • 
Figure 4-9 Gel image showing bands of 5alpha reductase type 1, 
after partial nested PCR with primers. 336 I 325 
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600bp 
Figure 4-10 Gel image showing bands from first round PCR using 5 alpha 
reductase type 2 primers 350 I 329. 
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600bp -. 
Figure 4-11 Gel image, showing bands from nested PCR using primers 350 I 351 
The gel images are representative of the accumulation of experiments which were 
undertaken. Each peR was performed 4-6 times for each age group and 6-8 animals 
were used for each age group. 
These bands were extracted from gel using scalpel and purified using mini columns 
(Chemicon International Inc, Temecula). The eDNA obtained was then sequenced using 
ABI Prsim automated sequencer (protocol described in chapter 2). The sequence 
obtained was entered in a blast search and was found to highest sequence identity to rat 
50.- reductase type 1. In addition to the mouse sequence already entered in the EST 
database, there were also several hundred base pairs of previously unpublished sequence. 
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Figure 4-12 Bestf"rt match of new mouse Sa-reductase type 1. and rat Sa -reductase type 1 
equence In red and ital ic repre ent equence obtained from peR product of mouse 
re tl cD equen e In black represents rat equence. Sequence 10 red without 
complimentary black quence repre ent mou e E T sequence from which the fi rst 
primer -were de igned for t p 1 i oform. Sequence in blue represents primer po itions. 
Real time P R primer and probe were de igned from mouse EST which was a fu rther 
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800bp downstream so it was not possible to highlight them. At the time of this project 
there was no mouse 5 a. reductase sequences available in Genbank which is why the 
alignment was performed for both types with known rat sequence. However there is now 
mouse sequence available for both isoforms and a Blast search was later performed on 
both sequences. The best alignments produced showed around 97% homology with 
submitted mouse 5 a. reductase sequences. 
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Type 1 
ccaggggaggcct gtttgaatatgtatcttcagccaacta tttt gggga gctcgtggagt 
:';,~' "')'11-"'"'-3'- gq.-caqc'qg -.- tccaggg.-g gg gtttg.-tc ,t 
I I I 1111111111 1111111111111 
gg---tggtgtggctttgcactggcca gctggtccctccagggcgtggtgtttgctctgt 
, -, , , .. r r ~ : 3 -. " r '.3 - 'd Ja:, -'J 3 J JC.3'j'-.3 ca t ·~·a Jt oJ·J r ,.-·:tc :J3'~3 a J t 
I 
tcaccctgtgtg cactgttcaccagagc g aggcagcatc a t cagtggta cctcga g aagt 
";,,' ,. '-'--ad .,-a3~aaaaa a'- aat ceatt.- 9 t ag-gtg('t t ... · 
I II I I I I I I I I I I I I I I I I I I I I I I I I I I I 
ttgaagattaccccaaaacaagaaaaat a ctaattccattcctgcattagtgtgctgtcc 
~' ~ ., ~ .. l' . r - - • d' "a J 'r: J 3 J t J t : r J t - t t : :.- J q' .J ~ " - • J C : ' 'J a'~': a .- d r 
I 11111111 I III 
atgctgttgtcttccataagctg agtgtctgtcttcc cggtggc tttgctctgagcacat 
;' J3-'~r'" "'tat tctcrtg- - gttcrdtag t aggaaggqeaatgg 
I 1111 1'1111 
acaagtgaattgttttccttatttc tcctg cagttc cat a gttctcagga agg gcaatgg 
..: ~ ..; ..:..;' r t .j' ::.~ - - t- ~ ~ +- 3.3:3 J'j a '::03 a a'J ~ ~ a d :1'- a :3 a a ={ ... t .3.3 t ,- .... .3 ,'" ... a t'J" a ... a·] 
I I I 1111111111111111111 I 
gagggtgttgtcccctggtaaagga c aaagccaaac aaaaactaatccacca tgta c a gt 
. ~ - - .. 3' :' 1-- 'd'l dqqt'-aqaag agggag('aat - agtea gg gee e g.,J'-
I I III 1111 III 111111111111111111 
taggggctacagtgcctagtaggtcagaa g cagggagcaatgagtca tggtgc ctct ggc 
ttctggtaccccttacaacaagaattccaccc 
Figure 4-13 Blast pa irwise alignment of new mouse type1 sequence and submitted 
mouse sequence. Accession no. XM_127470 
New sequence obtained 
Ex2 Ex3 Ex4 
Figure 4-14 5a. Reductase type 1 exon arrangement highlighting area of new 
seQuence obtained 
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4.7.1.2 Sa Reductase Type 2 mouse and rat Sequence alignment 
51 '.:" ,r.-::: ;. '. ~ :~A:CAGGT NT CACATTGGCC 
·'·~:r .. :-r;~, ;.~. '~T:;AT--TS TGr:TTAG p328 
I I I 
~ ,.;;..:.. - '-G 'CA:;7TACGGGA.l\ACA A AGAGAGTGTGTCGTCGGGAGTT 
p.:J50 
III I11111111111111 1111 
:-c;:c;:;::;:--;G7:"G::;GA;'GCTCGCTTGGCAG CGCGCT CCT TTCGGAC 
I II 11I1 I 111I11 I 
• ':"-;'-:7A7T7A':T GTT . GCTCACAA AGGG .• AGGCCTTTCCC 
111111 11111 111111111111 
.; • .; :-:-.:"':'" --::7'\::;7.'\CC7GG:TT}'CTGCGCAGAATACCCCGAGGAGTGGTAC 
I I I I I I I I I I I I I I I I I I I I I II I 
,.r.--: • -i\.'\':'T: -:GSGCGAG.lI.TTATTGAATGGATTGGCTACGCCTTGGCC 
;:",51 
T 'T" - - - -AAA" 
III II III 1111 11I11 I 111111 
~~ ...... 'L:' - • -':-:-:''':'.::' ....... . . :.. -'--,n.:.:.,:'; -';':'T: . ~.r... ~C'TT.z\AGAT ~T':'':' 
AG 
p327 
Figure 4-15 Bestfit match of new mouse sequence and rat Sa-reductase type 2 
= ExonJlntron boundaries 
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Primer are highlighted in blue, start and stop codons are highlighted in yellow and Real 
time peR primer and probe are highlighted in green. 
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Type 2 
; '" 1" ' "" '- )' "1'a '1"3 aq"c -.~g -rtgraggagctgcc tc,·t tgg --
1111 II 1111111111111 I 
ggagttcccctcctgcccgcacg catagcctggttcctgcaggagctgccttcctt tgtg 
···"'J~'~1:j';' - ',' --g~:3~CCJCJ.:t~cctctt ggacct::cgga'JaaaaJ 
II 1111 I II I 
gtgtcggtagggatgctcgcttgg cag c cgcgctccctctttggacctccgg gg aat-gt 
; , 3~" ",'" ,., ·t "g'3 'atta'ttr,'acaga<:jarat tatttac·cat ag 
I III 111111111111111111 I 
gct - gct-gggtctcttctccgca c att a cttccacagag acatttatttactc att - g 
'-"":"3~'J'al~J"'''a''aJ''J; ga c :rctqaa3'J:"ac'J':c-~:'J':d 
I II I II 
ctcaccagag-gcag-g cctttatcagcggtgatctttctgaaag ccactgcctt ctgca 
• ';)d ':: ., "'J'iH)"t,tta r ,' ggtttat gcgrggaataccctgaggagt 
1111 II III 1111 111111111111 
tagggaacggact cctgcaagcctactacctggtttattgcgcggaataccct g aggagt 
;:' ')';; ", ;'Jr"]Jcgt '.J .. tgtcttcttcttta tctJ999at J'J9Jatca 
II 1111 1111 I I I I 
ggtacacagacatgcggtttagcgtcggtgtc ttcttcttta ttctgggga t g g g g a t c a 
, " J ,.). it)'r J r 1 '-aC) qagqaaqcccggagaggtcatc acayya 
I 1111 III 1111111111111111 
acatccacagtg actg catgctgcgccagctcaggaag cccg gag a ggtcatctacagga 
, , ; ';' 1 ; ... ;.,. 3 ''1' 3' gr J': 'r J'J aJc 'a" ': t • : ·t J J'J 'qaga t : a -: J 
I III 1111 II I 
tcccacaaggtggcttgttt acgta tgtgtctggagccaatttcct gggcgaga t tatt9 
.. ' ';~ ". ', •• " 11,·,' - 'ttlqt·t-,ltt cage tttgc tt 
II II III 
aatggatgggctacgctttggccacttggtctgttccagcctttg ctt t 
Figure 4-16 Blast pairwise alignment of new mouse sequence obtained and submitted 
mouse type 2 sequence. Accession no. AB049456 
ew mou e equence I in nonnal font and the submitted mouse sequence is in bold 
New sequence obta ined 
~~I _EX_2~1~1 _EX_3~1 ~1 _EX_4~1~ 
Figure 4-17 50. Reductase type 2 exon arrangement highlighting area of new 
sequence obtained 
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Figure 4-18 mRNA expression levels of A - 5 alpha reductase type 1 and B- type 2 in 
mouse whole testis at various developmental stages. 
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Figure 4-19 Production of CHT by mouse testis at different ages 
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4.9 Discussion 
The results clearly show that both Sa-reductase type 1 and type 2 are expressed in the 
testes, although these expression levels are low and do vary depending on the stage of 
development. Low expression levels were confirmed by ruling out poor cDNA quality. 
The strong actin bands shown in figure 4.7 are indeed confirmation of the cD N A being 
of good quality. The bands obtained after peR amplification suggest that there is 
obviously a high level of sequence homology between species as the primers designed 
from rat sequence were able to successful amplifY the mRNA in mouse testes. 
With the testis being an androgen target tissue, it was assumed that expression of type 2 
isoform of 5 a reductase would be predominant over type 1. The peR results showed 
that both isofonns have very low expression levels as was indicated from the very faint 
bands obtained on gel after primary peR amplification. Only after a nested peR was 
performed were the bands strong enough to visualise and extract from gel for 
purification and sequence analysis. Mouse sequence was obtained for both type I and 2 
genes, which proved that the use of rat primers was successful for amplification. For the 
type I isofonn. 80010 of new sequence within the coding region of the gene was obtained 
and for the type 2 around 85%. These were good results as at that time there was no 
mouse entry of either of the 5 a reductase isofonns in GenBank. Other groups did later 
submit these sequences. 
The peR results showed that both isofonns appear to be equally expressed in the testis 
although initially it was presumed that type 1 would be much lower. Real time peR 
results suggest however that the type 1 isoform is expressed in slightly higher levels than 
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the type 2, The highest levels for both forms being expressed around the time of puberty 
(d25) These results corroborate the findings ofa study done in rats where the highest 
abundance of type 1 isoform was expressed during puberty. Immunolocalisation of the 
protein demonstrated the peptide is present in the interstitial tissue of the testis (Viger 
and Robaire 1995) Northern blot analysis revealed that the type 1 transcript was indeed 
present in the testis at all the stages of development. These levels however were highest 
between days 21 - 28. Quantitation revealed that 5 a type 1 mRNA concentrations rose 
by three fold between days 7 - 21, and plateaued between 21 - 28, then fell sharply 
between days 28 - 35. There after levels remained constant. These findings appear to be 
in complete agreement with the results presented. 
Quantitation of the type 1 isoform was also assessed in a separate study comparing levels 
in normal mouse testis and AR-nuU. These results are presented and discussed in detail in 
chapter 5. 
The Enzyme activity data also appears to be in agreement with the Real Time peR 
quanti tat ion study as it was demonstrated that mRNA expression are at their highest at 
around D25, which was also the case with enzyme activity. Mice reach puberty at 025 
and these results confirm that there is a much greater need for DHT at around this time. 
It is largely required for prostate function and maturity of genitals. Both are requirements 
of successful reproductive function. In humans the conversion of testosterone to DHT in 
androgen target tissue is known to be largely dependant on type 2 isoform of the 
enzyme, whereas in mice it appears that both isoforms are involved. Expression levels 
were very low throughout most stages of development 
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One conclusion, which can be deduced from these results, is that 5 a reductase mRNA 
expression is developmentally regulated. This assumption can be gained from variation in 
mRNA expression levels at different stages. 
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Chapter 5 
Quantitative analysis of 
gene expression in normal 
and mutant mouse testis. 
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5 Quantitative analysis of gene expression in 
normal and mutant mouse testis 
It is well established that various cell types in the body are required to function in 
different ways at different times. This also applies to the cells of the testes. The 
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functional aspects of any cell are entirely dependant on the genes being expressed there 
at anyone given time. Throughout development gene expression may vary in a temporal 
fashion depending on the functional requirements of the cell. This also applies to levels of 
gene expression. This is certainly the case if a particular protein is required in large 
amounts at only specific times and is not essential at others. Production of testosterone 
by the testis is an example of this, whereby it is required in greater amounts at critical 
times throughout development, puberty and in adulthood. LH receptor, StAR protein, 
P450scc and 5a-reductase all play important roles in the androgen production pathway. 
In the mouse, androgen production varies in a temporal fashion. The fetal Leydig cells 
begin production rapidly after Leydig cell differentiation on about embryonic day 12.5-
13 (E 12. 5-13). Androgen levels quickly reach a peak around E 17-18 before declining 
again at birth. Studies have shown that levels of intratesticular testosterone decline after 
birth, becoming very low at around days 10--20. Thereafter, testosterone levels increase 
more than 16-fold between days 25 and 30, and then show a further doubling up to 
adulthood. (O'Shaughnessy et aJ 2002) This decline in testosterone mirrors the 
steroidogenic activity of the testes as measured using in vitro studies. (O'Shaughnessy el 
aI1991). 
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5.1 Androgen Receptor (AR) - null mouse 
The importance of the expression of specific genes can usually be established by 
assessing the phenotype of animals which carry a mutation in that particular gene 
resulting in defective or complete absence of the protein it encodes. Many mouse models 
now exist where specific genes have been targeted and disrupted, or the defect has arisen 
by a natural mutation. One example of this is the AR-null mouse (Tfin). These animals 
have a single base deletion causing a frame shift mutation in the gene encoding the 
androgen receptor (AR). The gene consists of eight exons, of which exons 2-3 code for 
the DNA-binding domain, and exons 4-8 code for the ligand-binding domain (Brinkmann 
et a11989) as a result of the mutation these animals are completely insensitive to 
testosterone. 
Studies using the AR-null mouse allow us to assess the importance of testosterone and 
its receptor during development and for initiation and maintenance of reproductive 
function. The phenotype of the AR - null mouse differs in many ways from that of wild 
type. The testes themselves are greatly reduced in size and they remain in the abdominal 
cavity in an undescended state. These testes are functional in that they do produce 
testosterone (in small amounts), but this is not recognised by the defective receptors and 
therefore cannot generate any signal. It has been shown that serum testosterone levels 
much lower than wild type due to a reduction in testicular androgen production (Charest 
et al 1991) In addition circulating LH levels are much higher. Progesterone is the major 
steroid produced by the AR-null testes and this has been shown to be due to a loss in 
17a -hydroxylase activity (Murphy and O'Shaughnessy, 1991). This is the enzyme which 
converts progesterone to the 17a -hydroxy form, the precursor of androstenedione, 
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which itself is the precursor of testosterone. So it appears that the steroidogenic pathway 
in the Leydig cells is interrupted in these animals and it is arrested at progesterone 
production. (Murphy and O'Shaughnessy 1991) 
It has now been clearly established that testosterone is the major androgen produced by 
the adult Leydig cells and that they are dependant on LH for this purpose, whereas the 
fetal population of Leydig cells produce androstendione, which they do independently of 
LH (O'Shaughnessy et a/2(00). It is possible therefore that these two distinct cell 
populations may be affected in different ways in the AR-null mouse. 
There are several possible explanations for the underlying cause of steroidogenic failure 
in AR-null adult mice. It could be due to: Incomplete adult Leydig cell differentiation, 
decreased Leydig cell precursor proliferation (resulting in greatly reduced cell numbers), 
or even failure of normal adult Leydig cell development. 
Recent studies have characterised the normal pattern of Leydig cell proliferation and 
gene expression during testicular development in wild type mice (Baker and 
O'Shaughnessy 2001, O'Shaughnessy et a/2002). This allows us then to examine 
differences in gene expression between normal and AR-null mice to determine the role 
of androgens in regulating specific gene expression 
5.2 FSHJ3 and FSH receptor knockout mice 
The FSHP and FSHR knockout mice are good experimental models to use in assessing 
the level of dependence that expression of a specific gene has on FSH. FSH plays an 
important role in the development and reproductive function in male mammals. It is a 
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glycoprotein hormone and is released from the anterior pituitary with the gonads as the 
target site. 
FSH is the most important pituitary hormone regulating Sertoli cell function. The FSH 
receptor, like the LH receptor, is a seven transmembrane G-protein coupled receptor. In 
males it is unique and highly specific because the protein is selectively localized on the 
surface of the Sertoli cells. outside the tight junctions (Wahlstrom et a/1983) FSH is 
essential for the normal development and function of Sertoli cells. It consists of an a 
subunit (which is common also to LH and TSH) and a specific J3 subunit. In the FSHJ3 -/-
mouse, the gene encoding the beta subunit has been disrupted resulting in FSH-deficient 
mice. Phenotypically females are infertile due to a block in folliculogenesis prior to antral 
follicle formation. Although FSH is predicted to be necessary for spermatogenesis and 
Sertoli cell growth in males, FSH-deficient males are fertile despite having small testes 
(Kumar et al 1997) 
Another mouse model which lacks FSH signalling is the FSHReceptor (FSHR) knockout 
mouse. This mutant was generated by targeted deletion of exon one of the gene 
encoding the receptor (Abel el aI2(00). Female mice homozygous for this mutation are 
infertile, they have underdeveloped uterine horns and small ovaries compared to normal . 
Males are fertile, although testis size is only about 50010 that of normal mice. 
Both models demonstrate that FSH signa1ling is required for establishment of normal 
testicular size, seminiferous tubule diameter, sperm number and motility, although certain 
differences are discernible in the two models with regard to circulating testosterone 
levels and male fertility. FSHJ3 mutant males are reportedly fully fertile, (Kumar et al 
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1997), while FSHR mutant males exhibit delayed sexual maturity and reduced fertility 
(Dierich el al 1998. Abel et al2000, Krishnamurthy et a12oo0) 
5.3 Objectives 
The aim of this study was to quantitatively analyse expression patterns of Sa.-reductase 
and LHReceptor genes in mouse testis. And to determine the level of dependence 
expression of these genes have on testosterone and FSH by comparing expression levels 
in normal mice to those of AR-null, FSHf3-null and FSHR-null mice. In addition, for 
comparative purposes. the expression patterns ofP450scc and steroidogenic acute 
regulatory (StAR) protein are reported here. 
P450Kc is a key enzyme involved in the synthetic pathway of testosterone, since it is 
the rate-limiting enzymatic step. 
StAR protein is essential for normal steroidogenesis since it delivers cholesterol (a 
steroid substrate) to the inner mitochondrial membrane within the Leydig cells. This is 
also a rate determining step of the androgen production pathway. 
5.4 Materials and Methods 
Variations from previous chapters only are included 
5.4.1 Animals 
AR-null Normal and AR-null (Tfin) mice were bred on a C3h1HeH-IOIIH genetic 
background from stock animals obtained originally from the MRC Radiology Unit, (now 
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the MRC. Mammalian Genetics Unit, Harwell UK). Animals were maintained as required 
under Home Office regulations and were used for study at ages indicated in the text. The 
testes of normal mice undergo final descent to the scrotum at about 25 days whereas 
testes in AR-null mice remain intra-abdominal into adult life. To control for the failure 
of testicular descent in AR-null mice normal animals were surgically rendered 
cryptorchid at 21 days and used for experiments when adult (Murphy and O'Shaughnessy 
1991). Surgical manipulations of the animals were carried out by ProfP.J. 
O'Shaughnessy. Animals were killed at the appropriate age and testes were frozen in 
liquid N2 for subsequent study of specific mRNA levels. 
FSHR-null and FSH(3-null mice were provided by Dr HM Charlton (University of 
Oxford). The testes were frozen in liquid N2 in Oxford and were sent to Glasgow by 
courier frozen in dry ice. The control groups were FHS(3+I- as these mice were 
phenotypically normal. 
5.5 Testis Morphology 
For morphological analysis, testes were incubated overnight in Bouin's fixative and then 
stored in 70010 ethanol. Sections were cut at 2J.111l and were stained with Meyer's 
haematoxylin and eosin. Pictures of sections ofFSH(3- and FSHR-null mice, prepared in 
the same way, were provided by Dr M. Able (University of Oxford). 
5.5.1 Stere%gy 
Testes were embedded in Technovit 7100 resin, cut into sections (20 J.lm thickness) and 
stained with Harris' haematoxylin. Total testis volume was estimated using the Cavalieri 
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principle (Mayhew, 19920), and the slides used to count the number of cells were also 
used to measure testis volume. The optical disector technique (Wreford, 19950) was 
used to count the number of Leydig cells in each testis. The numerical density of Leydig 
cells was estimated using an Olympus BX50 microscope fitted with a motorized stage 
(Prior Scientific Instruments, Cambridge, UK) and Stereologer software (Systems 
Planning Analysis, Alexandria, V ~ USA). Stereology data was provided by Dr Paul 
Baker. 
5.5.2 Reverse Transcription and Real-time peR 
Reverse transcription and real-time PCR were carried out as described in Chapter 4 with 
the exception that luciferase mRNA was added to the tissue at the start of the RNA 
extraction process to act as an external control. This is a method developed by Prof P J 
O'Shaughnessy and described in detail in Baker & O'Shaughnessy (2000). This method 
adds a standard known amount of luciferase mRNA to each sample which acts as a 
control for losses during RNA exraction and for the efficiency of cDNA synthesis. In 
addition. since a standard amount ofluciferase RNA is added to each testis prior to RNA 
extraction then expression of a gene of interest relative to luciferase is a relative measure 
of that gene per testis. In this way levels of gene expression can be compared directly on 
a "per testis" basis. In studies reported here 5ng ofluciferase mRNA (Promega UK, 
Southampton. UK) was added to each sample. 
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Primers and Probes for Real-time PCR 
Sequence for LHR and 5a reductase primers and probes are in chapters 2, 3 and 4 
P450Kc GenBank Accsession AF195119 
Forward Primer - CCAGTGTCCCCATGCTCAAAC 
Probe - TGCCTCCAGACTTCTTTCGACTCCTCAGA 
Reverse Primer - TGCATGGGTCCTTCCAGGTCT 
StAR GenBank Accession L36062 
Forward Primer - CCGGAGCAGAGTGGTGTCA 
Probe - CAGAGCTGAACACGGCCCCACC 
Reverse Primer - CAGTGGATGAAGCACCATGC 
Luciferase (sequence provided by Promega) 
Forward primer - TCGAAGTATTCCGCGTACGTG 
Reverse primer - GCCCTGGTTCCTGTGGAACAA 
Probe - TGTTCACCTCGATATGTGCATCTGT AAAAGCA 
Primer/probe sets for LHReceptor and 5a-reductase were as in Chapter 4. 
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Measurement of LHReceptor and StAR mRNA levels by real-time PCR was carried out 
by technicians within the laboratory as part of a larger study into regulation of Leydig 
cell gene expression. The results are included here for comparative purposes. 
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5.6 Analysis of results 
Results were analysed by analysis of variance. Differences between mouse groups were 
determined using analysis of variance followed by the Neuman-Keul test. Where 
heterogeneity of variance oca.arred values were log-transformed before analysis. 
Differences between AR-null animals and the appropriate control group at each age 
(normal animals when aged 5 and 20 days and cryptorchid animals when adult) were 
assessed by t-tests using the pooled variance. 
5.7 Results 
5.7.1 Testis morphology 
Testis morphology of cryptorchid and AR-null adult mice differed greatly from that of 
normal mice. The diameter of seminiferous tubules was much less, with the difference 
being more pronounced in the AR-null testis (figure 5.1) In addition there was a marked 
reduction in overall testis size compared to normal (control, 112 ± 5mm3 , AR-null, 4.2 ± 
O.3mm3, cryptorchid, 21.6 ± 2.6mm3). The interstitial area appeared to be significantly 
increased although Leydig cell morphology was not clearly different. 
In FSHJ3-I- and FSHR-I- mice tubule size was reduced, and germ cell number appeared 
less. There was no clear effect on the morphology of the Leydig cells. 
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5.7.2 mRNA expression levels 
5.7.2.1 LH Receptor 
The temporal pattern of expression ofLH receptor mRNA was initially low at d5 with an 
increase at d20 and then a marked increase in adulthood (table 5.1 and figure 5.2A). 
Although there was a significant difference in levels between the different ages, there was 
no significant difference between normal, AR-null and cryptorchid mice. 
5.6.2.2 5 a Reductase type 1 
Expression levels of 5 a reductase type I were barely detectable at d5 in both normal 
and AR-null mice. By day 20, however, there was a marked increase in normal testes. In 
AR-null testes there was also an increase in expression levels, although this was 
relatively minor compared to normal mice. At day 20, therefore there was a significant 
difference in expression levels between normal mice and AR-null. In the adult, the 
expression levels were slightly less than those observed at day 20, although there was 
still a significant difference in all three groups with normal testes displaying the highest 
levels and cryptorchid and AR-null expressing significantly lower levels. (Table 5.2 and 
Figure 5.3). Expression in adult AR-null testis mice was significantly less than that in 
adult cryptorchid testis. 
StAR 
StAR expression levels showed a similar profile to that of the LH receptor in that levels 
were low initially at d5 increased about 5-fold at day 20 and then continued to increase 
significantly up to adulthood. There was no significant difference between normal, AR-
null and cryptorchid animals (Table 5.3 and Figure 5.4) 
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P450scc 
The expression pattern ofP450scc was also similar to that of the LH receptor in that 
levels were low at day 5, increased at day 20 and then showed a marked increase up to 
adulthood. In contrast to the LH receptor there was a significant difference in expression 
levels between all three adult groups with normal having the highest levels, followed by 
AR-null then cryptorchid the lowest of the three. (Table 5.4 and Figure 5.5) 
5.7.3 FSH mutant mouse study 
To study the role ofFSH in regulation of expression ofLHReceptor and 5 a reductase 
levels of mRNA encoding these proteins were measured in normal mice and in FSHR-
null and FSHI3-null mice. Levels of 5 areductase type 1 varied between groups but there 
was no overall significant difference between any of the groups (Fig 5.6A) Expression of 
the LHReceptor was unaffected by any of the null-mutations (Fig 5.6B.) StAR mRNA 
expression levels were significantly higher in FSH-I- and FSHR+I- (Fig 5.6C) and 
P450scc levels were lower in the FSHR.-I- testes (Fig 5.6D) 
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Figure 5-1 Light micrographs showing morphology of testes from A- normal, B- AR-null 
and C- cryptorchid adult mice. Bar = SOJ,lm. 
(Image were pro ided by Dr PauJ Baker) 
I 
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LHR mRNA expression levels relative to Luciferase 
Age of mice Nonnal AR -null Cryptorchid 
5 days 1.7 ± 0.3 2.3 ± 0.6 NA 
20days 9.1 ± 1 9.3 ± 1.8 NA 
Adult 41 ± 4 34 ± 8 32 ± 7 
Table 5-1 LHR mRNA expression levels in nonnal, AR-null and cryptorchid mouse testis 
at different ages. 
LHR 
0 50 c=J normal a 
-Q) _ AR-null 
.~ 40 ~crypt 
-cu 4) Q; 0 
... cu 30 L. Ja-S! 4)'-
> () 
Q) ~ 20 
--oJ 
< a z 
a:: 10 
E a a 
0 5 days 20 days adult 
Age of mice 
Figure 5-2 Expression of A - LHR, mRNA levels relative to luciferase in testes of normal 
AR-null and cryptorchid mice. Different letter superscripts indicate a significant 
difference in mRNA levels (P<:O.05). data is represented as mean ± s.e.m. (n = 4-6) 
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5 a.Reductase type 1 mRNA expression levels relative to Luciferase 
Age of -mice Normal AR -null Cryptorchid 
5 days 0.2 ± 0.02 0.1 ± 0.004 NA 
20days 9 ± 3 1 ± 0.5 NA 
Adult 5.5 ± 1 0.3 ± 0.05 1.5 ± 0.5 
Table 5-2 5 a. Reductase type 1 mRNA expression levels in normal, AR-null and 
cryptorchid mouse testis at different ages. 
5 a reductase Type 1 
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Figure 5-3 Expression of 5 a reductase type 1 mRNA levels relatine to luciferase in 
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testes of normal AR-null and cryptorchid mice. Different letter superscripts indicate a 
significant difference in mRNA levels (P<O.05). data is represented as mean ± s.e.m. (n = 
4-6) 
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StAR mRNA expression levels relative to Luciferase 
Age of mice Normal AR -null Cryptorchid 
5 days 4.0 ± 1.1 6.0 ± 1.3 NA 
20days 22 ± 2.1 23 ± 3.2 NA 
Adult 195 ± 37 189 ± 57 134 ± 18 
Table 5-3 StAR mRNA expression levels in nonnal, AR-null and cryptorchid mouse testis 
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Figure 54 Expression of StAR mRNA levels relative to luciferase in testes of normal AR-
null and cryptorchid mice. different letter superscripts indicate a significant difference 
in mRNA levels (P<O.05). data is represented as mean ± s.e.m. (n = 4-6) 
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P450scc mRNA expression levels relative to Luciferase 
Age of mice Normal AR -null Cryptorchid 
5 days 2.2 ± O.5 6.1 ± 2.1 NA 
20days 11 .6 ± 2.2 21 .6 ± 3.5 NA 
Adult 242 ± 35 177 ± 38 90 ± 25 
Table 5-4 P450scc mRNA exp~ssion levels in nonnal, AR-null and cryptorchid mouse 
testis at different ages. All data are exp~ssed as mean SEM 
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Figu~ 5-5 P450scc mRNA levels ~Iative to luciferase in testes of nonnal, AR-null and 
cryptorchid mice. Diffe~nt letter superscripts indicate a significant difference in mRNA 
levels (P<O.05). data is represented as mean:!: s.e.m. (n = 4-6) 
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5.7.4 FSH mutant data 
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Figure 5-6 Figure 5-6 Expression of A - 5areductase type 1, B - LHR, C - P450scc 
and StAR mRNA levels in testes of FSHb+/-, FSHb-l-, FSHR+/- and FSH-I- mice. 
The level of each mRNA species is expressed relative to an external standard 
(luciferase). Within each mouse group, different letter superscripts indicate a significant 
difference in mRNA levels (P<O.05). data is represented as mean ± s.e.m. Cn = 4-6) 
5.8 Discussion 
LHR mR A expression levels were very low in both AR-null and normal testes at 5 
days, but there was an increase of about three fold in both groups by puberty, and by 
adulthood there was a further 4 fold increase in expression levels in all three groups with 
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there being no significant difference detected between any of them. These results 
therefore suggest that LHR mRNA expression is not dependant on androgen action. It is 
worth mentioning however that due to the position of the Real Time PCR primers and 
probe, they may have been amplifYing both fuU-length LH receptor and the largest 
spliced transcript which was discussed in chapter 3. It is possible, therefore, that there 
could be a change in the splice pattern which would not be detected by real-time peR. 
This could be examined directly by normal PCR although that is not quantitative. 
Alternatively, it would be possible to design the primers and probe to span the boundary 
of exons 10 and 11. Only full-length LH receptor would be detected in that case. 
One possible factor controlling LHR mRNA expression may be LH itself. Studies in 
adult male rats using a single dose of the cytotoxic drug ethylene dimethane sulphonate 
(EDS) which is know to eliminate the mature Leydig cell population (Molenaar et af 
1985, Morris et a/1986) demonstrated that repopulation ofJeydig cells occurs after 
three weeks. The ceUs differentiate from existing undifferentiated precursors. It has been 
reported that repopulation is largely dependant upon LH action (Teerds et a/1989). 
After administration of EDS there was a significant depletion of serum testosterone 
levels and a marked increase in serum LH levels (Tena-Sempra et a/1999). A key 
developmental event in Leydig cell differentiation is the acquisition of LH receptors. One 
group observed that early leydig cell precursors express a truncated form of the LH 
receptor (Tena-Sempre 1994 endocrinology 135 1018-1024). Full-length LH receptor 
expression was not detected until 15 days post recovery. (Tena-Sempre 1999) 
Expression of full-length LHR transcript is likely to be inversely dependant on availability 
of LH as levels are high immediately after EDS treatment and then they gradually return 
to normal. High levels ofLH may prevent expression of full-length transcript. 
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Expression levels of 5 a reductase type 1 mRNA show a different pattern to those 
observed for the LHR. At all ages examined levels were very low relative to luciferase 
although they did vary throughout development. Levels were barely detectable in day 5 
testis for both nonnal and AR-null testis, however by day 20 there was a marked increase 
in nonnal testis and only a slight decrease in AR-null testis. The difference in expression 
levels between the two groups at this stage was significant. By adulthood the levels in 
the nonnal testis had dropped slightly, but were still significantly higher than those 
observed for AR-null and cryptorchid testis. Interestingly, though, cryptorchid testis 
showed significantly greater expression levels than AR-null testes. These results strongly 
suggest that expression of 5areductase type 1 mRNA in the prepubertal and the adult 
mouse are dependent on androgen action. In female mice 5 alpha reductase expression 
has been shown to be regulated by progesterone (Matsui et a/2002). As progesterone is 
a precursor of testosterone and the predominant steroid hormone in females then it 
would be safe to make the assumption that expression of 5 a reductase type 1 is an 
androgen dependant event. 
In the FSH mutant mice there was a trend for increased expression levels of 50.-
reductase type 1 mRNA in all three mutant forms compared to nonnal and in particular 
the FSH+/- mouse (figure S.3A), however these levels failed to reach significance after 
statistical analysis. It would appear therefore that regulation of expression of 50.-
reductase type 1 mRNA is independent ofFSH action. 
A rate limiting and acutely regulated step in LH-stimulated steroidogenesis in the gonads 
is the delivery of cholesterol to the inner mitochondrial membrane (Crivello and Jefcoate 
1980) This was shown to be mediated by StAR protein. (Clark et a/ 1994, Stocco and 
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Clark 1996). This assisted transportation is a crucial step for rapid steroid synthesis as it 
is here the P450scc enzyme is situated. Expression of star protein in the adrenals and 
gonads is known to be stimulated through the cAMP signalling pathway and is closely 
correlated with the acute steroidogenic response of these cells to tropic hormone 
stimulation (Stocco and Sodeman 1991. Epstein. and Orme-Johnson1991). The results 
show that there was no significant difference in StAR mRNA expression levels between 
mouse groups at any of the ages examined. This clearly demonstrates that in absence of 
androgen action StAR mRNA expression is unaffected in the testis 
With regard to regulation ofP450scc. several groups have reported that cultured porcine 
Leydig cells increase synthesis ofP450scc after treatment with heG or dibutyril cAMP. 
This has been demonstrated at both protein level (Mason et a/1984) and mRNA (Orava 
et a/1989). Another study corroborated these findings using cultured mouse Leydig cells 
whereby cAMP added to the cutured cells resulted in a two fold increase ofP450scc 
synthesis (Anakawe and Payne 1987). A subsequent study by the same group 
demonstrated that glucocorticoids inhibit both synthesis ofP450scc and decrease steady 
state levels ofmRNA in mouse Leydig cells. This inhibition ofP450scc synthesis by 
glucocorticoids is prevented by the antiglucocorticoid RU-486. Other steroids such as 
progesterone and testosterone have no effect on P450scc (Hales and Payne 1989). 
P450scc mRNA expression was low in day 5 and day 20 testis. levels increased 
dramatically in the adult testis. although a significant difference was detected between 
the three groups. Normal testis showed the highest levels. followed by AR-null and then 
cryptorchid. Our study has shown that normal adult mouse testis expressed significantly 
higher levels ofP450scc mRNA than AR-null testis. this may suggest therefore that 
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testosterone has an indirect regulatory mechanism on P450 mRNA expression in vivo. 
Although these results may appear to be slightly conflicting with the previous studies 
which suggested that testosterone had no regulatory effect on P450scc, it is worth 
bearing in mind that these studies were performed in vitro and the mouse testis cells used 
for culture would have already been exposed to testosterone in vivo. The testis extracted 
from the AR-null mice in our study would have had no previous exposure to 
testosterone. 
On comparison with these results therefore it could be suggested that prior exposure to 
testosterone by the testis is required for optimal expression levels ofP450scc mRNA, 
and that further addition of testosterone has no effect.It appears therefore not to be an 
absolute requirement as the cells will synthesise p450scc in its absence. 
Of the four genes assessed StAR and P450scc displayed the greatest levels of expression 
in adult testis relative to Luciferase. On comparison of results they indicate a clear 
difference in expression levels in two of the four genes examined in normal and AR-null 
testis. These differences however do not become apparent until after day 20. Because 
these genes are all expressed in the Leydig cells of the testis, this suggests that the fetal 
Leydig cell population are developing and functioning independent of androgen action. 
This proposal is strengthened by the fact that gene expression patterns are very similar in 
the normal and AR- null mice and they only start to differ after day 5. In addition Leydig 
cell numbers are also very similar until this stage. This was established in a different 
study (O'Shaughnessy et aI2002b). 
It was also shown that the difference in Leydig cell number becomes much more 
apparent by day 20 where the cell count in AR-null testes was 30% less than that of 
Quantitative analysis of gene expression Chapter 5 175 
normal. The Leydig cells of the AR-null testes do proliferate at puberty through to 
adulthood. but to a lesser extent than normal. Leydig cell number in the adult AR-null 
testis is about 60010 of normal. Expression levels of the LHR were in normal range on day 
5 and day 20. 
In normal mouse testis 5 a reductase type 1 expression levels peaked at day 20, this 
correlates with the onset of puberty and a greater need for the 5 a reduced androgen 
dihydrotestosterone. Compared to normal testis the AR-null the showed a similar peak in 
5a-reductase type 1 expression levels. but overall they were significantly less than 
normal, they did however appear in the normal range at day 5. 
Results from the FSH mutant mouse study showed there to be no difference in 
expression levels of LHR and 5 a reductase. This suggests therefore that mRNA 
expression of these genes is not dependent on FSH action in adult testis. There was 
however a significant decrease in the levels ofP450scc in the FSHR-I- testes, but no 
change in the FSHJ3-I-.It would have been expected that the effects of induced Null 
mutations in the hormone J3-subunit gene or the hormone receptor gene would induce 
similar changes in expression levels of other genes seeing as both these mutant strains 
have reduced testis size and reduced spermatogenesis (Kumar et al 1997, Dierich et al 
1998, Abel et al. 2000). One study however has demonstrated that there are indeed 
phenotypic differences between the two mutants. Leydig cell number is normal in FSHP-
/- animals whereas they are greatly reduced in the FSHR-/- in addition testosterone levels 
are much lower in these animal as is expression of key mRNA species associated with 
steroidogenesis in the affected animals (Baker et a12003) 
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It has been proposed that the difference in Leydig cell number and androgen production 
may be due to the presence of constitutive activity within the FSHR in the absence of 
hormone ligand (Baker et a12(03)or that some other ligand may be acting on the 
receptors in the FSHJ3-I- mice. If this is the case then it would suggest that P450scc 
expression does have some dependance on FSH receptor activation, however this cannot 
be the sole modulator as expression levels are merely reduced and not entirely absent. 
With regard to FSH, according to the quantitation studies on LHR and 5a-reductase 
type I mRNA in the testis, it seems that both these genes are expressed in the adult 
mouse testis independent of FSH action. Results suggest that as all of the genes 
examined are known to be expressed in the Leydig ceUs of the testis, function and 
regulation of the fetal population appears to occur independently of androgen action, 
whereas it is necessary for optimal function in the adult population. 
In summary, androgen action is only required for expression of 5 alpha reductase type 1 
mRNA in both prepubertal and adult testis. The other three genes are expressed 
independent of androgen action, however it would appear that for optimal expression of 






It is clear that there are many factors involved in the differentiation and functional 
regulation of the testis. This project has examined only a few of these factors, although 
each may play an essential role in testis development. In the wider picture, some of the 
genes expressed in the testis may only contribute in a temporal fashion and expression 
may only be required for a short, but crucial time point. This would include the genes 
like SRY, WNt4 and SOX9. Mutations in these genes whether in mice or in humans have 
shown that they do play an essential role in sexual differentiation of the testis as their 
absence leads to incomplete virilisation and in some cases fonnation of a female 
phenotype. Mouse models are an excellent tool for further understanding the importance 
of the role a particular gene may play. Absence of expression of one gene can also lead 
to various effects on the expression of others. Comparing the expression pattern of 
various genes in nonnal mice with the same genes in mutant animals allows us to assess 
in greater detail the effect of absence of protein and how this may effect several aspects 
of the phenotype as has been clearly shown in the AR-null and hpg mice. 
6.1 LH receptor 
The initial objectives of the LH receptor project were to characterise and sequence the 
variant forms of the receptor, these objectives were largely met. In chapter 3 the results 
showed clearly that there are four transcripts of the LH receptor present in mouse testis 
in various combinations at different stages of development. The presence and abundance 
of all four transcripts varied throughout the different developmental stages examined. At 
15 + 16dpc there was no full-length receptor detected and only two of the shorter forms 
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were present. These findings would suggest either a) that androgen production is 
occurring independently of LH action at this stage; or b) That LH can act through the 
truncated receptors. 
Evidence from other studies would suggest that the fetal Leydig cell population 
differentiates and initially functions in the absence ofLH action. (O'Shaughnessy et al 
1998). This has been demonstrated in the LHR - null mice. Androgen production occurs 
normally during fetal development independent of LH action. This coincides with the fact 
that although steroidogenesis by the testis is occurring, it is relatively low at this time 
period. During 17 - 18dpc there is abundant expression of the full-length receptor 
transcript, which may be in response to the increased requirement for androgen 
production. This would further amplifY the intracellular mechanisms occurring in the 
androgenic pathway. At this stage in the mouse androgens are required for differentiation 
of the Wolffian ducts and external genitalia. This is a crucial time point in the mouse, and 
one which requires greatly increased androgen levels. This would suggest that the fetal 
Leydig cells are now undergoing androgen production via the intracellular signalling 
cascade initiated by LH receptor and ligand binding, whereas previous to this time 
androgen production was independent ofLH intervention. (O'Shaughnessy et a/1998). 
Results from this study (in Chapter 3) show that the full-length receptor transcript is 
undetectable from 19dpc - d25. This does not mean however that it is not being 
expressed, but merely that levels may be expressed in much lower abundance than the 
other transcripts, and they were too low to be detected by the molecular methods used 
for this study. This also coincides with a decrease in testosterone levels during this 
period (O'Shaughnessy et aI2(02) 
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Expression of the truncated forms of the LH receptor are more abundant between the 
time of birth and the onset of puberty, which in the mouse occurs between d25 - d30. 
Form day 5 it is highly likely that the detection of any LHR transcripts is due to their 
presence in the adult population of Leydig cells, as it has been shown that the fetal 
population are no longer functionally active from this stage (Habert and Picon 1982, 
Tapanainen et a/ 1984, Habert and Brignaschi 1991). At day 25, this is the onset of 
puberty in the mouse, and is another time point in development when there is a much 
greater need for testosterone. The fetal Leydig cells are no longer active at this stage and 
detection of the LH receptor transcripts is from the adult population only. 
These experiments were performed between 2-4 times on different animals for each age 
group examined. This was to ensure consistency and reproducibility of the results 
obtained. Consistency of expression of the various transcripts at specific time points was 
observed and it is possible therefore that these truncated forms of the receptor may have 
distinct biological roles. Analysis of the protein hydrophobicity plots performed on all 
four receptor forms revealed structural differences between them. 
A study by Inhae and Tae (1991) demonstrated that both the extracellular region of the 
receptor and the transmembrane region can function independently in their own right. 
They showed this by constructing a mutant form of the receptor. One consisted of exons 
1-10 only and the other consisted of exons 1 + 11 only. Through transfection into an 
expression vector they were able to produce the truncated proteins. Cells expressing 
these receptor forms as well as ones expressing full-length LH receptor were subjected 
to two different tests to determine whether either of the truncated forms were 
functionally viable. One test assessed binding efficiency and the other determined ability 
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to initiate cAMP production. Results showed that in a binding assay the truncated 1-10 
fonn was able to bind hCG with just as high an affinity as the the full-length receptor 
cells. This suggests therefore that the extracellular region of the receptor can bind to 
ligand independently of the transmembrane region. This receptor fonn however was 
unable to initiate cAMP production in another assay 
This adds further weight to the possibility of the truncated fonns of the LH receptor 
having a functional relevance perhaps as a soluble receptor fonn which binds honnone 
but does not initiate signalling cascade. 
6.2 5 a Reductase 
From the results in chapter 4, we clearly see that expression of the two 5 (l Reductase 
enzymes in the testes is very low throughout most of development. There are however 
two distinct peaks of increased expression and these occur coincidently at crucial time 
points in the mouse development. The first occurs at embryonic stages E17-E18 for a 
few days and the second occurs around about time of puberty. 
This adds convincing evidence to the concept that the major effect of 5 (l reductase is to 
amplify the androgenic signal at specific time points when it is required more. This is 
further corroborated by the fact that male mice with apparent absence of 
dihydrotestosterone as the result of targeted disruption of the genes for both type 1 and 
type 2 enzymes have fully fonned internal reproductive system and only slightly affected 
external genitalia (Mahendroo et aI2(01). These findings suggest that virilisation is 
occurring as a result of testosterone action alone and it would appear that 5 (l reductase 
plays a less crucial role in the mouse as its absence (and therefore lack of 
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dihydrotestosterone) can easily be compensated by testosterone This finding is in 
contrast to the profound impairment in virilisation in human males with a 5 a. reductase 
type 2 deficiency. 
One explanation for difference in the two species is that in humans, prostate testosterone 
levels change very little with the inhibition of 5 a. reductase (McConnell et a/1992). In 
mice however, disruption of the 5 a. reductase genes result in prostate and testicular 
levels of testosterone levels of more than one hundred fold greater. (Mahendroo et al 
200 1) This is clear implication that very high levels of testosterone can perform the same 
role as low concentrations of dihydrotestosterone, thus although dihydrotestosterone 
may perform some as yet unidentified unique functions (Hsiao et a/200 1), its major role 
in males is to greatly amplify a weak androgen signal. 
6.3 Sequence analysis of the 5 a Reductase genes 
As mentioned previously in chapter 4 at the time this study was undertaken there was 
very little published mouse sequence of either type 1 or 2 form of the 5 a. reductase 
genes. The techniques applied in order to obtain new mouse sequence for both type 1 
and type 2 genes proved successful and almost all of the sequence within the coding 
regions of both genes was obtained. This success was in part due to the high species 
homology enabling the design of rat primers, which were able to amplify mouse 
sequence. In addition molecular biology computer programmes such as BLAST allowed 
for identification of the sequence obtained from extracted bands of peR products. 
Unfortunately by the time this project was completed, there was already submissions of 
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extended mouse sequence for both type 1 and 2 5 a reductase to GenBank, however 
initial objectives were met. 
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6.4 Quantitation of gene expression in normal and AR-
null mouse testis 
Loss of a functional androgen receptor due to a mutation in the gene encoding it clearly 
has detrimental effects on the phenotype of male mice. The result is 
pseudo hermaphrodism, whereby there is a loss of internal reproductive duct systems and 
failure of testicular descent. This confirms that differentiation of the Wolffian duct and 
testicular descent are both events which rely heavily upon androgen action. In addition to 
the developmental defects. spermatogenesis is also disrupted with a loss of normal germ 
cell development although it is as yet unclear how much of this is due to the cryptorchid 
state of the animals and how much is due directly to loss of androgen receptors. In 
addition to these defects, it has been shown that adult Leydig cell numbers are greatly 
reduced in AR-null mice, with total cell number in AR-null testis being only 60% that of 
normal. (O'Shaughnessy et a/ 2002b) This is a clear indication that proliferation is also 
dependent, either directly or indirectly on androgen action. 
With the gene expression patterns, loss of androgen action appears to have little effect 
on LHR mRNA levels, cryptorchidism had very little effect also with the Real time peR 
quantitation results showing no significant difference between the normal, AR-null and 
cryptorchid adult testis. This would suggest that regulation of expression of this gene 
occurs independently of androgen action, either that or some compensatory mechanism 
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has been initiated and this then regulates expression levels, keeping them within the 
normal range. 
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Expression levels of 5 a reductase type 1 are similar in all three groups at day S. In mice, 
the fetal Leydig cell population persists after birth but becomes subordinate to the adult 
population which begins to differentiate sometime between days 7 and 10 after birth 
(Vergouwen et al. 1991 ~ Baker et aJ. 1999~). These expression patterns therefore are 
from the fetal population of Leydig cells. This suggests that the fetal cells function 
independant of androgen action. 
Chapter 5 concentrated on gene expression in normal and mutant mouse testis. The 
mutant strains lacked either androgen action due to defective receptor, or FSH action 
due to absence of specific 13 unit or defective receptor. Of the four genes assessed in this 
chapter LHR and StAR mRNA expression occurred independently of androgen action. 
Evidence of this is presented by the lack of variation in expression levels between the 
normal, cryptorched and AR-null mouse groups assessed. In contrast, however, Sa 
reductase type 1 and P450scc do show variation in mRNA expression levels between 
groups. Normal mouse testis had the highest levels at day 20 and adult stages, with the 
other two groups being significantly lower. P450scc plays an important role in the 
androgen production pathway (discussed in detail in chapt 1) and likewise 5 a reductase 
in the production of the more potent androgen dihydrotestosterone. The differences in 
expression levels of these genes between mouse groups is therefore suggestive that 
certain steps in the androgen pathway may in fact require androgen action for 
optimisation. 
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All of the results in this study have centred around expression of genes in various mouse 
strains in a temporal fashion. For a more complete picture it would be desirable to assess 
the protein levels as gene expression levds dont always correlate with abundance and 




AMH .................................... Anti mullerian hormone 
AR-null. ................................ Androgen receptor null 
CAIS .................................... Complete androgen insensitivity syndrome 
cAMP ................................... Cyclic adenisine monophosphate 
cDNA. .................................. Complimentary deoxy ribonucleic acid 
DHT .................................... . Dihydrotestosterone 
dNTP'S ................................. Deoxynucleoside Triphosphates 
dpc ...................................... . Days post coitum 
DTT ...................................... Dithiothreitol 
EST's .................................... Expressed sequence tags 
FSH .................................. ..... Follicle stimulating hormone 
Hpg ....................................... Hypogonadal 
LH. ...................................... . Lutemlsmg hormone 
PCR. ...................................... Polymerase chain reaction 
P450scc .. ............................... . P450 side chain cleavage 
PAIS ...................................... Partial androgen insensitivity syndrome 
StAR. ................................... . Steroid acute regulatory protein 
TBE ... .................................... Tris-Borate EDT A. 
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7.6 Materials and Methods 
Sonication - A method used for the disruption of cells and tissue using a metal probe 
which emits high frequency ultrasound vibrations. Cell membranes are ruptured as a 
result of this and the cell contents released. 
Ultra violet (UV) light treatment - UV treatment to water or any other solution will 
destroy any contaminating DNA as it cross links [which?] chemical bonds to form in 
DNA. The exposure thus interrupts normal DNA replication. 
Denhardts Reagent - this is generally made up as a x50 stock solution and is usually 
diluted ten fold into prehybridisation buffer 
X 50 Denhardts contains; 
5g Ficoll (type 400 Pharmacia), 5g polyvinylpyvrolidone, 5g bovine serum albumin and 
H2O to 500 mls. 
XIO stock ofTBE Buffer 
Measure -800ml H20, Add 108g Tris base. 55g Boric acid Add 9.3g EDTA Adjust 
volume to IL with additional distilled dH20. This is diluted to a working concentration 
ofXO.5 
Bioprime Labeling kit - GibcolBRL 
DNA free - Ambion Inc, supplied by AMS Biothech, UK 
Luciferase mRNA - Promega, Southampton, UK 
Minicolumns - Chemicon International Inc, Temecula 
M-ML V Rreverse transcriptase - Gibco, Paisley 
PCR primers - MGW Biotech, Ebers-Berg, Germany 
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Real time peR primers and probes - Primer Express, Aplied Biosystems, Warrington, 
UK 
RNAzol - Biogenesis Ltd, Bournmouth, UK 
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